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Neural stem cells (NSCs) are multipotent cells capable of differentiating into 
neurons, astrocytes and oligodendroctyes in response to developmental signals. 
Although they do not have the required gene expression patterns to identify a 
differentiated stage, their chromatin will be epigenetically modified to achieve 
distinct stages of differentiation. The most abundant epigenetic modification in 
vertebrate DNA is methylation, which is normally associated with transcriptional 
silencing. This occurs primarily through recruitment of methyl-CpG binding proteins 
(MeCPs) to methylated DNA, which further recruits chromatin-modifying activity, 
resulting in the formation of repressive chromatin. 
Additionally, another protein from the MeCP family, Mbd3 does not itself bind 
methylated DNA but acts as a scaffold protein of the Nucleosome Remodelling and 
Deacetylation complex, NuRD. Previous evidence has outlined a central nervous 
system function for the MeCPs, but MeCPs mutant mice are viable and fertile, with 
the exception of MeCP2 deficient mice. However, Mbd3 has a role in early cell fate 
decisions during development, and Mbd3 mutant mice do not survive post-
implantation stage. 
In my thesis I have investigated the role of the two different mechanisms of 
epigenetic silencing: Methyl-CpG binding protein-dependent repression and 
chromatin remodelling activity in the neural stem cell system. I hypothesised firstly, 
that MeCPs may have a redundant role in neural stem cell function. Secondly, that 
the effect of lacking Mbd3 in neural stem cells may be different and more severe 
than the absence of the methyl-CpG binding proteins. The approach to investigate 
these hypotheses consisted of a first stage in the study of the neuroectoderm 
differentiation capacity of ES cells lacking one MeCP, Kaiso, followed by studying 
the function of neural stem cell (NS) lines derived from the cortex of mice lacking 
the MeCPs Kaiso, MeCP2 and 1\4bd2. I have found no defects in proliferation or 
self-renewal of triple null NS cells. Additionally, although triple null NS cells 
present a normal astrocyte differentiation, they present a delay in neuronal 
differentiation, a defect that is only visible at early differentiation stages. Therefore, 
these proteins are dispensable for viability and differentiation of NS cells ex vivo. In 
contrast, I have found that Mbd3 is important for differentiation of neuroectoderm in 
culture, as Mbd3 null ES cells differentiate into neurons at very low frequency but do 
not differentiate into astrocytes. Moreover, Mbd3 is essential for establishment 
and/or maintenance of ES óell-derived NS cell lines. Thus while there is no evidence 
for a role of three MeCPs in NS cell maintenance or differentiation, the activity of 
the NuRD co-repressor complex is important for both properties. 
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1. 1 Chromatin compaction 
Chromatin structure in eukaryotic nuclei is highly ordered. DNA is wrapped 
around histone proteins, forming the nucleosome. The nucleosome consists of 146 
base pairs of DNA wrapped around a core histone octamer which consists of two 
molecules each of histories H2A, 142B, H3 and H4 (Kornberg and Lorch, 1999; 
Luger et al., 1997). Additionally, the linker histone Hi binds to nucleosome core 
particles and organizes the linker DNA on either side of the nucleosome to facilitate 
the folding of chromatin into a -'30 nm fiber in vitro (Bednar et al., 1998; Thoma et 
al., 1979). 
To gain access to the highly compacted structure of the chromatin, there are in 
the cells chrornatin remodelling activities that can be divided in two major 
mechanisms: The first one relies on the use of the energy derived from ATP 
hydrolysis to remodel nucleosomes (Kadonaga, 1998; Travers, 1999; Tsukiyama and 
Wu, 1997; Varga-Weisz and Becker, 1998). The other mechanism involves covalent 
modification of the histone tails of the nucleosome. These modifications include 
methylation, acetylation, phosphorylation, ubiquitylation, sumoylation and ADP-
ribosylation. The acetylation of lysine residues on histone N-terminal tails is 
catalyzed by histone acetyltransferases (HATs) (Woiffe and Pruss, 1996) and is 
generally associated with transcriptional activation. In contrast, deacetylation carried 
out by histone deacetylases (HDACs). (Pazin and Kadonaga, 1997) is generally 
associated with transcriptional repression. Both groups of proteins function in 
different large multiprotein complexes, where sequence-specific DNA-binding 
proteins target them to specific genes, leading to chromatin modification. 
1. 2 NuRD 
The NuRD (Nucleosome Remodeling and Histone eacetylation) co-repressor 
complex (Wade et al., 1998; Xue et al., 1998b; Zhang et al., 1998a) is a co-repressor 
implicated in silencing in mammals, flies, nematodes, and plants (Ahringer, 2000; 
Bowen et al., 2004). In vertebrates, NuRD is a multi-subunit protein complex 
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containing both histone deacetylase and nucleosome-dependent ATPase subunits. In 
mammals NuRD plays a role in cell fate decisions by transcriptional silencing 
mechanisms in B-cell (Fujita et al. 2004), thymocyte (Hutchins et al., 2002) and 
erythroid development (Hong et al., 2005; Rodriguez et al., 2005). 
The largest subunit in the NuRD complex is Mi-2, a member of the 
SWI2/SNF2 helicase/ATPase family (Eisen et al., 1995; Tong et al., ; Zhang et al.) 
that also associates with histone deacetylases. in mammals there are two highly 
similar proteins Mi-2a and Mi-2f3 transcribed from two different genes Mi-2a and 
Mi-213 (Seelig et al., 1996). In the NuRD complex, the predominant form is Mi-213 
(Feng and Zhang, 2003; Zhang et al., 1998a). Mi-2P contains two PHD (plant homeo 
domain)-zinc finger domains, two chromodomains and a SWI2/SNF2-type 
ATPase/helicase domain. 
Another subunit consists of a four-unit complex formed by two histone binding 
proteins, RbAp46 and RbAp48, and two histone deacetylases, HDAC1 and HDAC2. 
This complex is also present in the co-repressor complex Sin3. Hdac 1-deficient ES 
cells have slow growth, and Hdac 1-deficient mice die by 9.0 dpc (Lagger et al., 
2002). A compensation effect of Hdac2 and Hdac3, which are upregulated in Hdacl 
deficient mice, could explain this late embryonic lethality. 
There is a major polypeptide of approximately 70-8OkDa called Mta2, that is 
thought to have a role in modulating histone deacetylase activity in NuRD (Zhang et 
al., 1999b). MTA2 is 65% similar to the metastasis associated protein MTA1, which 
has also been reported to associate with NuRD (Xue et al., 1998a);(Mazumdar et al., 
2001). Further, MTA3, the shorter isoform translated from the MTA3 gene in 
humans, does also form part of NuRD (Fujita et al., 2003a). It is currently believed 
that individual members of MTA family associate with NuRD depending of the, 
location and function (Bowen et al., 2004). 
The smallest component of the NuRD complex is the MBD3 protein (Wade et 
al., 1999; Xue et al., ; Zhang et al., 1999a). MBD3 was originally identified in mice 
and humans as a protein containing a region with high homology to the methyl-CpG 
binding domain (MBD) of MeCP2 that, unexpectedly, did not specifically bind 
methylated DNA (Hendrich and Bird, 1998). Mammalian MBD3 does not bind 
methylated DNA because it has two amino acid residues different than the rest of 
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MBD containing proteins that eliminate the methyl-CpG binding activity (Ohki et 
al., 2001; Saito and Ishikawa, 2002). 
Nevertheless, the NuRD complex can interact with methylated DNA by 
association with another methyl-CpG binding protein, MBD2 (Feng and Zhang, 
2001; Ng et al., 1999). The transcriptional repressor complex formed by Mbd2 and 
NuRD complex was originally named MeCP1 complex (Meehan et al., 1989). 
Mbd3 is ubiquitously expressed from morula to the egg cylinder stage (6.5 
dpc) and is localised into the nucleus. Maternal Mbd3 protein is expressed until the 
morula stage. The development of Mbd3 null embryos is morphologically normal 
until 5.5 dpc, when they display a runted morphology with a reduced number of 
pluripotent Oct4 positive cells. This population will be gradually lost in time 
synchrony with the lost expression of maternal Mbd3, since a majority of diapaused 
Mbd3 blastocysts fail to express Oct4. By 5.5 dpc, Mbd3 null embryos fail to 
initiate rapid proliferation, cavitation and distal displacement of 1CM population, 
together with a failure of extraembryonic development. Thus, Mbd3 is required for 
transition of pluripotent cells in pen-implantation embryos. Hence Mbd3 is 
necessary for maintenance of pluripotent population (Kaji and Hendrich, 
unpublished). 
Mbd3 ICMs fail to downregulate expression of a number of preimplantation 
specific genes, possibly contributing to the failure of embryonic development beyond 
5.5 dpc. This gene missexpression correlates with inappropriate expression of those 
genes in Mbd3 ES cells (Kaji et al., 2006; Kaji et al., unpublished). This aberrant 
expression is accompanied by increased levels of histone acetylation, providing 
evidence of a failure of histone deacetylation. On the other hand, expression of 
Dppa3, an early marker of primordial germ cells (also known as Pgc7 or Stella) 
(Saitou et al., 2002; Sato et al., 2002) is inappropriately silenced in Mbd3 ES cells 
(Kaji et al., 2006). 
While Mbd3 1CM cells fail to mantain expression of Oct4, Mbd3-deficient ES 
cells are viable, and show persistent Oct4 expression when induced to differentiate in 
vivo and in vitro. Mbd3 ES cells show no difference in gene expression of NuRD 
subunits compared with wild type ES cells but their protein levels are reduced for 
Mtal, Mta2 and RbAp48, although the levels of Hdacl are not changed. 
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Additionally, Mtal, Mta2, Hdacl and Mbd3 can not be coimmunoprecipitated in 
Mbd3 ES cells. These facts indicate that Mbd3 is necessary for the formation of 
NuRD complex. 
There are three independent Mbd3 isoforms in the NuRD complex differing in 
their N-termini: Mbd3a, b, and c (Kaji et al., 2006; Zhang et al., 1999b). Mbd3b is 
the major isoform in ES cells, but Mbd3a and Mbd3c are also detectable (Kaji et al., 
2006). Mbd3b is also the prevalent isoform in NuRD of proliferating HeLa cells 
(Zhang et al., 1999b) and in embryonic neural cells (Jung et al.,2003). Interestingly, 
the ratio between Mbd3a and b will vary during brain development and hence it may 
indicate a role for Mbd3 in development. Mbd3 is expressed in the embryonic 
forebrain, including cortical neuroepithelia, striatum and hippocampus. These 
regions show expression of Mbd3 during adulthood though at decreased levels. 
Meanwhile, olfactory bulb and cerebellum will show an increase in levels of Mbd3 
during adulthood (Jung et al., 2003). 
Mbd3 in Xenopus binds to methylated DNA and is essential for embryonic 
development (Wade et al., 1999). xMbd3 is highly expressed during embryogenesis, 
specifically in the developing eye, brain and bronchial arches. Concordantly, partial 
inhibition of xMBD3 affects the eye formation and brain development. This eye 
phenotype occurs also with the over expression of xMbd3. When xMbd3 is almost 
completely depleted, the embryos are arrested at the late gastrula or early neurula 
stages, in concordance with Mbd3 deficient mice (Iwano et al., 2004). 
1.3 DNA methylation 
DNA methylation in vertebrates is achieved by the transfer of a methyl group 
to cytosine by a DNA methyltransferase to the 5 'position of the pyrimidine ring. This 
cytosine is followed by a guanine forming a dinucleotide CpG (Johnson, 1925); 
(Hotchkiss, 1948). 
DNA methylation is found in most organisms, from bacteria to mammals, but 
the distribution of methylation in animals varies between species. Caenorhabditis 
elegans does not have methylated cytosines in its genome and does not encode a 
DNA methyl-transferase. Drosophila melanogaster has a DNA methyltransferase-
like gene (Hung et al., 1999; Tweedie et al., 1999) and contains very low levels of 
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methylcytosine, mostly in the CpT dinucleotide (Gowher et al., 2000; Lyko et al., 
2000). In contrast, another invertebrate, Ciona intestinalis, has blocks of methylated 
DNA separated by equivalent domains of unmethylated DNA (Bird et al., 1979; 
Tweedie et al., 1997). In vertebrates, DNA methylation is present throughout the 
genome at 60-90% of all CpGs. The majority of the unmethylated CpG dinucleotides 
occurs in CpG islands. CpG islands are found in short regions of 1-2kb containing 
unmethylated cytosine, GC-rich in —60-70%, meanwhile the rest of the genome has a 
GC content of 40%. These regions are usually functioning as strong promoters, being 
found in all the house keeping genes and majority of genes with a tissue-restrictive 
pattern of expression (Delgado et al., 1998; Gardiner-Garden and Frommer, 1987). 
The majority of CpG islands are unmethylated in the germline, at all stages of 
development and in all somatic tissue types. Thus, CpG islands can remain 
methylation-free even when their associated gene is silent. 
1.4 The roles of DNA methylation 
Methylation interferes with protein-DNA interactions, leading to changes in 
chromatin structure. This interference can cause transcriptional repression. 
Methylation of CpG rich promoters is used by mammals to prevent transcriptional 
intitiation and to ensure the silencing of genes on the inactive X chromosome, 
imprinted genes and parasitic DNAs (Colot and Rossignol, 1999; Yoder et al., 1997). 
The most direct mechanism of repression is to interfere with the binding of 
basal transcriptional machinery or transcription factors that require contact with 
cytosine in the major groove of the double helix (Watt and Molloy, 1988). However, 
the majority of the repression of methylated genes occurs by the binding to methyl 
CpG to methyl-CpG binding proteins (Boyes and Bird, 1991). Transcription can then 
be inhibited by steric impediment, where the MeCP bound to the DNA blocks the 
access of the transcription factor, by impediment of RNA polymerase activity or by 
chromatin changes directed by Methyl-CpG binding proteins (MeCPs). 
1.4.1 X chromosome inactivation 
During early development in mammals, one X chromosome is inactivated in 
females. This inactivation is random in embryonic cells, and inactivation status will 
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be propagated to their daughter cells creating a mosaic of X chromosome 
inactivation. The extraembryonic lineages placenta and primitive endoderm in mice 
are the exception since it is the paternal X chromosome that remains silenced (Huynh 
and Lee, 2003; Mak et al., 2004; Okamoto et al., 2004). X chromosome inactivation 
is controlled by the X chromosome inactivation centre, from where are expressed 
two non coding RNAs: Xist and its antisense Tsix. The initiation of X inactivation by 
Xist starts very early in development (2-4 cell stage). Xist will coat the entire X 
chromosome initiating the inactivation process (Huynh and Lee, 2003; Okamoto et 
al., 2004). The maintenance of the silencing state is achieved by chromosome wide 
inactivation, where the combination of methylation of CpG islands of most of the 
genes, recruiting of polycomb group proteins Ezh2/Eed and histone modification 
leads to a heterochromatin status and stable silencing (de Napoles et al., 2004; Fang 
et al., 2004) (Brockdorff, 2002; Plath et al., 2003). 
1.4.2 Imprinting 
Genomic imprinting results in the differential expression of the two alleles of 
a gene in somatic cells due to epigenetic modification of the parental chromosome in 
the gamete or the zygote (Efstratiadis, 1994). This differential expression is due to 
the specific heritable parental methylation patterns, termed differentially methylated 
regions (DMR5). DMRs include imprinting control regions (ICRs), which control 
gene expression within imprinted domains, often over large distances. These ICRs 
carry allele-specific methylation patterns established in the germ line and retained 
thereafter (Reik and Walter, 2001). ICRs subsequently will influence epigenetically 
the modulation of allele-specific, tissue-specific or temporal-specific regulation of 
imprinting genes (Ferguson-Smith and Surani, 2001). 
A number of in vivo and in vitro studies of ICRs have revealed that the 
chromatin insulator protein CTCf binds only to the unmethylated parental allele, and 
then regulates the ability of distant enhancers to access promoters in an allele-
specific manner (Kurukuti et al., 2006; Ling et al., 2006; Schoenherr et al., 2003). 
Currently, there are 80 genes known to be imprinted, being this number in 
continuous increase. 
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1.4.3 DNA methylation and disease 
Loss of imprinting (LOl) is the disruption of imprinted epigenetic marks 
through gain or loss of DNA methylation, losing normal allele-specific gene 
expression (Robertson, 2005). This aberrant imprinting leads to human diseases 
normally as a result of activation of a normally silent allele. Hence, it is present in 
many tumour types as a consequence of LOl of growth inhibitory imprinting genes. 
Examples are Wilms' tumour and some types of breast and ovarian cancer, lung and 
colon. 
In general, loss of genomic methylation is a frequent event in cancer that 
correlates with disease severity and metastasic potential in many tumor types 
(Widschwendter et al., 2004). The abnormal methylation of CpG islands in tumor 
suppressor genes is frequent in tumorigenic cells, although it is currently unknown 
whether this silencing is a cause or consequence of the onset of tumorigenesis 
(Prokhortchouk and Hendrich, 2002). Early and general demethylation in 
tumorigenesis may predispose cells to genomic instability meanwhile a gene-specific 
demethylation might occur later as a adaptative mechanism of the tumorigenic cell to 
the local environment and promote metastasis (Robertson, 2005). 
Apart from cancer, there are an extensive number of diseases known to be 
related with an aberrant imprinting such as Beckwith-Wiedeman, Prader-Willi and 
Angelman syndrome. - 
1.4.4 Silencing of parasitic DNA elements 
A high fraction of methylated CpG dinucleotides are located within parasitic 
DNA elements or retrotransposons, which are inactivated copies of repetitive DNA 
in the mammalian genome. These elements are classified in SINE or short 
interpersed DNA elements, LINE or long interpersed DNA elements and LTR 
containing elements (Smit and Riggs, 1996), and can be activated or inserted in 
novel locations causing chromosome rearrangements or translocations with 
devastating effects (Kazazian and Moran, 1998; Montagna et al., 1999). SINES and 
LINEs are very CpG rich, heavily methylated and may recruit chromatin modiflying 
repression (Yoder et al., 1997). Intracisternal A particules or TAPs, -are a class of 
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LTR that tend to decrease its methylation levels during aging in mouse with the 
consequence of increase in transcriptional activation of these elements (Barbot et al., 
2002). 
1. 5 DNA cytosine methyl transferases: 
1.5.1 Dnmtl 
Maintenance methylation describes the process that reproduces DNA 
methylation patterns between cell generations (Riggs, 1975). During DNA 
replication, both new double-stranded DNA molecules are hemimethylated, being 
only methylated on the parental strand. Dnmtl, which has a strong preference (15 
fold) for hemimethylated DNA (Goyal et al., 2006), will methylate the cytosine on 
the unmethylated strand restoring the symmetry. With this mechanism, methylation 
patterns are inherited to the next cell generation (Bird, 2002). The recruitment of 
Dnmtl to the replication fork is targeted by the proliferating cell nuclear antigen, 
PCNA (Chuang et al., 1997). PCNA has a role in DNA replication and repair. This 
interaction can be disrupted by the cell cycle regulator, p21WAF/CIP  which can bind 
PCNA in an exclusive manner in relation with Dnmtl. Therefore, p2 1WAF/CIP , whose 
function is to mediates the ability of p53 to arrest cell division in response to DNA 
damage (Li et al., 1996), prevents Dnmtl access to damaged DNA and consequently 
can lead to hypomethylation (Chuang et al., 1997). 
The catalytic domain of Dnmtl, which is common to the Dnmt family, 
consists on a set of six highly conserved motifs located in the C-terminal domain 
(Kumar et al., 1994). Additionally, Dnmtl has a region of alternating glycine and 
lysine residues and in its N-terminal region has several domains attributed with a 
number of functions. Firstly, there is a nuclear localisation signal (NLS) that is 
required for import Dnmtl into nuclei. Secondly, the N-terminal region is believed to 
be necessary to target the association with replication foci in S phase (Leonhardt et 
al., 1992). Furthermore, the N-terminal region is believed to confer specificity for 
hemimethylated DNA (Bestor et al., 1992) and also play a role in coupling 
stabilization of DNA to the growth state of cells (Ding and Chaillet, 2002). Dnmtl 
has a diffuse nucleoplasmic distribution in GI but associates with replication foci 
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during S phase, being expressed at very low levels in non-cycling cells (Fan et al., 
2001). 
Role of Dnmtl through the study of the Dnmtl deletion 
There is a severe demethylation in mice and ES cells homozygous for null 
alleles of Dnmtl, although methylation levels persist in 5% (Lei et al., 1996). As a 
result, multiple consequences are observed in null mice and ES cells. Firstly, mutant 
mice lacking a functional Dnmtl gene are normal during pre-implantation 
development but they start to show developmental delay at around 9.5 dpc, failing to 
develop past 12.5 dpc (Li et al., 1992). Secondly, deletion of Dnmtl causes the 
biallelic expression of most imprinted genes in homozygous embryos; some, such as 
H19 are expressed from both alleles, whereas others such as Igf2 are not expressed 
(Li et al., 1993). Thirdly, there is an inactivation of all X chromosomes in 
homozygous mutant embryos due to the demethylation and activation of Xist 
(Panning and Jaenisch, 1996). Lastly, deletion of Dnmt] causes demethylation and 
expression of very high levels of transposons of the intracisternal A particle (lAP) 
class, (Walsh et al., 1998). The Dnmtl is the only gene known to be required for the 
repression of transposons in mammalian somatic cells, protecting these elements 
from demethylation during cleavage. The study of Dnmtl deficient ES cells revealed 
an enhaced mutation rate at several endogenous loci (Hprt and tk) caused by 
chromosomal rearragements, namely loss of heterozygosity because of increased 
mitotic recombination (Chen et al., 1998). 
Interestingly, ES cells that lack Dnmt 1 grow normally in the undifferentiated 
state and retain low but detectable levels of DNA methylation through more than 20 
cell divisions (Lei et al., 1996). However, Dnmtl null ES die by apoptosis when 
induced to differentiate in vivo or in vitro. These effects are paralleled by the 
apoptosis observed in Dnmtl deficient embryos (Li et al., 1992). The mechanisms 
that lead to apoptosis are not known. 
Dnmtl is highly expressed in the cytoplasm of postmitotic neurons. The 
cytoplasmic localisation of Dnmtl could be explained by a regulatory mechanism of 
the neuron to ensure the optimal protein in a post-mitotic state, or by an additional 
function in the cytoplasm. Conditional mutant transgenic studies where Dnmtl is 
specifically deleted in the central nervous system have been used to show that Dnmtl 
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is necessary for the regulation of the respiratory function and the survival of post-
mitotic neurons (Fan et al., 2001). 
Dnmtl deletion has been shown to affect the differentiation of CD8 T cells 
in the presence of a viral infection (Chappell et al., 2006). Additionally, when Dnmtl 
is knocked out with a mutation that leads to 10% expression levels of Dnmtl, this 
mutation causes a very high rate of lethal T-cell lymphomas (Gaudet et al., 2003). 
Demethylation and mobilization of endogenous retrovirus cause the majority of 
leukemias and lymphomas in most mouse strains. And ultimately, studies of 
overexpression of Dnmtl reveal both that Dnmtl has de novo methylase activity and 
that high levels of Dnmtl are lethal because it causes de novo methylation of 
normally unmethylated allele at imprinted loci (Biniszkiewicz et al., 2002). 
1.5.2 Dnmt2 
Dnmt2 has sequential and structural high affinity with the other DNA 
methyltransferases Dnmtl and Dnmt3. However, Dnmt2 lacks biochemically 
detectable methyltransferase activity (Okano et al., 1998b; Yoder and Bestor, 1998) 
and Dnmt2 deficient ES cells (Okano et al., 1998b) D.melanogaster and A. thaliana 
are viable, fertile and morphogically indistinguishable from wild type (Goll et al., 
2006). The role of Dnmt2 is to methylate the small RNA aspartiá acid transfer 
tRASP INA , function that is highly conserved in among mammals, flies and plants. 
Dnmt2 shares with the rest of Dnmts an indirect sequence recognition requirement in 
eukaryotes, giving the hypothesis of an ancestral Dnmt2 as origin of eukaryote 
Dnmts (Goll et al., 2006). 
1.5.3 Dnmt3 
There are two known de novo methyltransferases, Dnmt3A and Dnmt3B 
(Okano et al., 1999; Okano et al., 1998a) which primarily methylate CpG 
dinucleotides. A third homologue, Dnmt3L lacks cytosine methyltransferase activity, 
but interacts with de novo methyltransferases targeting methylation to the dispersed 
retrotransposon elements (Bourc'his and Bestor, 2004; Bourc'his et al., 2001; Hata et 
al., 2002). Dnmt3L functions as well as a regulatory factor in male and female germ 
cells, playing an important role in genomic imprinting (Bourc'his and Bestor, 2004; 
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Hata et al., 2002). Dnmt3a and Dnmt3b are highly similar proteins. Both have C-
terminal catalytic domains, and in their N-terminal domain they have a PWWP 
domain and a cysteine rich zinc-binding region related to the one contained in the 
chromatin remodelling protein ATRX (Xie et al., 1999). The PWWP domain is a 
highly conserved aminoacid sequence found in many chromatin associated proteins 
(Qiu et al., 2002; Slater et al., 2003; Stec et al., 2000). 
The question of how the methyltransferases are targeted to unmethylated 
DNA has been extensively studied with in vitro cell culture systems. There are three 
working possibilities. Firstly, in mouse cells Dnmt3 enzymes might be targeted to the 
pericentromeric heterochromatin regions by its PWWP domain (Chen et al., 2004). 
An alternative targeting mechanism might be by transcription factors that interact 
with the Dnmt to recruit methyltransferase activity as part of a molecular silencing 
signal to shutdown gene expression (Brenner et al., 2005; Di Croce et al., 2002). A 
third way of targeting could be via an RNA-mediated interference system targeting 
de novo methylation to specific DNA sequences (Santoro and Grummt, 2005). A 
combination of the three mechanisms should be also considered. 
Dnmt3a and b are highly expressed in early embryonic cells, where most 
programmed de novo methylation events occur, and to much lesser extent in 
differentiated cells and adult tissues (Okano et al., 1998a). Because DNA 
methylation is believed to play an important role in the central nervous system, 
extensive studies of Dntm3a and Dnm3b in the mouse CNS have been made. Both 
proteins are, expressed throughout the developing cortex in neural precursors. While 
Dnmt3b is preferentially expressed between E10.5 and E13.5, Dnmt3a remains 
expressed through E17.5 and switches its expression from neural precursors to post-
mitotic neurons with an increased expression through the first 3 weeks of postnatal 
development followed by a decreased expression into adulthood (Feng et al., 2005). 
The same pattern of expression is followed in other sensory systems, as in the 
olfactory system Dnmt3b is expressed in mitotic olfactory precursors, while Dnmt3a 
is expressed only in post-mitotic immature neurons. Furthermore, in the vomeronasal 
organ, the retina and taste buds, Dnmt3b is found in more primitive mitotic 
progenitors, whereas Dnmt3a is expressed in more highly differentiated post-mitotic 
neurons (MacDonald et al., 2005). 
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Dnmt3b is thought to be involved in methylation of specific genomic 
regions: including pericentromeric repetitive DNA sequences and CpG islands on the 
inactive X chromosome. This is known because Dnmt3b null mice and also human 
patients with DNMT3B mutations are deficient in methylation of pericentromeric 
repetitive DNA sequences and CpG islands on the inactive X (Okano et al., 1999). 
Point mutations in human DNMT3B are responsible for the rare autosomal recessive 
human disorder immunodeficiency, centromere instability, and facial anomalies 
syndrome (ICF) (Hansen et al., 1999; Xu et al., 1999). ICF is characterised by 
developmental defects, mental retardation and distinct facial features. Patients have a 
specific loss of methylation of classical satellite DNA, also known as satellites 2 and 
3 at the pericentromeric regions of chromosomes 1, 9, and 16 in their lymphocytes. 
Dnmt3a' mice are born but die after 4 weeks, while Dnmt3b mice are not 
viable and have multiple developmental defects (Okano et al., 1999). Both present 
global demethylation of their genomes, although in lesser degree than Dnmt1 
mutant embryos. Dnmt3b/Dmt3a double mutant ES cells are unable to 
methy!ate newly integrated retroviral DNA. Conditional deletion of Dnmt3a in germ 
cells results in sex-specific phenotypes. Female Dmt3a germ cells die in utero 
lacking methylation and allele-specific expression of maternally imprinted genes. 
Meanwhile conditional Dmt3a null male germ cells have impaired 
spermatogenesis and misregulation of paternally imprinted genes. On the other hand, 
germ cells are not affected by deletion of Dnmt3b (Kaneda et al., 2004a; Kaneda et 
al., 2004b). 
Lsh forms part of the chromatin remodelling SNF family of proteins. Lsh 
control normal heterchromatin sturucture and function in mice, contributing to the 
silencing of repetitive elements (Huang et al., 2004; Yan et al., 2003a; Yan et al., 
2003b). Concordantly, Lsh mutant mice have developmental defects and early 
lethality (Dennis et al., 2001; Geiman et al., 2001). Recently it has been discovered 
that Lsh interacts with Dnmt3a and Dnrnt3b and it is required for their function in de 
novo methylation of endogenous genes (Zhu et al., 2006). 
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1.6 Epigenetic reprogramming cycle 
Epigenetic modification undergoes reprogramming during the life cycle in 
two phases: during gametogenesis and preimplantation development. 
In the zygote, after fertilization, the paternal genome has been carried by the 
mature sperm and is single copy packaged densely with protamines. The maternal 
genome is arrested at metaphase II and is packaged with histories. Upon fertilization, 
protamines in the sperm chromatin are rapidly replaced with highly acetylated 
histones (Adenot et al., 1997; Santos et al., 2002) although histone methylation is 
also detectable (Erhardt et al., 2003; Lepikhov and Walter, 2004; Santos et al., 2005). 
Meanwhile, the maternal genome completes meiosis. Following this process begins 
the genome wide demethylation: The paternal genome undergoes active 
demethylation and is completed by one cell stage before DNA replication starts in 
the paternal pronucleus. On the contrary, the maternal genome undergoes passive 
demethylation, and is completed by the morula stage (Santos et al., 2002). There are 
some regions of the genome that are designed to not become demethylated; These 
are heterochromatin in the centromeres and close regions, probably to maintain 
chromatin stability (Rougier et al., 1998; Santos et al., 2002), TAP retrotansposons to 
avoid transpositions (Lane et al., 2003) and paternally methylated imprinted genes 
for imprinting maintenance (Olek and Walter, 1997). These processes have been 
observed in the mouse, rat, pig, bovine and human zygotes. However, DNA 
methylation dynamics of sheep zygotes are slightly different because the paternal 
pronucleus retains more DNA methylation. 
At the blastocyst stage in the mouse there are two cell lineages, the inner cell 
mass (1CM) and the trophectoderm (TE). DNA methylation is still decreased through 
the cleavage divisions (Monk et al., 1987) because of the exclusion of oocyte Dnmtl 
(Dnmtlo) from the nucleus during the first three cleavage divisions (Carlson et al., 
1992). This progressive demethylation that depends on DNA replication (Howlett 
and Reik, 1991) is known as passive demethylation. As a result, there will be a low 
level of methylation in the TE meanwhile the 1CM will go through an extensive de 
novo methylation starting from morula stage (Santos et al., 2002). This difference 
may be the cause of the fact that Dnmt3b is detectable in blastocyst in the 1CM but 
not in the TE (Watanabe et al., 2002). The difference in DNA methylation changes 
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between 1CM, and TE could be that the differentiation potential and longevity of 
extraembryonic tissues are much more limited than the embryonic tissues (Morgan et 
al., 2005). 
Primordial germ cells (PGC) are derived from epiblast cells in the posterior 
primitive streak at embryonic day E7.5, from where they start to migrate to the 
genital ridge and arrive at E11. 5  (McLaren, 2003). Female PGCs enter meiotic arrest 
in prophase of meiosis I, while male PGCs enter mitotic arrest about birth when 
mitosis of spermatogonial stem cells is resumed. The epigenetic marks that the PGCs 
are carrying are similar to other epiblast cells, such as random X chromosome 
inactivation, imprinted gene expression and DNA methylation. However, these 
marks need to be erased, and indeed this happens when the PGCs reach the genital 
ridges with a wave of demethylation that occurs between E1l.5 and E12.5 (Hajkova 
et al., 2002). This demethylation is believed to be active because it happens in very 
short period of time and in presence of Dnmtl in the nucleus. Following 
demethylation, the genomes of the gametes are de novo methylated and acquire 
parent-specific imprints. This process continues until E18.5 in males and in maturing 
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Figure 1.1 Epigenetic reprogramming cycle. After fertilisation, the 
paternal DNA undergoes active demethylation, while maternal DNA 
undergoes passive demethylation that is completed at morula stage. At 
blastocyst stage, the inner cell mass undergoes extensive de novo 
methylation, while the trophectoderm chromatin remain demethylated. 
Epigenetic marks at primordial germ cells (PGCs) are erased by another 
wave of demethylation between embryonic age El 1.5 and E12.5. 
Subsequently, the genomes of the gametes are de novo methylated and 
acquire parent-specific imprints. This process continues until E18.5 in 
males and in maturing oocytes before ovulation in females. Adapted from 
Morgan ci al., 2005. 
1.7 Methyl-CpG binding proteins 
The first entity found to bind methylated DNA and mediate transcriptional 
repression was MeCP1 (Meehan et al., 1989). This factor later was revealed as a 
multi-component complex. Subsequently, another was identified capable to bind 
methylated DNA, MeCP2 (Lewis et al., 1992) that can bind a single symmetrically 
methylated CpG pair. MeCP2 contains both a methyl-CpG binding domain (MBD) 
and a transcriptional repression domain (TRD) (Nan et al., 1997; Nan et al., 1993). 
By searching for sequences homologous of the MBD from the MeCP2, the MBD-
containing protein Mbdl was identified (Cross et al., 1997), and subsequently Mbd2, 
Mbd3 and Mbd4 (Hendrich and Bird, 1998) (figure 1.2 and figure 1.3). 
The multi-component complex MeCP 1 was shown to contain a methyl-CpG 
binding protein able to repress transcription in a methyl-CpG binding dependent 
fashion. This protein was initially believed to be Mbdl (Cross et al., 1997), but 
subsequent studies revealed that Mbd2 was the methyl-CpG binding activity in the 
complex (Ng et al., 1999). Additionally, MeCP1 was later on shown to be a complex 
formed by the Nucleosome Remodelling and Deacetylation Repressor NuRD 
Complex, and the Mbd2 protein (Feng and Zhang, 2001). 
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Figure 1.2 Methyl-CpG binding proteins. MePC2, Mbdl-4 share MBD 
domain which allows the proteins to bind methylated DNA, while Kaiso bind 
methylated DNA through its zinc fingers. Mbdl also contains three zinc 
finger domains (CxxC), one of them allows MbdI to bind non-methylated 
CpG dinulceotides. MeCP2 and Mbdl have a transcriptional repression 
domain TRD. Kaiso repress transcription in a methylation dependent manner 
with involvement of both zinc fingers and POZ domain. Mbd2 and Mbd3 are 
70% homologous, but Mbd3 MBD does not bind methylated DNA in 
mammals due to two amino acid residues different that eliminate the methyl-
CpG binding activity. Mbd4 can bind methylated DNA through its MBD 
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Figure 1.3 Transduction of the methylated signal. MeCPs bind methylated 
DNA (red circles) targeting the chromatin remodeling complexes where they 
are included, which leads to silencing of gene expression. In HeLa cells Kaiso 
forms part of the NCoR corepressor complex and Mbd I associates with the 
H3-lysine9-specific methylase SETDBI. Mbd3, which does not bind 
methylated DNA in mammals, forms part of the nuclear corepressor NuRD, 
which associates with Mbd2 that bind methylated DNA. MeCP2 may 
associate with several co-repressor complexes including Dnmtl, CoREST, 
Suv39HI, and Sin3a.Adapiedfro,n Bird., 2002. 
1.8 MeCP2 
MeCP2 is a 80kDa protein that binds a single symetrically methylated CpG 
(Lewis et al., 1992). Its MBD, as in the rest of MBD proteins, is located in the N-
terminus of the protein. In the middle of the protein is located its transcription 
repression domain (TRD) of 100 amino acids (Nan et al., 1997) that can repress 
transcription up to 2kb from the transcription initiation site. The transcriptional. 
repression activity is linked to histone deacetylation (Jones et al., 1998; Nan et al., 
1998) and histone methylation (Fuks et al., 2003b). There are several co-repressor 
complexes that may associate with MeCP2 in mammals including Dnmtl, CoREST, 
Suv39Hl, c-SKI andSin3a (Kimura and Shiota, 2003; Kokura et al., 2001; Lunyak 
et al., 2002; Nan et al., 1998). This last complex, once believed to be the corepressor 
partner of MeCP2, has been demonstrated to intereact with MeCP2 in low proportion 
with a non stable interaction (Kiose and Bird, 2004). 
Recently it has been demonstrated that MeCP2 requires an AlT run of four or 
more base pairs adjacent to the methyl-CpG for efficient binding (Kiose et al., 2005). 
In the absence of another MeCP, Mbd2, MeCP2 can not bind to the sites normally 
bound by Mbd2 in the majority of the cases. On the other hand, in the absence of 
MeCP2, Mbd2 can bind to most of the normal MeCP2 binding sites (Kiose et al., 
2005). Therefore, Mbd2 can functionally compensate for MeCP2 but not vice versa. 
There are two MeCP2 isoforms as a result of alternate splicing of the four 
exon MeCP2 gene. These are termed Mecp2a/3 in mice, and MECP2A/B in humans, 
and they differ in the aminoacid composition of the N-terminus (Kriaucionis and 
Bird, 2004; Mnatzakanian et al., 2004). MECP2B in humans or Mecp2a in mouse 
are more highly expressed than MECP2A1Mecp2J3 transcripts in most tissues. 
Although MeCP2 is ubiquitously expressed through the mouse and human tissues, is 
the brain where the expression is remarkably high. 
Within the brain, MeCP2 is predominantly expressed in neurons, with 
strongest expression in the more mature neurons (Kishi and Macklis, 2004; Mullaney 
et al., ; Shahbazian et al.). The extensive studies of Mecp2 expression in rat 
(Mullaney et al., 2004) and mouse (Braunschweig et al., ; Shãhbazian et al., 
2002b)Shahbazian et al., 2002) have revealed a pattern of expression that correlates 
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with the maturation of the different brain regions, and indicates a function for 
MeCP2 in mature neurons. Moreover, neuronal precursor differentiation assays 
reveal no evidence for defects in the proliferation or fate decisions of neuronal 
precursors in the absence of MeCP2 (Kishi and Macklis, 2004). However, increasing 
evidence suggests a role for MeCP2 in maturation and maintenance of postmitotic 
neurons in murine brains (Kishi and Macklis, 2004; Matarazzo et al., 2004). 
1.8.1 Rett syndrome (RTT) 
Rett syndrome is caused by mutations in the MECP2 gene (Amir et al., 1999). 
RTT is a neurological disorder that affects primarily girls, with an incidence of 
1/10000 to 1115000 live births (Hagberg, ; Kerr and Stephenson, 1985; Rett, 1966). 
The affected individuals are born asymptomatic and develop normally during the 
first few months of life, achieving the expected milestones in motor language and 
social areas. After 6-18 months of age, however, acquired speech and motor skills 
begin to be lost (Hagberg). Purposeful hand movements are replaced by 
characteristic hand-wringing motions and gait apraxia, followed by growth 
retardation and deceleration of head growth. In addition, half of affected individuals 
develop seizures and autistic behaviour, and by 4-7 years display gross cognitive and 
motor impairment together with profound hypoactivity which remains throughout 
their lives (Hagberg and Witt-Engerstrom). 
Histopathological studies on post-mortem RTT brains have revealed that the 
observed microcephaly correlates with reduced brain size, particularly of the 
prefrontal, posterior frontal, and anterior temporal regions (Subramaniam et al.). This 
characteristic reduction in size roughly correlates with both a decrease in the size of 
individual neurons and increased neuronal packing densitiy in these regions (Bauman 
et al., 1995a; Bauman et al., 1995b). Additionally a reduction of dendritic 
arborization in cerebral cortical layers II and IV in the frontal, motor and inferior 
temporal regions has been observed (Armstrong et al., 1995). 
1.8.2 MeCP2 mutant mice models 
Once MeCP2 was linked to be the cause of Rett syndrome, many laboratories 
started the generation of mouse models to try to understand the function of MeCP2. 
Mecp2 heterozygous female mice are viable, fertile, and appear normal well into 
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adulthood (Chen et at., 2001; Guy et al., 2001) even though they have the same 
genotype as RTT girls. At around six months of age, however, these females begin to 
show neurological symptoms reminiscent of RTT (Guy et al., 2001), indicating that 
the onset of Rett Syndrome is unlikely to depend upon the developmental stage of 
affected individuals, as humans and mice develop a similar disease after the same 
amount of time, despite being at completely different developmental stages. 
Hemizygous null male or homozygous null female mice appear healthy at birth, but 
began to display RTT-like phenotypes after about six weeks and die at an average 
age of approximately 8 weeks (Chen et al., 2001; Guy et at., 2001). Brain 
architecture in null mice is grossly normal, although a slight decrease in the size of 
neurons and an increased packing density in the hippocampus, cerebral cortex and 
cerebellum could be identified (Chen et al., 2001; Kishi and Mack!is, 2004). This 
finding correlates with disease pathology in humans where a decrease in the size of 
individual neurons and increased packing density are likely contributory factors to 
the smaller brain size often observed in RTT patients (Armstrong et al., 1995; 
Bauman et al., 1995a; Bauman et al., 1995b). 
Another mouse model was produced that expresses a truncated form of MeCP2 
often seen in RTT patients (Shahbazian et al., 2002a). These Mecp2 mutant males 
(MeCP2308 ) were aphenotypic until 4- 5 months of age, after which time they began 
to display tremors, kyphosis and motor dysfunction. Heterozygous females 
(MeCP2308 'X) have impaired motor features at 35-39 weeks and show phenotypic 
variability ascribed to differences in patterns of X chromosome inactivation. In early 
studies, results of learning and memory tests were reported to be normal (Shahbazian 
et al., 2002a). However, recent thorough studies of behaviour, synaptic function, 
electrophysiological and ultrastructural experiments revealed compound memory and 
learning deficits associated with synaptic function (Moretti et al., 2006). 
Mice in which MeCP2 was deleted in Nestin-positive neural precursors (and 
their progeny, i.e. all neurons and glia) displayed a phenotype indistinguishable from 
that seen in MeCP2-null mice (Chen et at., 2001; Guy et al., 2001), indicating that 
the primary site of action for MeCP2 is in the brain. Furthermore, Chen et al. 
produced mice in which the Mecp2 gene was only deleted in cells expressing 
aCamKII, a kinase specifically present in postmitotic neurons (Chen et al., 2001). 
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The aCamKII promoter is normally active in postnatal excitatory neurons of the 
forebrain, hippocampus and brainstem, and to a much lesser degree in the cerebellum 
(Silva, 2003), although the exact distribution and strength of its activity within the 
forebrain can vary from one transgenic line to another (Chen et al., 2001; Tsien et al., 
1996). These mice appeared normal until about 3 months of age, at which time they 
began to display ataxic gait and reduced nocturnal activity. Histological analysis 
revealed reduced brain weights and smaller neuronal cell bodies in cortex and 
hippocampus (Chen et al., 2001). interestingly, these phenotypes were not seen in the 
cerebellum where aCamKII is not expressed (Caballero et al., 2005). 
1.8.3 MeCP2 in Xenopus 
- MeCP2 is also expressed in Xenopus ubiquitously, and concordantly with 
mice and human, it is also highly expressed in all neural tissues. However, the 
depletion of xMeCP2 results in arrest of development at the neurula stage, which 
results in significant developmental defects such as reduced dorsal axis and abnormal 
head structures (Stancheva et al., 2003). Hence, xMeCP2 play an essential role in 
early development of Xenopus in contrast with the situation in mammals where 
MeCP2 is not essential for embryogenesis. Xenopus Hairy2a was identified as a 
target gene for repression by xMeCP2. xHairy2a is a downstream gene of the 
Notch/Delta signalling pathway. When Xenopus embryos express a truncated form of 
MECP2, (a frequent mutation in Rett syndrome), xHairy2a is inefficiently repressed 
which causes an increase in neuronal precursors with consequent disruption in 
neuronal patterning (Stancheva et al., 2003). Hence, identified target genes in 
Xenopus are related with neuronal precursor functionality, but given the differences 
on the onset of the phenotype as a consequence of depletion of MECP2 in human 
and mice versus Xenopus, its target genes may differ between species. 
1.8.4 MeCP2 target genes 
Since MeCP2 is involved in transcriptional repression when bound to the 
widely distributed methyl-CpGs of the genome, it was predicted that loss of MECP2 
in a cell would result in inappropriate expression of a large number of genes (Willard 
and Hendrich, 1999). However, microarray studies with cell lines and tissues of mice 
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or mutant human patients found only very subtle gene expression changes 
(Colantuoni et al., 2001; Matarazzo and Ronnett, 2004; Tudor et al., 2002) or protein 
expression changes (Matarazzo and Ronnett, 2004). Some of the genes found to be 
discretly upregulated are involved with glucocorticoid signaling pathway like Sgk 
and Fkbp5 (Nuber et al., 2005). Interestingly, the changes appear before the onset of 
Rett-like symptoms in the mice which indicates that the upregulation of these genes 
may not be consequence of the Rett-like phenotype (which includes misregulation in 
metabolism). Additionally, both genes have been linked to neuronal function and 
therefore is plausible that misregulation of these genes would be involved in the Rett 
syndrome phenotype. 
On the other hand, candidate gene approaches have lead to the identification of 
additional MeCP2 bona fide target genes. The first example was the brain-derived 
neurotrophic factor (BDNF), which was found to be misexpressed in Mecp2-null 
brains. This missexpression occurs only in certain cell types, and only to a level of 
about two-fold (Chen et al., 2003; Martinowich et al., 2003). BDNF is  neurotrophin 
required for survival, growth, and maintenance of neurons during development 
(Barde, 1994). BDNF is known to be involved in learning and memory and has the 
ability to modulate synaptic plasticity by regulating axonal and dendritic branching 
and remodeling (Alsina et al., 2001; Lo, 1995; Lom and Cohen-Cory, 1999; Shimada 
et al., 1998; Yacoubian and Lo, 2000). MeCP2 was found to associate with and 
maintain repression of Bdnf in resting neuronal cultures. Following neuronal 
depolarization, MeCP2 becomes phosphorylated and disassociates from the Bdnf 
promoter, allowing for full transcription of the gene. In the absence of MeCP2, Bdnf 
repression becomes leaky in unstimulated neurons, resulting in a two-fold increase of 
Bdnf mRNA levels (Chen et al., 2003). This increase in mRNA levels does not 
constitute 'activation' of the Bdnf gene, as transcript levels in resting Mecp2-
deficient neurons are still approximately 100-fold lower than those found in activated 
neurons (Chen et al., 2003). Rather, the absence of MeCP2 results in incomplete 
repression of Bdnf. No difference in Bdnf expression was detectable in depolarised 
neuronal cultures derived from Mecp2-deficient or wild-type mice (figure 1.4). 
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Figure 1.4. MeCP2 regulation of the neurotrophic factor Bdnf. A. In resting neurons, 
MECP2 (orange) and its associated co-repressor (HDAC, in green) represses transcription of 
the Bdnf promoter. III. B. In the absence of MeCP2, repression of Bdnf is leaky, resulting in 
low-level transcription and, presumably, Bdnf protein production that may cause a variety of 
downstream effects leading to dysfunction at different levels such as reduced long term 
potentiation (LTP), altered learning and memory and decreased dendritic arborization. C. 
Upon membrane depolarisation (i.e. neuronal stimulation), MeCP2 is displaced from 
promoter III and Bdnf transcription is activated, resulting in Bdnf protein production. Figure 
adapted from Kandel, Schwartz, Jessell, Principles of Neural Science. 41/2  Edition 2000. 
Although MeCP2 has been shown to physically associate with the silent alleles 
of various imprinted genes (Drewell et al., 2002; Fournier et al., 2002; Gregory et al., 
2001), no loss of imprinting could be found at these loci in Mecp2-deficient mice 
(Chen et al., 2001; Guy et al., 2001). However, the imprinted D1x5 gene was recently 
found as a target for MeCP2 repression (Horike et al., 2005). D1x5 and D1x6 encode 
homeobox proteins known to regulate the expression of genes involved in 
neurotransmitter production (Stuhmer et al., 2002) and are important in various 
aspects of embryonic development, including brain patterning (McLarren et. al., 
2003). 
Moreover, another imprinting gene, Ube3a has been found to be misregulated 
in Mecp2-deficient animals (Samaco et al., 2004). The deficiency or deletion of this 
gene is the cause of Angelman Syndrome (Kishino et al., 1997; Matsuura et al., 
1997). Again, a small but significant decrease in expression of Ube3a/UBE3A was 
found in brains of Mecp2-deficient mice and RTT patients (Samaco et al., 2004). 
Further, expression of a nearby non-imprinted gene implicated in autism, 
Gabrb3IGABRB3, was reduced in the same samples. A similar reduction in UBE3A 
and GABRB3 expression was also found in brain samples from autism and Angelman 
Syndrome patients, indicating that the similarities in phenotype between these 
syndromes may have a common molecular etiology (Samaco et al., 2004). In this 
case no evidence for loss of imprinting or for direct MeCP2 binding to either gene 
was found. 
Recently MECP2 has been reported to have a direct role in splicing regulation 
through its association with YB-1 (Young et al., 2005), which controls multiple steps 
of mRNA processing (Raffetseder et al., 2003), giving a new vision to MeCP2 as a 
multifunctional protein. 
1.9 MBD2 
Mbd2 has two isoforms, Mbd2a, which is the full-length protein and Mbd2b 
that has an N-terminal truncation expressed by an alternative start codon. Both 
isoforms can bind methylated DNA (Hendrich and Bird, 1998). 
Mbd2 shares an identical genomic structure with Mbd3 in mammals. Methyl-
CpG binding protein Mbd3, forms part of the methyl binding domain (MBD) family 
of proteins, but does not bind methylated DNA in mammals in contrast with the rest 
of the family. Mbd2 and Mbd3 encode proteins that are 70% identical. These facts 
support the theory that Mbd2 and Mbd3, could have been separated in vertebrates by 
a gene duplication event from the ancestral Mbd2/Mbd3 gene. in invertebrates 
(Hendrich and Tweedie, 2003). 
1.9.1 Mbd2 knock out mice and Mbd2 function 
The function of Mbd2 has been investigated through the study of the knock 
out mice (Hendrich et al., 2001). Mbd2" mice are viable and fertile, and their DNA 
methylation and imprinting levels are normal. Mbd2 is a transcriptional repressor and 
therefore, when Mbd2 is deleted from fibroblast cell lines there is a decrease in 
repression of methylated reporter genes. However, the level of expression is only 
25% of the expression level with unmethylated promoters. This data indicates a 
possible redundancy between MeCPs in the repression of methylated promoters 
(Hendrich et al., 2001). 
Abnormal maternal behaviour. 
The Mbd2 pups were observed to be smaller than normal because a defect 
in nurturing behaviour of the Mbd2 mothers. This observation was concluded after 
cross-fostering experiments showed that pups from Mbd2 	mothers developed 
normally when nurtured by wild type mothers, whereas when nurtured by Mbd2 
mothers the pups showed low weight. This low weight was proven to be independent 
of the maternal milk composition (Hendrich et al., 2001). 
Normal postpartum nurturing behavior in rodents is quite stereotyped and 
includes creating a nest, cleaning the pups, retrieving them to the nest and crouching 
over them for warmth and nursing (Barnett and Burn, 1967). The ability of the 
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postpartum mother to retrieve the newborn pups to their nest is the definitive 
diagnosis of a possible abnormal nurturing behaviour (Li et al., 1999). Mbd2 
mothers were significantly slower than the wild type in this task. The postpartum 
nurturing response has two components, one experiential and one hormonal 
(Rosenblatt, 1994). Both require specific hippocampal circuitry involving the main 
olfactory bulb that receives the olfactory stimulus from the newborn pup. This signal 
is transmitted to the amygdala and preoptic area (POA) of the hypothalamus. 
Therefore, it is possible that Mbd2 null mice suffer from an unidentified neurological 
defect related with neuronal circuitry. 
A mutation in the fosB gene, which is involved in the POA circuitry, causes a 
nurturing behavior phenotype while other sensory and cognitive functions are normal 
(Brown et al., 1996). By a targeted disruption of the dopamine-/3-hydroxylase gene, 
mice are unable to synthesise norepinepbrine (NE) and epinephrine (Thomas and 
Palmiter, 1997). With the absence of the ligand NE mice present nurturing 
abnormalities, which have been specifically associated with a disruption of 
noradrenergic input in the olfactory bulb and other primary olfactory regions of the 
CNS. Both gene disruptions, foxB and Dbh results in a dysfunction of the induction 
of early genes in response to pup exposure. 
Other proteins involved with maternal nurturing behavior are Peg3 and Mest, 
which are imprinting genes. No misexpression of imprinted genes has been shown in 
Mbd2 mutant animals, including Peg3 or Mest. Therefore it is more likely that Mbd2 
is required as a transcriptional repressor in the olfactory circuitry of the central 
nervous system. 
T cell differentiation. 
Looking closely to possible gene misregulations in the absence of Mbd2, 
investigators studied organization of T cell development in absence of Mbd2. Helper 
T cell differentiation comprises a complex cascade of gene expression that is known 
to involve transcriptional reprogramming and developmental effects (Bird et al., 
1998). The progenitor naïve helper T cell starts a differentiation program under 
microbial threat and differentiates into Thl or Th2 lineage. Thi is characterised by 
the expression of the transcription factor T-bet and the secretion of IFN-y. 
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Meanwhile, Th2 is characterised by the expression of the transcriptional activator 
Gata-3 and secretion of IL-4 (Mullen et al., 2001; Ouyang et al., 1998; Szabo etal., 
2000; Szabo et al., 2002; Zheng and Flavell, 1997). However, when Mbd2 is not 
present, both Thi and Th2 cells, and also the progenitor helper T, express 1L4, 
bypassing the transcriptional differentiation effect of Gata-3. In normal conditions, 
Gata-3 is believed to compete with the binding of Mbd2 to the 1L4 enhancers, so in 
the absence of Mbd2 1L4 is expressed regardless the cell type (Hutchins et al., 2002). 
Additionally, it was found that Mbd2 also competes with T-bet in the expression of 
WN-y, since Mbd2 repress and T-bet activates expression of IFN-y. Consequently, 
the number of IFN-y expressing cells is higher in Mbd2 null mice. These in vitro 
observations have recently been assayed one step further when Mbd2 deficient mice 
were challenged with parasitic pathogens. The interesting outcome from these 
experiments is that Mbd2 deficiency confers enhanced resistance to Leishmania 
major because of the enhanced population of IFN-y expressing cells, but impaired 
immunity to Trichuris murs. This intestinal helminth activates the immune response 
of Th2 cells that secrete IL-4, and the resistance to the infection is antagonized by 
IFN-? (Hutchins et al., 2005). 
Tumorigenesis. 
Another characteristic of Mbd2 null mice is that they have a decreased 
incidence of tumour formation. Mice that are heterozygous for the tumour suppressor 
Apc gene are very susceptible to develop intestinal tumours (Su et al., 1992). Mbd2 
homozygous null mice, on an Apc Min/+  heterozygous background present less number 
of tumours with less size, and consequently they live longer. The absence of Dnmtl 
has been also shown to reduce the intestinal tumours in Apc minl+  mice (Laird et al., 
1995). It is believed to be related with a decrease in the aberrant methylation of 
tumour suppressor genes (Campbell and Szyf, 2003). However, the hypomethylation 
of the genome caused by Dnmtl deficiency can also result in increased or 
accelerated tumorigenesis. The type of tumours seen with Dnmtl defficiency appears 
to be linked with chromosomal instability, in particular sarcomas and aggressive T 
cell lymphomas (Eden et al., 2003; Gaudet et al., 2003). In contrast, Mbd2 null mice 
do not develop lymphomas. This conclusion was derived from the study of Mbd2- 
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null mice crossed with lymphomagenesis-prone p53-deficient mice (Sansom et al., 
2005). p53 misregulation is the most established model of lymphomagenesis, and 
does not induce intestinal tumorigenesis. 
It is an open question what methylated sequences Mbd2 binds (Klose et al., 
2005). There is no sequence specificity known for this protein, and therefore it could 
be targeted to any selected sequence. This idea has been reinforced with the 
discovery of a protein named MIZF (Mbd2-interacting zinc finger), that can repress 
transcription in an HDAC-dependent manner (Sekimata et at., 2001). This protein 
has been shown to enhance the repression function of Mbd2 in co-transfection 
experiments. Since this protein can bind to a specific 5bp recognition sequence with 
a subsequent repression of transcription of the genes that have that consensus 
sequence within its promoter (Sekimata and Homma, 2004), it is plausible that MIZF 
targets Mbd2 and the NuRD complex to specific genomic regions. 
1.10 Mbdl 
Ectopically expressed of Mbdl, 2, and 4 can bind to methylated CpG 
sequences that in mouse cells is concentrated in the major satellite. These 
heterochromatic foci can be visualized as DAPI bright spots (Miller et al., 1974). 
However, this localisation is lost for Mbd2 and Mbd4 in methylation deficient 
mutant cells (Hendrich and Bird, 1998). In contrast, Mbdl can still be visualized at 
DAPI bright spots in deficient cells because it can also bind unmethylated CpGs. 
This particular binding capability will be described below (Jorgensen et al., 2004). 
Mbdl is the largest protein in the MBD family. In the C-terminus, Mbdl has 
a specific transcriptional repression domain TRD that is capable of strong methyl-
dependent repression from binding sites far upstream of its promoter (Ng et al., 
2000) (Fujita et al., 2003b). Since TSA treatment variably relieves the repression by 
Mbdl, histone deacetylation may not be consistently involved in the repression (Ng 
et at., 2000). 
Both human and mouse cells have several isoforms of MBD 1 protein, derived 
from alternative splicing of MBDJ mRNA and differing in the number and spacing 
of cysteine rich motifs (CxxC) (Fujita et al., 1999; Hendrich and Bird, 1998). These 
CxxC motifs are located in the N-terminal domain, which also contains the MBD 
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that can bind a single symmetrically methylated mCpG pair. In mice there are three 
known Mbdl transcripts, Mbdla, b and c. The three of them have two CxxC, and 
Mbdla has additionally a third CxxC. Mbdla can bind to unmethylated CpGs and 
repress transcription through its CxxC (Jorgensen et al., 2004). This special 
capability confers Mbdl the ability to bind to CpG sequences regardless their 
methylated status. Similar CxxC domains can be found in Dnmtl, CpG binding 
protein (CGBP), and the mixed lineage leukemia protein (MLL) (Ng et al., 2000), all 
-of which have been demonstrated to bind to nonmethylated CpG sites in vitro (Birke 
et al., 2002;-Lee et al., 2001; Voo et al., 2000). 
In HeLa cells MBD1 associates with the histone H3-lysine9-specific 
methylase SETDB 1 via its second CxxC motif and to a chromatin assembly factor, 
CAF-1 by the first CxxC motif (Sarraf and Stancheva, 2004). CAF-1 is a complex of 
three subunits, p150, p60, and p48, and is responsible for the assembly of 
nucleosomes onto newly replicated DNA (Kaufman et al., 1995). The p150 subunit 
is known to interact with the proliferating cell nuclear antigen PCNA, a protein 
implicated in a wide range of DNA replication and repair processes (Moggs et al., 
2000; Reese et al., 2003) that functions in S phase. This complex meets a neat 
process of transmission of transcriptional silencing through the cell cycle. MBD1 
and SETDB1 form a stable pair in all the cell cycle stages. At GI, MBD1/SETDB1 
complex is bound to methylated DNA to repress transcription. When the cell enter S 
phase to start the DNA replication, MBD1 recruits CAF-1, and the CAF -
1/MBD1/SETDB1 complex is formed. CAF-1 then recruits PCNA. This complex is 
transient because it may prevent spreading of 113-K9 methylation beyond the 
methylated DNA region. During S phase, this complex may associate with Dnmt 1, 
which also binds to PCNA, to copy the parental methylation pattern to the daughter 
DNA strand, and together with the histone methylation activity by the SETDB 1, the 
epigenetic status of the silenced chromatin is maintained at the replicated DNA. 
1.10.1 Mbdl expression 
Mbdl is expressed in the majority of somatic tissues, being expressed highly in 
brain and only at very low levels in ES cells. In the mouse brain Mbdl is expressed 
everywhere and the highest expression is in the hippocampus, being particularly high 
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the Cornu Ammoni 1 (CAI) and dentate gyrus (DG) regions. The cells that express 
Mbdl most abundantly are Neuronal Nuclei (NeuN)-positive neurons, but it is also 
expressed in Nestin-positive precursor cells. Mbdl is not expressed in 
oligodendroctyes neither in astrocytes. The CAI and DG are the neuronal layers with 
higher expression of Mbdl. 
1.10.2 Mbdl deficient mice and Mbdl function 
Mbd1 	mice are healthy and fertile with a normal life span (Zhao et al., 
2003). They display no defects in routine neurological tests and the cellular and 
structure brain arrangements are normal. In vitro studies showed normal proliferation 
rates in hippocampal adult neural stem cells but revealed a decrease in neuronal 
differentiation while astrocytic differentiation was not affected. Given this finding, in 
vivo studies followed the neuronal differentiation phenotype to find that cell 
proliferation as measured by BrdU incorporation was not affected in the null 
hippocampus. However 4 weeks after injection there were less 50 percent of 
proliferating cells in the (DG) of Mbdl null than wild type, and from this percentage 
around 50 percent were newborn neurons, giving it a total of approximately 75% less 
newborn neurons in total in null adult mice. Ultimately, the neuronal differentiation 
and survival impairment in null Mbdl hippocampus was conclusively linked with 
specific DG hippocampal learning and memory tests studies, since this test showed 
impaired spatial learning ability and a three-fold decrease in LTP in the DG-specific 
region, which has been associated with decreased neurogenesis (van Praag et al., 
1999). 
Adult hippocampal neural stem cells were used in microarray studies in the 
search for genes misregulated in Mbdl-null cells. From these experiments 
intracisternal A particles (lAP) were found to be expressed at higher level in null 
adult neural stem cells (ANCs) than in wild type. As described before, the increased 
expression in lAPs has also been observed in the absence of Dnmtl (Walsh et al., 
1998) since TAPs are heavily methylated (Yoder et al., 1997). In contrast, in Mbd1 
ANCs there is no evidence of demethylation. Interestingly, upon TSA treatment the 
lAP expression increases three times more in null cells than in wild type cells, giving 
evidence of a mechanism of repression that involves deacetylation machinery. lAP 
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expression is a signal for chromosomal aberrations, and in concordance, Mbdl null 
ANC have double aneuploidy rates than in wild type cells, namely gaining of 
chromosomes. Given that aneuploidy is a cause of cell death, it is possible that the 
decreased cell survival in the DG is the cause of the increased expression of lAP 
found in their precursors. 
Another piece of evidence that corroborate a function for Mbdl in regulation 
of precursor cell fate is the recent discovery that Mbdl is required in hematopoietic 
precursors to fully prevent cell differentiation. This function requires Mbdl 
association with methylated PML-RARa target promoters, namely RARI32 via 
HDAC3 repression (Villa et al., 2006). 
1.11 Mbd4 
Mbd4 binds symmetrically methylated CpG sites through its MBD (Hendrich 
and Bird, 1998) although it has a higher affinity for 5mCpG/TpG mistmatches 
(Hendrich et al., 1999), which are common mutation products of the deamination of 
methylcytosine at mCpGs and account to more than 20% of all base substitutions in 
human genetic diseases (Krawczak et al., 1998). Mbd4 also contains a glycosylase 
domain (Hendrich and Bird, 1998; Petronzelli et al., 2000) which can remove T or U 
in a mismatched base pair in vitro with G without cleaving the DNA strand 
(Hendrich et al., 1999). Both domains confer upon Mbd4 the appropriate 
characteristics to function as a mutability repair enzyme to reduce mutation at 
methylated CpG sites in vivo, and indeed mice lacking Mbd4 have an increase in the 
frequency of mutation at m5CpG pairs, and are prone to intestinal tumorigesis on an 
ApcMmn background (Millar et al., 2002; Wong et al., 2002). Moreover, loss of Mbd4 
alters wild type Ape allele due to CpG to TpG mutations that causes APC protein 
truncation (Millar et al., 2002). Deficiency of Mbd4 also causes reduction of the 
apoptosis response in DNA damage (Sansom et al., 2003). Additionally, the MBD 
has recently been found to function not only to direct the enzyme to possible 
mismaches, but also as part of the transcriptional repressor machinery (Kondo et al., 
2005). Mbd4 is involved in transcriptional repression at hypermethylated promoters, 
which are also H3/H4 deacetylated and H3K9 methylated. Repression of 
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transcription probably occurs through recruitment of HDAC1/Sin3A (Kondo et al., 
2005). 
1.12 Kaiso 
Kaiso protein is a member of the BTB/POZ (broad complex, Tramtrack, Bric 
A brac/pox viruses and zinc fingers) family of proteins. The BTB/POZ domain 
consists of a highly conserved hydrophobic domain of approximately 120 amino 
acids located at the extreme N terminus. This POZ/BTB domain enables Kaiso to 
homodimerize or heterodimerize and interact with other proteins, recruiting 
corepressor complexes such as N-CoR, Sin3a and possibly Groucho or TLE (van 
Roy and McCrea, 2005). However, in the Kaiso-containing methyl-CpG specific 
complex, mSin3a, HDAC1 or SMRT where not isolated (Prokhortchouk et al., 
2001). 
In the carboxy-terminal there are three krupple-like C 2H2 zinc fingers that 
have the ability to bind from two to three consecutive methyl-CpG base pairs with 
the highest reported affinity of any protein for DNA methylated at CpG 
(Prokhortchouk et al., 2001). Kaiso binds to DNA through its zinc fingers 2 and 3 
and localised, as the rest of the MeCPs with the major satellite repeats in the 
chromosome, although mouse major satellite repeats do not contain the sequence 
CGCG and therefore Kaiso may not be targeted by methylation binding (Filion et al., 
2006). 
p120 catenin (p120) is a member of the armadillo family of proteins, 
characterised by the presence of an Armadillo domain which consist of series of ten 
or more tandem copies of a 42 amino acid repeats in helical conformation (Huber et 
al., 1997; Kobe, 1999). The function of the armadillo domain is protein-protein 
interaction (Peifer et al., 1994). As other catenins of this family, like 13  and y 
catenins, p120 is involved in cell-cell adhesion, and hence related to metastasic 
events, but also is directly involved in regulation of gene expression by regulating 
the transcriptional repression activity of Kaiso (Daniel et al., 2002). Through its 
NLS, p120cm  is translocated to the nucleus and associates through its armadillo 
domain with Kaiso. Steric hindrance of Kaiso by p120cth  may inhibit Kaiso 
transcriptional repression activity (Kelly et al., 2004b). 
Intracellular localisation of Kaiso is still controversial. There have been 
reported two different nuclear localisations: both a bright dot spots and diffuse 
localisation, with a variation between cell lines but also among same cell lines 
(Daniel and Reynolds, 1999; Filion et al., 2006). Apart from nuclear localisation, 
some cases of cytosolic localisation have also been reported for Kaiso. Although a 
role for p120 in sequestering Kaiso to the cytosol to modulate its transcriptional 
repression activity was initially postulated (Daniel and Reynolds, 1999), it has been 
recently shown that a NLS mutant form of p120 unable to translocate to the nucleus 
and fails to inhibit Kaiso-mediated transcriptional repression (Kelly et al., 2004b). 
Additionally, Kaiso itself has a highly basic ten amino acid NLS, upstream of the 
Kaiso zinc-finger domain that target Kaiso to the nucleus and that is involved in the 
transcriptional repression activity of the protein (Kelly et al., 2004a). One report 
assigned Kaiso a cellular localisation that is environment-dependent. For example, in 
vitro cultured cells were shown to mainly have a nuclear Kaiso localisation, while 
three dimensional cultures, normal tissues and tumor growths seemed to show 
predominantly cytoplasmic localisation, perhaps being cell density dependent 
(Soubry et al., 2005). However, other immunocytochemistry studies have pointed out 
a predominantly nuclear localisation in vivo in mice colon tumors (Prokhortchouk et 
al., 2006). 
Kaiso can repress transcription in a methylation dependent manner and both 
POZ and zinc finger domains are necessary. Transcriptional silencing may not 
depend upon histone deacetylase activity since addition of TSA does not disturb the 
repression activity (Prokhortchouk et al., 2001). Additionally, through its zinc fingers 
Kaiso can bind the consensus Kaiso binding site (KBS) TCCTGCNA. Through this 
consensus Kaiso has been shown to repress the transcription of the genes 
MATRYSILIN (Spring et al., 2005) in humans and Wnt-11 in Xenopus (Kim et al., 
2004), but also is able to activate the transcription of rapsyn (Rodova et al., 2004). 
Additionally, Kaiso interacts with the DNA binding protein CTC-binding factor 
(CTCF) through its Kaiso binding site (KBS). The enhancer blocking activity of 
CTCF has been shown to be negatively regulated by Kaiso (Defossez et al., 2005). 
Through recognition of mCGmCG Kaiso can repress transcription of MTA2 (Yoon 
et al., 2003b), and can bind to the human tyrosine hydroxylase TH gene (Aranyi et 
al., 2005). TH is essential for catecholaminergic neuronal specification and display 
different tissue specific methylation status, which determines KAISO binding. 
Therefore, it would be interesting to check whether the absence of Kaiso in neural 
stem cells increases their TH specification. However, these characterised target genes 
were not found to be upregulated in Kaiso-null tissues (Prokhortchouk et al., 2006). 
1.12.1 Kaiso in Xenopus 
In Xenopus, xKaiso is essential for development. Depletion of Kaiso in 
Xenopus embryos causes a striking phenotype consisting of developmental arrest and 
cellular apoptosis, characteristics that mimic the phenotype of Dnmtl depletion in 
Xenopus (Stancheva et al., 2001) and mouse embryos (Jackson-Grusby et al., 2001). 
These severe effects are consequence of the premature activation of genes expressed 
in the mid blastula stage that are normally silenced by DNA methylation. Mid 
blastula transition is the time when a dependence upon maternal transcripts gives 
way to the start of zygotic transcription, and precedes a period of transcriptional 
silencing lasting 12 cell divisions. Thus, loss of Kaiso results in up-regulation of 
more than 10% of genes in early development. 
xKaiso cooperates with the' T cell factor/lymphocyte enhancer factor 
(TCF/LEF) family to repress transcription of targets from the canonical Writ 
signalling pathway with the recruitment of the corepressor N-CoR (Kim et al., 2004). 
Particularly, xKaiso interacts with xTCF-3, and exogenous xTCF-3 can rescue some 
defects resulting from xKaiso depletion (Park et al., 2005). xKaiso represses 
transcription of Siamois, Xnr3 (Park et al., 2005) and xWnt-1 1(Kim et al., 2004), and 
other t3-catenin gene targets such as PPAR- , c-Myc, Cyclin Dl and Matrilysin, 
which has a Kaiso consensus site adjacent to TCF binding site. From these targets, 
Cyclin Dl and c-myc have been shown to be upregulated after xKaiso depletion in 
vitro and further confirmed in vivo for cyclin Dl (Park et al., 2005). To circle the 
pathway, it is interesting to note that Xp120-catenin can relieve xKaiso repression of 
Siamois and xWnt-l1. 
1.12.2 Kaiso and the family of MeCP Zinc finger proteins 
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Recently two human proteins were identified containing Kaiso-like zinc 
fingers, ZBTB4 and ZBTB38 (Filion et al., 2006). These two proteins can bind 
sequences containing a single methylated CpG and have been shown to be methyl-
dependent transcriptional repressors. The homolog of ZBTB38 in rat is called Zenon 
(Kiefer et al., 2005), and in mouse is called CIBZ (Sasai et al., 2005). Kaiso protein 
is common to all vertebrates and it might have duplicated in evolution from an 
ancestor that originated Kaiso and another protein that probably duplicated itself in 
ZBT38 and ZBT134 because they are 75% similar within each other and around 40% 
with Kaiso. ZBT38 is expressed in brain and in neuroendocrine tissues, while 
ZBTB4 is expressed in most tissues, being the highest in brain, lung, kidney, muscle 
and heart, intermediate level in placenta, liver, spleen and thymus, and lowest 
expression in the testis (Filion et al., 2006). 
1.13 Nuclear CoRepressor Complex 
N-CoR is a class I HDAC-containing corepressor, primarily associated with 
HDAC3 (Guenther et al., ; Li et al., 2000; Wen et al.). N-CoR purified from HeLa 
nuclear extract contains 10-12 proteins (Yoon et al.): Among these are: TBL1 and 
TBLR1, two highly related WD-40 repeats histone-binding proteins; GPS2, an 
intracellular signalling protein and TRIO a coronin-like actin binding protein. 
TBL1/TBLR1 bind to histones H2B and H4 preferentially through their N-terminal 
region (Yoon et al., 2003a). Additionally, Kaiso has been identified as a component 
of the N-CoR complex in HeLa cells. N-CoR has been shown to repress transcription 
in a methylation-dependent manner in vivo (Yoon et al., 2003b). 
Neuron-specific genes have a conserved 21-23 base pair DNA response 
element, known as RE-for NRSE (repressor elementi/neuron restrictive silencer 
element) which is bound by the RE-i silencing transcription factor/neuronal 
restricted silencing factor (REST-NRSF) (Chong et al., 1995; Schoenherr and 
Anderson, 1995). N-CoR associates with the REST/NRSF transcriptional repressor 
and brings together histone deacetylase activity (HDAC3) to the promoter of 
neuronal genes, which is essential for the repression of these genes in non-neuronal 
cells (Jepsen et al., 2000). 
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1.13.1 N-CoR function through N-CoR null mice 
N-CoR-deficient embryos exhibit defects in the developmental progression of 
specific erythroctye, thymocyte and neural events (Jepsen et al., 2000). MAP2 
expression, a marker for late neuronal differentiation, was reproducibly enhanced in 
the outer cortical layers in N-CoR embryos (Jepsen et al., 2000). MAP2 can be 
induced by retinoic acid and harbours Retinoic Acid Response Elements (RAREs) in 
its promoter, and its upregulation in the cortex at the onset of neurogenesis identifies 
it as a putative target gene for N-CoR mediated repression through unliganded RAR 
(Neuman et al.). Decreased levels of Map2 have been suggested to inhibit neuronal 
differentiation and neurite formation (Dinsmore and Solomon, 1991). Concordantly, 
E12.5 N-CoR-deficient embryos also express decreased levels of Nestin (Jepsen et 
al.). Additionally, Gfap expression, indicative of astrocytic differentiation, is 
increased and precocious in N-CoR deficient embryos, starting the expression as 
early as E14.5 (Jepsen et al., 2000). These results indicate an early fate specification 
of nestin- expressing neural stem cells differentiated cells. 
In addition to the in vivo studies, detailed in vitro experiments have been used 
to dissect the specific role of N-CoR in neural stem cell function. Neural stem cells 
are able to be maintained in an undifferentiated state and retain the capacity to self-
renew in response to fibroblast growth factor-2 (FGF2) (Temple). Cultured in vitro 
cortical progenitors derived from E13 N-CoR mice fail to proliferate and self-
renew, and undergo spontaneous differentiation into astrocytes even in the presence 
of high concentrations of FG172 (Hermanson et al.). Therefore, the phenotype of N-
CoR neural stem cells may be due to an intrinsic inability to maintain the FGF2-
mediated undifferentiated and proliferative state. 
Treatment with ciliary neurotrophic factor (CNTF), which promotes a rapid 
and efficient differentiation of neural stem cells into Gfap-expressing astrocytic cells 
(Johe et al., 1996), results in a translocation of N-CoR from the nucleus to the 
cytoplasm which may result in degradation (Hermanson et al., 2002). This 
mechanism occurs by enzymatic regulation: CNTF co-ordinately down-regulates 
protein phosphatase- 1 (Aggen et al., 2000; Egloff et al., 1997) and activates Aktl - 
kinase (Bellacosa et al.), resulting in an increased phosphorylation and cytoplasmic 
localisation of N-CoR. Since Fgf2-treated neural stem cell cultures show endogenous 
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nuclear N-CoR localisation, and overexpression of N-CoR inhibits the astrocytic 
differentiation and Gfap expression that occurs in response to CNTF stimulation, it 
can be concluded that N-CoR is a principal component of cell type determination. 
Platelet-derived growth factor (Pdgf) increases neuronal differentiation of 
neural stem cells after initial Fgf2-dependent expansion (Johe et al., 1996). 
Treatment with Pdgf in N-CoR neural stem cell cultures did not increase the 
number of TuJ 1-positive cells compared with wild-type cells. This indicates that in 
contrast to the spontaneous differentiation along the glial pathway, neuronal 
differentiation is not induced by the absence of N-CoR in cultured cells. 
1.14 Self-reinforcing cycle of repressed epigenetic status 
At the earliest developmental stages the embryo is formed by cells that have 
the potential to give rise to any cell of the adult organism. This pluripotency will 
gradually be restricted through multiple cell divisions, giving a range of 
differentiated cells with specialised protein expression patterns to function in the 
different tissues of the organism. Cell memory is the process by which the cell 
inherit its protein expression pattern and it is established early in development. There 
are two important epigenetic mechanisms that regulates cell memory: DNA 
methylation and histone modification. Considerable evidence indicates that these two 
mechanisms are interegulated in mammals. 
Firstly, DNA methyltransferases and methyl-CpG binding proteins recruit 
histone deacetylase-containing corepressor complexes (Bird, -2002). Secondly, the 
MeCP Mbdl binds to the histone H3-lysine9-specific methylase SETDB1 and 
together with the chromatin-assembly factor CAF-1 favours the stable transmission 
of silenced chromatin states at methylated DNA (Sarraf and Stancheva, 2004). 
Similar interaction with histone methylases may occur with the other MeCPs. In 
mammals, Dnmt transferases require interaction with the Suv39h H3K9 
methyltransferase and heterochrornatin protein 1 adaptor molecule (HP 1). This has 
been concluded from the observation that Suv39h-knockout ES cells decrease 
Dmmt3b-dependent CpG methylation at major centromeric satellites (Fuks et al., 
2003a; Lehnertz et al., 2003). 
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Another repression mechanism is methylation at histone H3 at lysine 27 
(H3K27) by the Polycomb group protein EZH2. This enzyme form together with the 
EED and SUZ12 proteins the Polycomb repressive complexes 2 and 3 (PCRC2/3) 
(Kuzmichev et al., 2004). Whether EZH2 methylates Hi or H3 will depend upon 
which other proteins are in the complex (Kuzmichev et al., 2004). Recently, EZH2 
has been shown to interact with the three DNA methyltransferases (DNMT1, 
DNMT3A and DNMT3B) in vivo and in vitro (Vire et al., 2006). Repression of 
EZH2 target genes require both EZH2 and DNMTs. Depletion of EZH2 disturbs 
recruitment of DNMTs to the regulatory regions of the EZH2 target genes which 
cause the expression of these genes. 
1.15. Mouse Embryonic Stem Cells 
The mouse 3.5 days post-coitum (d.p.c) embryo is called a blastocyst. It 
consists of around 60 cells organised in two different structures: the inner cell mass 
or 1CM and the trophectoderm where the former is attached. The cells contained in 
the 1CM are pluripotent and they will give rise to all the tissues of the organism with 
the exception of the trophctoderm. 
Arresting the further development of the blastocyst and culturing the 
outgrowth of the 1CM in vitro makes it possible to obtain a very special type of cells, 
embryonic stem cells, that are also pluripotent and undergo symmetrical self-renewal 
divisions so they can be maintained for indefinite time in in vitro cultures in defined 
conditions. (Evans and Kaufman, 1981; Martin, 1981). The confirmation of 
pluripotency is obtained by their capacity to be reintroduced in the mouse embryo 
and contribute to a variety of tissues of the resulting chimera and even to pass 
through the germline (Bradley et al., 1984). 
There is an orchestrated signalling network involved in the maintenance of 
pluripotency of the embryonic stem cells that has been extensively studied and fairly 
well established. An embryonic stem cell maintains its pluripotency during its 
replication by its capacity to self renew by a symmetric cell division into two 
identical daughter embryonic stem cells. There are two cytokines indispensable for 
the self-renewal of ES cells, Leukaemia Inhibitory Factor, LIF (Smith et al., 1988; 
Williams et al., 1988) and Bone Morphogenetic Protein, Bmps (Ying et al., 2003a). 
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Each one stimulates a signalling pathway through the cell involving many 
downstream elements. Lif is a member of the 1L6 family of cytokines and targets a 
heterodimeric cell surface receptor complex comprising the Lif receptor subunit 
(Gearing et al., 1991), and glycoprotein 130 (Davis et al., 1993). The downstream 
signalling is followed by JAK-kinase mediated recruitment, activation and nuclear 
translocation of the signal transducer and activator of transcription factor Stat3. 
There are other related cytokines, like CNTF, that interact with the Lif receptor 
LIFRIgp 130 complex and can substitute LIF for ES cell self-renewal (Pennica et al., 
1995). Gp130 cytokines can also activate the mitogen activated protein kinases 
(MAPK) Erki and Erk2 (Fukada et al., 1996) of the ERK pathway, which appears to 
be a pro-differentiative signal (Burdon et al., 1999b). Thus it has been found useful 
to reduce ERK signalling in order to facilitate ES cell derivation (Buehr and Smith, 
2003) and to promote self-renewal (Burdon et al., 1999a). In the absence of LIF, ES 
cells lose their self-renewal capacity and differentiate into flattened epithelial-like 
cells. In the absence of BMP4, ES cells differentiate into the neural lineage (Ying et 
al., 2003a). Bmp family members known to contribute to pluripotency and self-
renewal are Bmp2, Bmp4 and Gdf6 and they act by inducing expression of members 
of the Id family of negative transcriptional modulators (Ying et al., 2003a). 
Additionally, .there are two key transcription factors involved in self-renewal, 
Oct4 and Nanog, which together with Sox2 complete a transcription cascade, to 
active genes involved in self-renewal and pluripotency and to inactivate genes 
involved in differentiation (Boyer et al., 2005; Loh et al., 2006). Depletion of Oct4 in 
ES cells causes their differentiation into trophectodermal cells, meanwhile 
overexpression of Oct4 induces differentiation into primitive endoderm and 
mesoderm lineages (Niwa et al., 2000). Nanog confers cytokine independent self-
renewal, acting synergistically with Stat3 signalling since overexpressing Nanog 
cells form pure stem cell colonies at clonal density but with significant increased 
efficiency when LIF is added (Chambers et al., 2003). 
1.16. Neural Induction 
ES cells have the capacity to differentiate into any cell of any tissue of the 
organism. Different cell types can be obtained under specific in vitro conditions, 
55 
despite the lack of germ line signals and normal developmental environment, or 
niche signals. There is a very important potential for ES cell differentiation as a tool 
for tissue regeneration since the amplification of ES cells is almost unlimited. 
Additionally, ES cells provide a practical system to study which signals govern cell 
specification. Neuronal differentiation from ES cells is a well-established 
differentiation system since there is a great interest in understanding the origins of 
neurodegenerative diseases in order to design therapeutic approaches. 
A high percentage of ES cells growing in the presence of L1F, but in the 
absence of BMP ligands, will become specified towards neural lineages and 
consequently a high percentage will adopt a neuronal fate (Ying et al., 2003a). An 
established, though debated hypothesis is that of neural induction by default. This 
model considers that in the absence of repressive signals from BMP a mouse ES cell 
will adopt a neural fate (Tropepe et al., 1999). This theory origines from work in 
Xenopus laevis with the identification by Speman and Mangold of a region that could 
induce neural specification, which was called the organizer (known as Spemann-
Mangold organizer (Spemann and Mangold, 2001) or, in the chick, as Hensen's 
node) (Hensen, 1876; Waddington, 1936). The signals released by the organizer that 
were needed for the neural induction were identified subsequently to be antagonists 
of BMP receptors, namely Noggin, Chordin, Cerberus, Xn3 and follistatin 
(Hemrnati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 1994). However, 
later observations suggested that the default mechanism may not explain the 
complete picture of neural specification. For example, mice deficient for Noggin and 
Chordin can form neural tissue, although they have severe forebrain defects 
(Anderson et al., 2002). Additionally, ES cells require FGF/MAPK signalling in 
order to generate neural derivatives in vitro (Ying et al., 2003b)(and it will be 
explained in the next section). It is most likely that neural induction depends upon a 
variety of signals, including Fgf signalling and Wnt signalling which are both 
involved in repression of Bmps (Linker and Stem, 2004) but may also act 
independently of BMP repression. 
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1.17. ES neural specification in vitro 
The so-called monolayer differentiation system permits us to dissect signals 
and conditions that may be important for ES cells to differentiate into neurons (Ying 
et al., 2003b). This adherent culture system is relatively homogenous and the 
components of media culture are defined. From this system we know, firstly the time 
course with which neural precursors start to appear in the cultures; and secondly, 
that cell density is critical for differentiation, since high density leads to no neuronal 
differentiation, and low density leads to poor cell survival. Hence, cell-cell 
communication is necessary for cell specification. In concordance, a culture system 
with a high percentage of dopaminergic neuronal specification from ES cells 
described the importance of cell contact of the stromal feeder cell layer from mouse 
skull bone marrow and the ES cells, stromal-cell-derived inducting activity or SDIA 
(Kawasaki et al., 2000). 
These ideas correlate with what have been previously described from other 
less homogenous culture systems, such as neurospheres generated from low density 
cultures of ES cells in the presence of LIF, possibly as a cell survival cytokine 
(Tropepe et al., 1999). After 7 days, FGF signalling start to play an important role in 
neural specification, since FGF receptor 1 FGFR1 deficient ES have a decrease in the 
number of neural colonies (Ciruna et al., 1997; Tropepe et al., 2001). 
1.18. Development of the mouse nervous system 
The cells within the inner cell mass will generate two layers: the hypoblast or 
primitive endoderm and the epiblast. The primitive endoderm will contribute to 
extraembryonic tissues, and the epiblast will give rise to the three main germ layers 
in the embryo. The innermost layer is the endoderm, which gives rise to the gut, 
lungs, liver and pancreas. The middle layer or mesoderm, gives rise to connective 
tissues, muscle and vascular system, and the ectoderm, which is the outermost layer, 
gives rise to the central and peripheral nervous system and epidermis. Al! layers have 
a common origin from the primitive streak formed at 6.5 dpc. At the gastrula stage, 
around 7, or 7.5 dpc the ectoderm forms a sheet called neural plate that, receiving the 
joint influence of signals from the node and the axial mesoderm, acquires neural 
properties. At 9.5 dpc, the neural plate will fold into the neural tube. The caudal 
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region of the tube will give rise to the spinal cord, and the rostral region will form the 
prosencephalon. Because of a difference in the proliferation rate. among the cells 
forming the neural tube, it will develop in different 'bulbs'. Thus, the 
prosencephalon will form three brain vesicles: the forebrain, the midbrain and the 
hindbrain. The forebrain will give rise to the telencephalon and diencephalons, and 
the hindbrain vesicle will give rise to the metencephalon and myelencephalon. The 
dorsal part of the telencephalon or Pallium, is the origin of the cerebral cortex, that 
itself is divided in three structures: neocortex, paleocortex or piriform cortex and 
hippocampus or archicortex. 
Cerebral cortex development follows an inside-out model, so the newly 
generated neurons migrate towards the more apical brain areas through the older 
neuronal layers already formed (Angevine and Sidman, 1961). The cerebral cortex 
will be populated with a majority of excitatory glutamatergic projecting neurons that 
form layers by radial migration from the germinal zone of the dorsal telencephalon. 
The ventral part of the telencephalon will generate the basal ganglia or subpallium, 
primarily arising from the medial and lateral ganglionic eminences, or primordial 
globus pallius and primordial striatum, respectively, at the wall of the ventricle. 
Gabaergic interneurons are formed in the basal ganglia, and basal ganglia neurons 
migrate tangentially to the cerebral cortex, where they become cortical interneurons 
(Anderson et al., 1997; Nery et al., 2002; Wichterle et al., 2001). The spatial and 
temporal origin of the eminence progenitors is correlated with the type of mature 
cortical interneuron that will originate from them (Butt et al., 2005). A third 
eminence, the caudal ganglionic eminence or CGE contributes to layer-5 cortical 
neurons, the striatum and the limbic system. Interestingly, the migratory routes taken 
appear to be cell intrinsic to the CGE-derived neurons (Nery et al., 2002) (figure 
1.5). 
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Figure 1.5. Developmental telencephalon representation. 
Pyramidal neurons arise from the dorsal proliferative zone or ventricular 
zone (red), and migrate outward in an inside-out manner giving rise to the 
six layers of the neocortex. GABAergic interneurons arise in the 
proliferative zone of the ganglionic eminences (green) and will migrate 
tangentially towards the neocortex. Oligodendrocytes are born from the 
most ventral region of the telencephalon (dark green) and will also migrate 
dorsally. Cholinergic neurons, and striatal astrocytes are born in the ventral 
telencephalon and will remain in the basal ganglia. LGE: lateral ganglionic 
eminence. MGE: medial ganglionic eminence. Adapted from Ross et al.. 
2003 and GuiIIe,not. 2005. 
1.19 Progenitor cells in the Telencephalon 
1.19.1 History of developmental neurobiology 
Golgi was the first to describe epithelial cells in the developing neural tube 
that extended radial fibres from the ventricular surface to the pial surface (Golgi et 
al., 2001). Golgi preparations were invaluable to neurobiologists to study the 
morphology of cells in the developing cortex and study their temporal sequence. He 
defined them as spongioblasts, but designated the neural source to the rounded 
germinal cells visible at the ventricular surface. In contrast, Magini proposed that the 
spongioblasts where immature nerve cell, and called them radial neuroglial cells after 
the observed varicositites along their filaments (Magini, 1888) Morest presented 
evidence to show that neurons grow radial processes and subsequently translocate to 
the cortex (Morest, 1970). In the 70's Rakik defined the epithelial or spongioblasts as 
radial glial cells, being glial supportive cells with the role to guide ñeuronal 
migration (Rakic, 1971; Rakic, 1972). Thus radial glial cells were considered as a 
type of glial support cell. Surprisingly, in 2000 was discovered that radial glial cells 
not only could generate cortical neurons, but that they are the major source of 
cortical pyramidal neurons, which was originally proposed by Magini in 1888 
(Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001). 
1.19.2 Neuroepithelial cells 
Neuroepithelial cells are the first progenitor cells to appear during the 
formation of the neural plate and neural tube. They have epithelial characteristics and 
are polarized, with an apical distribution towards the inner or ventricular lumen, and 
basal distribution forming the basal lamina at the outer or pial surface. The apical 
membrane presents tight junctions and adherens junctions which are important for 
the apical-basal polarity of the cell, and the basal membrane presents receptors for 
basal lamina (Huttner and Brand, 1997). The neuroepithelium appears layered 
because of the interkinetic nuclear migration of the neuroepithelial cells, or the 
nuclear migration during mitosis from the apical surface at GI and G2 and to basal 
lamina at S phase and M phase (Sauer, 1935). 
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During forebrain development, neuroepithelial cells give rise to the earliest 
born neurons of the cortex by asymmetric cell division at El 0, and by the onset of 
neurogenesis, neuroepithelial cells lose some epithelial features such as the tight 
junctions, and the apical-versus-basal polarity of delivery of certain plasma-
membrane proteins (Langman et al., 1966; Martin, 1967; Reid et al., 1995). 
Neuroepithelial cells express Rcl and Rc2 markers (Misson et al., 1988) together 
with intermediate filament protein Nestin (Lendahl et al., 1990) and can be detected 
at E9/E10. 
1.19.3 Radial glia 
With the onset of neurogenesis between E12 and E14, neuroepithelial cells 
become a more fate-restricted population called radial glia. This population 
constitutes the most common neuronal precursor in the central nervous system 
(CNS). Characteristic radial glia markers are glycogen granules (Gadisseux and 
Evrard, 1985), astrocyte- specific glutamate transporter Glast, TN-C, vimentin, and 
subsets have Blbp, s10013, and glutamine synthase GS and Rc2 in some species 
(Malatesta et al., 2003; Malatesta et al., 2000; Mori et al., 2005). Human, primates 
and adult mouse radial glia also express GFAP. Radial glial cells have 
neuroepithelial characteristics, such as the expression of intermediate filament 
protein Nestin (Hartfuss et al., 2001), apical-basal polarity, adherent junctions and 
interkinetic nuclear migration (Chenn and McConnell, 1995; Gotz and Huttner, 
2005). This last feature differs with neuroepithelial cells being more restricted 
nucleus migration through the cytoplasm. 
Radial glia cells act both as neuronal precursors boundary and patterning and 
guide structures for migrating neurons. They primarily divide asymmetrically, 
generating a radial glial cell and a postmitotic neuron, or a radial glial cell and a 
basal progenitor (Noctor et al., 2001). They generate neurons in many distinct areas 
of the CNS. In most brain regions, radial glia cells constitute the majority of 
progenitors at El 3/E 14, and they persist until the end of neurogenesis, when the 
remainder transforms into astrocytes (Noctor et al., 2004). Radial glia generate 
neurons in many distinct areas of the CNS, but the numbers are highest in dorsal 
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telencephalon, while the majority of ventral telencephalon neurons are most likely 
derived from basal progenitors. 
Pax6 is a neurogenic fate determinant factor for radial glial cells. Pax6 also 
inhibits the generation of basal progenitors, since Pax6 mutant mice have an 
increased population of basal progenitors. In this mutant neurogenesis still happens 
by differentiation from basal progenitors and migration from ventral sources 
(Hartfuss et al., 2001; Hems et al., 2002). Pax6 can induce neurogenesis in non 
neurogenic postnatal astrocytes (Hems et al., 2002) and is sufficient to stimulate 
adult neurogenesis (Hack et al., 2005). Additionally, Pax6 is expressed specifically 
by dopaminergic interneurons in the glomerunal layer during adult neurogenesis 
(Hack et al., 2005). 
1.19.4 Basal progenitors 
Basal progenitors originate from the asymmetric division of neuroepithelial and 
radial glial cells at the apical surface of the neuroepithelium and ventricular zone 
respectively. They are characterised by the absence of ventricular or apical contact, 
they have a long G2 phase and undergo mitosis at the basal side of the ventricular 
zone (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). Their 
molecular characterisation includes Tbr2 (Englund et al., 2005), Ngn2 (Miyata et al., 
2004) and the absence of Glast or Pax6 (Haubst et al., 2004; Malatesta et al., 2003). 
Additionally basal progenitors express neuronal markers (Englund et al., 2005). 
At E13 in the ventral telencephalon and E15 in the dorsal telencephalon, 
basal progenitors become abundant enough to form a secondary progenitor layer 
called the subventricular zone (SVZ), located on top of the precursors lining the 
ventricle in the ventricular zone. The basal progenitors usually divide symmetrically 
and generally produce two neurons (Haubensak et al., 2004; Miyata et al., 2001; 
Noctor et al., 2002) (Haubensak et al., 2004). However, after E15, they will acquire 
EGF receptor expression, that will be sometimes distributed asymmetrically in 
correlation with the generation of astrocytes or oligodendroctyes (Sun et al., 2005). 
Therefore, early SVZ precursors are mostly neurogenic, and late SVZ precursors 
produce mainly glia. 
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1.20 Neural stem cell! Neural progenitors signalling 
During the central nervous system development, neural progenitor cells are 
immersed in a variety of signals that will direct the cell fate specification of these 
cells. In this section, some of the key factors involved in neural specification are 
described (figure 1.6) 
1.20.1 Retinoic Acid 
Retinoic acid (RA) has long been identified as a efficient neural differentiation 
signal for ES cells in vitro (Bain et al., 1995; Doetschman et al., 1985; Fraichard et 
al., 1995; Okabe et al., 1996; Strubing et al., 1995). RA treated embryoid bodies 
dissociated and replated originate high percentage of differentiated neurons (Li et al., 
1998). 
In addition to being able to induce neural and neuronal differentiation, RA 
has an effect on the regional identity and subtype of the neurons that are generated. 
Very similar protocols can generate either glutaminergic neurons when RA is added 
(Bibel et al., 2004) or GABAergic neurons when RA is not added (Conti et al., 
2005). There is also some evidence that RA restricts progenitors to CNS rather than 
PNS identity (Plachta et al., 2004) and can posteriorise CNS identity (Blumberg et 
al., 1997). There is however, opposite evidence from studies where RA was used to 
promote neural crest derivatives, motoneurons and GABAergic interneurons (Barberi 
et al., 2003; Mizuseki et al., 2003; Renoncourt et al., 1998; Wichterle et al., 2002). 
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Figure 1.6 Diagram of some signaling pathways involved in cell fate 
specification of neural stem cells in the telencephalon. Adapted from 
Guile Pnot, 2005. 
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1.20.2 bHLH factors 
Neurogenin 1, Neurogenin 2, Mashi and NeuroD are basic helix-loop-helix 
(bHLH) genes which promote neurogenesis and are expressed in the developing 
cortex. These factors form heterodimers with the ubiquitously expressed bHLH 
protein E2A and activate neuronal gene expression by binding to the E box 
(CANNTG) (Guillemot and Joyner, 1993). Expression of neurogenic bHLH 
transcription factors are downregulated by another pair of bHLH transcription 
factors, Hesi and Hes5. These factors can repress neurogenic effects not only by a 
direct binding to a N box (CACNAG), but as well through competitive binding to the 
heterodimeric binding of the E box (Akazawa et al., 1992; Sasai et al., 1992; 
Takebayashi et al., 1995). The proneural proteins bHLH Neurogenin 1 and 
Neurogenin 2 are responsible for both 
neuronal cell migration and cell fate specification by separate mechanisms. These 
proteins are primarily expressed in the cortical ventricular zone, and Ngn2 is also 
expressed in the intermediate zone. Ngnl and Ngn2 are implicated together with 
Pax6 in the acquisition of cortical neuron specification as well as to repress genetic 
programs that would regulate non cortical neuronal differentiation such as those 
operating in the ventral telencephalon. In the absence of these factors, cortical 
progenitors are misspecified, expressing genes typical of ventral telencephalic 
progenitors. The result seems to be a respecification toward ventral neuronal fates. 
Indeed, the cells generated appear molecularly more akin to the GABAergic 
interneurons produced in the ganglionic eminences (Fode et al., 2000; Schummers et 
al., 2004; Stoykova et al., 1997; Sun et al., 2001; Toresson et al., 2000). 
1.20.3 Notch 
The Notch signalling pathway is involved in cell-cell signalling. In 
vertebrates there are four Notch receptors, and Notch 1-3 are expressed in developing 
brain and postnatal CNS germinal zones (Irvin et al., 2001). When the ligands, which 
are grouped into Delta and Jagged families, bind to their receptors, the intracellular 
domain of Notch (NICD) is released from the plasma membrane and translocates 
into the nucleus (Schroeter et al., 1998), where it converts the Cbfl (or RBPJ-K) 
repressor complex into an activator complex (Weinmaster, 1997). The NICD/CDBF 1 
activator complex upregulates Hes, Hey and Herp genes, which are basic helix-loop-
helix transcriptional regulators that antagonize proneural genes such as Mash 1 and 
the neurogenins (Iso et al., 2001a; Iso et al., 2001b; Jarriault et al., 1995; Leimeister 
et al., 1999). This antagonism blocks early neuronal gene expression and is central to 
the inhibition of neuronal differentiation (Ohtsuka et al., 1999). 
In mammals Notch activation is involved in maintaining the undifferentiated 
state by blocking neuronal gene expression, in a process called lateral inhibition 
(Lardelli et al., 1996). The disruption of Notch leads to precocious neuronal 
differentiation (de la Pompa et al., 1997) of mouse neural precursors. However, 
Notch can also function to promote neighbouring cells to adopt the same cell fate, in 
a process called lateral induction. 
In the striatum, Notch governs the asymmetric division that leads to neuronal 
differentiation at different stages of neurogenesis (Mason et al., 2005). In the mouse 
forebrain, Notch signalling directly activates the radial glia marker brain lipid 
binding protein (Blbp) (Anthony et al., 2005). Moreover, Notchi and Notch3 
promotes radial glia identity during embryogenesis and to dispersed and 
periventricular astrocytes postnatally (Dang et al., 2006; Gaiano et al., 2000). It has 
been shown that activated Notch 1 promotes a proliferative response to bFGF in vitro 
(Yoon et al., 2004). 
1.20.4 bFGF 
The FGF family of proteins consists of 22 members that can be grouped into 
seven subfamilies based on sequence similarities and functional properties (Popovici 
et al., 2005). FGFs bind four high-affinity lingand-dependent FGF receptor tyrosine 
kinase molecules (FGFR1-4) forming stable dimers in the presence of heparan 
sulfate glycosaminoglycans and in the presence of heparan sulfate HS 
glycosaminoglycans (Zhang et al., 2006). Basic fibroblast growth factor (bFGF, also 
denominated FGF2) is a single-chain polypeptide composed of 146 amino acids, 
which was first purified from the bovine pituitary by high affinity binding to heparin, 
and was named after its biological activity of promoting the growth of fibroblasts 
(Gospodarowicz et al., 1984; Gospodarowicz et al., 1986). 
bFGF binds to the four cell surface receptors, binding with the highest affinity 
to FGFR1 (Stachowiak et al., 1997). bFGF signals through its receptor tyrosine 
kinase activity linked to the G-protein Ras, which activates ERKIMEK 
phosphorylation signaling. Additionally, heparin and cell surface heparan sulfate 
proteoglycan modulate FGF activity. Independently of the bFGF paracrine effect, 
another three bFGF isoforms with a higher molecular weight localize to the nucleus 
and exert activities through an intracrine pathway (Arese et al., 1999). 
bFGF has been reported to have both mitogenic and neurotrophic actions. 
bFGF is a survival factor for cultured CNS neurons (Vescovi et al., 1993). It also has 
an effect in the promotion of axonal branch growth (Aoyagi et al., 1994). 
Additionally bFGF has been reported to regulate proliferation of purified populations 
of astrocytes (Eccieston and Silberberg, 1985; Pettmann et al., 1985; Sensenbrenner 
et al., 1987) and oligodendrocytes (Eccieston and Silberberg, 1985). 
bFGF induces ventralisation of cortical neural precursors independently of 
their age. Cortical progenitor cultures in the presence of bFGF increase their 
expression of ventral markers like Mash 1, and Olig2 (which is a marker of 
oligodendroctye precursors) and downregulate Emxl, Pax6, (Hack et al., 2004), 
Neurogenini and Neurogenin2 (Abematsu et al., 2006). Although GABA neurons 
are differentiated from ventral neural precursors, the ventralising effect of bFGF is 
not sufficient to induce GABAergi c- specific differentiation of cortical progenitors 
(Abematsu et al., 2006). That effect is in concordance with the lack of any increase 
of D1x2 in cortical progenitors, a transcription factor necessary for GABAergic 
specification. In the contrary, in neurosphere cultures the addition of bFGF appears 
to induce differentiation of a GABAergic neuronal phenotype (Hack et al., 2004). 
Further, neurosphere cultures appear to present an increase in GABAergic neurons 
independently of the brain regional origin (Ciccolini et al., 2003; Hitoshi et al., 2002; 
Parmar et al., 2002). Interestingly, neurosphere cultures appear to be close to ES 
cells in terms of transcriptional factors expression (Ramaiho-Santos et al., 2002), 
which may explain the reason for the high percentage of GABAergic neuronal 
differentiation from ES cell derivation in vitro (Ying et al., 2003b). 
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1.20.5 EGF 
Egf signals via the 1 70-kD tyrosine kinase Egf receptor (EgfR) (Pimentel 
1994). EgfR can influence cortical progenitor fate choice, as its overexpression at 
midgestation causes astrocyte differentiation at the expense of neuronal lineages 
(Burrows et al., 1997). EgfR expression increases during cortical development at 
E13, which is the peak of neurogenesis, and the time when Egf-responsive stem cells 
arise (Kornblum et al., 1997; Tropepe et al., 1999). During cortical development, 
EgfR is asymmetrically distributed between two daughter cells, correlates distinct 
cell fates. The cell with higher EgIR expression will also express markers of radial 
glia such as Rc2, Glast, CD-15/Lewis X. In contrast, the cell expressing the lowest 
level of EgfR will preferentially become an oligodendrocyte precursor (Sun et al., 
2005). 
Egf responsive stem cells from the striatal subventricular zone are capable of 
differentiating into GABAergic neurons (Kornblum et al., 1995). 
1.20.6 Neuregulin-ErbB signalling 
Migrating neurons expressing the ErbB ligand Neuregulin signal through 
ErbB receptors to maintain radial glia (RG) characteristics. In the absence of NRG 
there is a reduction in Rc2 expression in cortical explants, and this can be rescued by 
addition of exogenous NRG. Furthermore a dominant form of erB2 can turn RG cells 
into astrocytes (Schmid et al., 2003). 
1.20.7 SOX Proteins 
The Sox proteins comprise a group of transcription factors with an SRY box, 
which is a 79 amino acid motif that encodes an high mobility group (HMG) DNA 
binding domain. There are seven groups within the Sox family, from which three 
groups have representation in the nervous system with a total of 12 proteins 
(Kamachi et al., 2000). These include the SOXB1 and SOXB2 subgroups in the 
CNS and SOXE subgroup in the PNS. The SOXB 1 subgroup comprises SOX1, 2 
and 3 which share more than 90% amino acid identity in the HMG-DNA binding 
domains (Bowles et al., 2000; Pevny and Lovell-Badge, 1997). 
In mice, the initial phase of Sox2 and Sox3 expression is pan-ectodermal; 
Sox2 being expressed from pluripotent ES cells (Yuan et al., 1995) and Sox3 from 
very early stages of differentiation towards the neurectodermal fate (Collignon et al., 
1996; Wood and Episkopou, 1999). Soxi expression appears as the earliest 
transcription factor to be expressed in ectodermal cells committed to the neural fate 
(Pevny et al., 1998). Concomitanly, expression of Sox2 and Sox3 becomes confined 
to cells that are committed to a neural fate. Forced expression of Sox] or Sox2 
promotes the differentiation of mouse embryonic stem cells into neuroectoderm at 
the expense of mesoderm and endoderm (Zhao et al., 2004). SoxBl proteins interact 
with POU domain factors to activate a Nestin neural enhancer directly (Tanaka et al., 
2004). 
Sox2 plays an essential role in early embryo precursor cells, as Sox2-null 
embryos can not give rise to embryonic or trophectoderm lineages. Additionally, 
Sox2 is also expressed in the adult subventricular zone of the lateral ventricles and in 
the subgranular layer of the hippocampal dentate gyms, where stem cells are found 
in the adult brain (Ferri et al., 2004; Wegner and Stolt, 2005). Sox2 is also expressed 
in adult-brain derived neural stem cells grown in vitro (Conti et al., 2005; Fern et al., 
2004). High expression of Sox2 was found in subtypes of postmitotic neurons 
including pyramidal cells of the cerebral cortex, thalamic neurons, medial dorsal L 
striatum and septum of the adult brain. It is possible that Sox2 has a role in neuronal 
function and maintenance, since mice Sox2 deficient display neurological 
abnormalities that correlates with the neuronal disruption of the neuronal type where 
Sox2 is expressed (Fantes et al., 2003). Furthermore, SOX2 mutation is linked to the 
neurological symptoms of anophtalmia in humans (Ragge et al., 2005). Sox]-null 
adult mice exhibit spontaneous epileptic seizures associated with the loss of Soxl 
expressing neurons in the ventral striatum, and the phenotype of Sox3-null mice 
suggests a role for Sox3 in a subset of hypothalamic neurons that regulate the 
hormonal output, of the anterior pituitary. Overall these phenotypes are relatively 
mild, and given the strong overlapping expression between them and their 
biochemical and functional similarities, there must be most likely functional 
redundancy between these proteins. 	 . 
1.21 In vitro neural stem cells 
Neural stem cells (NSCs) are undifferentiated cells with the ability to: (1) 
proliferate, (2) exhibit self-renewal, (3) generate a large number of differentiated 
progeny, (4) retain their multilineage potential over time, and (5) generate new cells 
in response to injury or disease (Reynolds and Weiss, 1996). NSCs appears in the 
CNS as early as E8.5 and are characterised by their proliferation, in vitro, in response 
to Fgf 2 (Tropepe et al., 1999). At Ell-12 a second population of NSCs appears that 
divide in response to Egf or transforming growth factor (Tgf) (Tropepe et al., 1999). 
1.2 1.1 Asymmetric versus symmetric cell division 
Asymmetric cell division occurs when a precursor cell undergoes mitosis and 
divides into two different cell types. An asymmetric cell division usually produces 
another precursor cell, maintaining self-renewal, and a more restricted cell type. 
Symmetric cell division is characterised by the origination of two cells of the 
same type after mitosis. These two daughter cells can be the same cell type as the 
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Figure 1.7. Lineage trees of neurogenesis. Asymmetric versus symmetric 
divisions in cell fate determination. NE: neuroepithelial cell. N: neuron. 
RG: radial glia cell. BP: basal progenitor. Adapted from Gotz and Huitner, 
2005. 
mother self-renewal, or two differentiated daughter cells. There are certain genes 
responsible for the intrinsic cell determination such as NOtch (Conlon et al., 1995) 
and Numb (Zhong et al., 2000). These genes are dispensable before the onset of 
neurogenesis, meanwhile extrinsic signals such as Wnts, BMPs and Sonic Hedgehog 
Shh are all essential for neural patterning during this period. 
• 1.21.2 NS cells 
ES cells can differentiate in vitro into a pure population of neural stem (NS) 
cells niche independent cultured in monolayer. These NS cells can undergo 
symmetric cell divisions giving two same cell NS daughters at a rate of double every 
24 h (Conti et al., 2005). They need Egf and bFgf signalling to maintain their 
characteristics. In the absence of Egf cells undergo apoptosis, and in the absence of 
bFGF differentiation occurs. The NS phenotype corresponds with radial glia cells 
because they are positive for Glast, Blbp, Nestin, Vimentin, and Pax6. However, in 
contrast with radial glia cells, NS cells also express markers of the entire 
telencephalon. Therefore, these cells may represent an isolated temporal neural stem 
cell that occurs in vivo at a specific time during radial glia formation, and being 
isolated in vitro and by continuous stimulation with Egf and bFgF they aquire the 
capacity for indefinite self-renewal capacity through symmetric cell division. The 
NS-derived neurons appear to be preferentially GABAergic as they show GAD67 
and GABA expression. 
Neural precursors obtained through different protocols, including embryoid 
body formation and addition of Retinoic Acid are also phenotypically defined as 
radial glia expressing RC2, Glast, Blbp, and Pax6. In contrast with NS-derived 
neurons, and as expected from this gene expression pattern, these cells will 
differentiate into predominantly of glutamatergic cells that express the vesicular 
glutamate transporter vGlut 1, a membrane protein specific to pyramidal cortical 
neurons (Bibel et al., 2004). 
The cause of the lack of consistency between the two protocols may reside in 
the two different signalling pathways to which both neural precursors are exposed: 
Retinoic Acid in one, and Egf and bFgF in the other. Additionally, NS cells can be 
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clonally isolated, proliferate and self-renew indefinitely, meanwhile RA-derived 
radial glia cells can not. Furthermore, NS cells can be isolated from different 
forebrain regions maintaining the same neural stem cell characteristics and 
apparently the same differentiation capabilities. Egf responsive stem cells from the 
striatal subventricular zone are capable of differentiating into GABAergic neurons 
(Kornblum et al., 1995). The presence of Fgf2 activates the expression of 
transcription factors ganglionic eminence. Overall, the preferential GABAergic 
specification of NS differentiation may be related with the continuous Egf and bFgf 
signalling. 
1.22 Neuronal specification 
Many genes are known to be involved in neuronal fate specification. The 
gene expression profile of a restricted neuronal precursor will determine their final 
neuronal phenotype. Restricted post-mitotic neuronal precursors that have been 
specified to a particular neuronal fate will migrate to their final destination and 
acquire dendritic morphology, generating an axon that will connect to the correct 
target. The proneural genes Neurogenin] and Neurogenin2 promote dorsal 
telencephalic fate by repressing the ventral proneural gene Mash] (Fode et al., 2000) 
and by specifying cortical projection neuron characteristics like glutamatergic 
neurotransmission and dendritic morphology (Hand et al., 2005; Schuurmans et al., 
2004). Striatal neuronal specification is led by Gsh2 expression with the involvement 
of retinoic acid (Waclaw et al., 2004). Cortical interneurons are directed towards 
tangential migration by Dlxi and Dlx2 (Cobos et al., 2005), and they require of Gdnf 
(glial derived neurotrophic factor) to delimit their morphology and axonal growth. 
Apart from its role in dorsal radial glia specification, Pax6, together with the nuclear 
receptor Tlx are involved in cortical neuronal specification, particularly of superficial 
neurons, which are the last neurons generated during development (Hack et al., 2005; 
Roy et al., 2004). 
1.23 Cell intrinsic mechanisms of cell fate determination 
Forebrain neural progenitors can differentiate into neurons early in 
development, starting from El1.5 with a peak of neurogenesis around E14.5. 
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However, gliogenesis will not occur until after completion of neurogenesis, peaking 
at E16.5 (Levers et al., 2001; Qian et al., 2000). This time-directed cell fate 
specification can be also observed within isolated neural progenitors in vitro (Qian et 
al., 1998; Qian et al., 2000). Interestingly, neuroepithelial cells aquire gliogenic 
potential simultaneously with loss of their neurogenic potential. Time specification 
of gliogenesis is crucial in forebrain development to ensure a coordinated nervous 
tissue organization; glial cells are important in critical neuronal maturation processes 
such as axonal pathfinding, synapse formation, and myelination (Shu and Richards, 
2001; Ullian et al., 2001). Since oligodendrocytes are generated from the ventral 
telencephalon, gliogenesis in the developing cortex is mostly directed towards 
astrocytic differentiation. There are a variety of mechanisms involved in 
astrocytogenesis, both intrinsic or extrinsic to the neuroepithelial cell. The main 
signalling astrocytic pathway is the JAK-STAT pathway, which is itself dynamically 
regulated through development (He et al., 2005). Several factors activate this 
pathway, including Cnft, Lif and IL-6 (Bonni et al., 1997). Bmp2, which belongs to 
the transforming growth factor 3 (TGF-13) super-family, and Lif share gpl30 as a 
signal transducing receptor component (Taga and Kishimoto, 1997) and both signal 
through Stat3 activation (Nakashima et al., 1999a). Activated Stat3, in its 
phosphorylated state, associates with the transcriptional coactivator Creb binding 
protein (CBP/p300) to activate expression of astrocyte-specific genes (Nakashima et 
al., 1999b). On the other hand, neurogenic bHLH family members are shown to 
suppress gliogenesis by sequestering Smadl-CBP/p300 complex away from 
astrocyte-specific genes and inhibiting activation of Stat3 (Nieto et al., 2001; Sun et 
al., 2001). 
Stat3 acts downstream of these cascade through the glial fibrillary acidic 
protein (Gfap) promoter. Gfap is the major intermediate filament protein in mature 
astrocytes (Eng et al., 2000) and is highly conserved throughout vertebrates (Messing 
and Brenner, 2003). The access of Stat3 to the Gfap promoter is strongly regulated as 
well by a number of mechanisms including histone methylation, DNA methylation, 
and transcriptional repressor complexes. 
bFGF regulates Stat3 access to the Gfap promoter by inducing an increase in 
lysine-4 methylation, which facilitates Gfap transcription, and a decrease in lysine 9 
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methylation at the Stat-binding site of the Gfap promoter with the opposite effect 
(Song and Ghosh, 2004). This chromatin-regulated mechanism is similarly seen at 
another astrocyte- specific gene s]00f3. Equally, bFgf stimulation modifies histone 
methylation switch from repressive lysine 9 methylation to permissive lysine 4 
methylation at the s10013 promoter (Song and Ghosh, 2004). 
A second mechanism of control over access to the Gfap promoter is DNA 
methylation-dependent repression. The Stat3 binding element in the Gfap promoter 
is highly methylated in E11 . 5 neuroepithelial cells, post-mitotic neurons and non 
nervous system cells, but is demethylated in cells where Stat3 induces the expression 
of Gfap (Takizawa et al., 2001). In parallel, the s]0013 promoter sequence also 
contains a highly methylated CpG site at El 1.5 neuroepithelial cells that is 
significantly demethylated in E14.5 neuroepithelial cells. Furthermore, Mecp2 binds 
to this methylated CpG dinucleotide at E11 . 5 stage which results in inactivation of 
the gene and does not bind it at E14.5 stage (Namihira et al., 2004). At this stage of 
high level methylation state, MeCP2 has been also shown to bind to the promoters of 
Gfap and Stat] (Fan et al., 2005). Moreover, these promoters have inactive histone 
marks during neurogenesis (dimethyl-lysine 9 of histone H3; H3dmK9) and active 
histone marks during astrogliogenesis (di- or tri-methyl-lysine4 of histone 113; 
H3dItmK4). Therefore DNA methylation plays an important role in astrocytogenesis. 
Transgenic nestin-Cre Dnmtl mice, which suffer from global hypomethylation 
during CNS development show precocious astrocytogenesis. This effect is caused by 
a precocious elevation of JAK-STAT signalling, which as discussed previously, 
controls the onset of astrogliogenesis. Consistenly, Dnmtl-deficient neural 
precursors display an increase in H3dltmK4 (active chromatin status) and decrease in 
H3dmK9 (inactive chromatine status) (Fan et al., 2005). 
In addition to DNA methylation, several transcription regulators are 
implicated in the control of astrocytogenesis, such as the nuclear corepressor 
complex N-CoR, and the orphan nuclear receptor TLX (Tailéss homolog) (Shi et al., 
2004). In parallel with precocious Gfap expression in N-CoR deficient mice, TLX 
deficient adult NSC show increased differentiation into Gfap-positive astrocytes 
together with upregulation of Gfap and slOOP in the TLX deficient forebrain. As 
previously discussed, N-CoR is associated with histone deacetylation, and this is also 
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the case for the neuron-restrictive silencer factor/repressor element- 1 silencing 
transcription factor (NRSF/REST). 
NrsffRest is a major controller of neuronal differentiation (Chong et al., 1995; 
Schoenherr and Anderson, 1995). Nrsf/Rest represses neuronal genes containing a 
region called repressor element 1 or Nrse/Rest. Rest mediates repression via 
recruitment of its corepressors mSin3a (Huang et al., 1999; Roopra et al., 2000) and 
CoRest (Andres et al., 1999). This in turn promotes additional transcriptional 
silencing by recruiting MeCP2, histone H3-lysine9 methyltransferase Suv39Hl and 
heterochromatin protein 1 (Hpl), which causes compactation of chromatin. The 
chromatin where this machinery acts will show histone deacetylation, the absence of 
H3-K4 methylation and the presence of H3-K9 methylation, creating a condensed-
silenced state of neuronal genes in non-neuronal cells (Lunyak et al., 2002): 
An alternative mechanism is necessary to maintain a semi-permissive 
chromatin state for embryonic stem cells that have the potential to differentiate into 
mature neurons. In ES cells Rest binds to Re] sites and repress gene expression, but 
when ES cells differentiate into mature neurons, the Rest corepressor complex 
dissociates from Re] sites allowing the expression of fundamental neuronal genes. 
However, evidence suggests that there are other neuronal genes that contain an extra 
repression mechanism, where in addition to the Re] site binding and repression, a 
methylated site is bound by MeCP2 which recruits mSin3a and HDAC and CoREST 
and is not released until an additional stimulus occurs, for example neuronal 
depolarization, which leads to MeCP2 phosphorilation and de-repression of the 
neuronal gene (Ballas et al., 2005), as investigated in the Bdnf promoter (Chen et al., 
2003) (Martinowich et al., 2003). 
In contrast with the transcriptional repression activity of REST, small 
noncoding double-stranded RNA (dsRNA) have been identified which have the 
ability to bind to REST sequences in neuronal progenitors of the adult hippocampus 
(Kuwabara et al., 2004). These dsRINAs have the ability to convert REST from a 
repressor to an activator complex, which leads to the activation of neuron-specific 
genes necessary for the induction of neurogenesis. 
In adult neural precursors and neurons, global levels of H3 and H4 
acetylation are increased as compared with oligodendrocytes and astrocytes (Hsieh et 
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al., 2004). Concordantly, an anti-epileptic drug, vaiproic acid, which has been shown 
to inhibit HDAC activity (Gottlicher et al., 2001; Phiel et al., 2001), have a 
interesting effect of increasing neuronal differentiation both in vivo and in vitro in 
adult neural precursors at the expense of oligodendrocyte and astrocyte 
differentiation (Hsieh et al., 2004). 
Overall, it can be concluded that dynamic changes in chromatin status such as 
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Figure 1.8 Diagram of epigenetic signaling pathways that control cell 
fate specification. At embryonic age El 1.5 and in post mitotic 
neurons, STAT3 activation is blocked by DNA methylation. At 
embryonic age E14.5 onwards, Stat3 binding site is demethylated 
which leads to Gfap activation and astrocyte differentiation. bI-ILH 
neurogenic transcription factors as Neurogenin I block Stat3 pathway 
and activates neuronal gene transcription. P=Phosphorylation. 
Adapted from Sun et al., 2003, Fukuda et al., 2004 and Hsieh et al. 
2004. 
1.24 Aim of the thesis 
During brain development, an orchestra of signals are necessary to drive the 
correct patterning that lead pluripotent stem cells to give rise to all the cell types 
necessary for brain tissue function. individual cell chromatin status will determine 
active or repressive transcriptional signals that will dictate its cell fate within its time 
and space environment. 
The aim of this thesis is the study of epigenetic mechanisms involved in 
neural stem cell function. Here I will describe the functional analysis I carried out to 
understand the role of the methyl-CpG binding proteins in neural stem cell function. 
The chapters 3 and 4 are concentrated in answering the question: What are the 
consequences of the absence of methyl-CpG binding proteins MeCP2, Kaiso and 
Mbd2 in neural development. The chapter 5 is focused in the study of an epigenetic 
silencing mechanism independent of binding to methylated DNA. Mbd3 forms part 
of the Nucleosome remodelling and deacetylation complex (NuRD), and in contrast 
with the rest of MBD proteins do not bind methylated DNA in mammals. This last 
chapter will uncover the key role of Mbd3 in stem cell fate decisions. 
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Chapter 2 
MATERIALS AND METHODS 
2.1 Materials 
Analytical grade chemicals were obtained from either Sigma or BDH Laboratory 
Supplies (unless otherwise specified). Stock solutions were prepared with reverse 
osmosis purified (ROP) water (MilliQ biocel, Millipore) and filtered or autoclaved as 
necessary. Synthetic oligonucleotides were synthesised by SIGMA. Agarose for 
electrophoresis was supplied by Invitrogen. Radioisotopes were supplied by 
Amersham Biosciences. 
2.1.1 Solutions and reagents 
DEPC treated water: 0.2% DEPC, mixed well and autoclaved. 
SSC 20x: 3M NaCl, 0.3M tn-Na citrate. 
TE: 10mM Tris-HCL, 1mM EDTA pH=8. 
Orange G DNA loading buffer: 15% Ficol, 0.2 M EDTA, 0.33% Orange G. 
TAE electrophoresis buffer (lOx): 0.4 M Tris-acetate, 100mM EDTA, pH=8.5. 
TBE electrophoresis buffer (lOx) 890 mM Tris, 890 mM Boris acid, 20mM EDTA, 
ph=8. 
TBS: 20mM Tris-HCL, 100mM NaCL pH=8. 
Loading buffer (SDS-sample buffer) 2X: 100mM Tris-HCL pH=6.8, 4% SDS, 
0.2% bromophenol blue, 20% glycerol, 200mM DTT. 
5X tri-glycine electrophoresis buffer: 125mM Tris, 1.25 •M glycine, 1% SDS. 
Transfer buffer SDS-PAGE: 48mM Tris, 390 mM glycine, 0.1% SDS, 20% 
methanol (for high molecular weight proteins), 25mM Tris, 190mM glycine, 20% 
methanol (for low molecular weight proteins). 
Phosphate buffered saline (PBS): 2.7 mM KC1, 137 mM NaCl, 4.3 mM 
Na2HPO4 .7H20, 1.4 mM KH2PO4 (pH 7.4). 
PBST: 1% Tween in PBS. 
Blocking solution for protein blots: 5% skimmed milk powder, PBST. 
Stripping buffer protein blot membranes: 20% SDS, 0.5 M Tris p11=6.8, 2.8% 2-
mercaptoethanol. 
Luria-Bertani (LB) broth: 1% (w/v) tryptone (Difco), 0.5% (w/v) yeast extract, 
85mM NaCl. 
LB agar: 1.5% (w/v) agar (Difco) in LB broth. 
STE buffer: 10mM Tris-Ci (pH 8.0), 0.1M NaCl, 1mM EDTA pH 8.0. 
PEG-Hybridisation buffer: 0.25 M NaCL, 1mM EDTA, 7% SDS, 10% PEG-6000, 
50tg/ml salmon sperm DNA, 125 mM NaPi pH=7.2. 
Lysis buffer for genomic PCR: 10% NP40, 10% Tween, 25 mg/ml Proteinase K 
(Roche) added just before use. 
PCR buffer: 750mM Tris pH=8.8, 200mM (NH 4)2504, 0.1% Tween, 30mM 
MgCL2. 
Lysis buffer for DNA extraction: 20% SDS, 25 mg/ml Proteinase K, TE buffer. 
CaC12 solution: 60mM CaC12, 10MM Pipes pH=7, 15% glycerol. (Filtered, and 
autoclaved). 
EMSA binding buffer: 0.2 M Hepes, 10mM EDTA, 20mM MgCl2, 100 tM 2-
mercaptoethanol, 40% glycerol, 500mM NaCl. 
Homogenization buffer: 2M sucrose, 10% glycerol, 25mM KCL, 20mM Hepes 
pH=7.8, 0.15 Spermine, 0.5mM Spermidine, 1mM EDTA, 0.5mM EGTA, 0.5mM 
PMSF and protease inhibitors cocktail (Sigma). 
Resuspension buffer: 75mM KCL, 25mM MgCl 2 , 1mM EDTA, 0.5mM EGTA, 
0.5mM Spermidine, 0.5 mM Spermine, 10mM 2-mercaptoethanoi, 20% glycerol, 
0.23M sucrose, 20mM Hepes 7.9. 
Buffer A for nuclei isolation: 0.5 mM EGTA, 20mM Hepes pH=7.9, 0.23 M 
sucrose, 60mM KCL, 15mM NaCL, 0.25 MM M902, 0.5mM Spermine, 0.15 mM 
spermidine, 14 mM 2-mercaptoethanol, 15 mM Tris-HCL, pH=7.4, 0.5mM PMSF 
and protease inhibitors cocktail (Sigma). 
Buffer B for nuclear extraction: 5mM Hepes pH=7.9, 26% glycerol, 1.5mM 
M902, 0.2mM EDTA, 400mM NaCL, 0.5mM PMSF and protease inhibitors 
cocktail (Sigma). 
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Solution 1 for minipreps: 50mM Glucose, 10mM EDTA, 25mM Tris pH 8, 
100ig/m1 RNase. 
Solution 2 for minipreps: 0.2N NaOH, 1% SDS. 
2.1.2 Antibodies 







anti-Oct 4 Goat 1:200 Santa Cruz SC-8628 
anti-Oct4 Mouse IgG2b 1:1000 Santa Cruz SC-5279 
anti-GFAP Rabbit 1:200 Sigma G9269 
anti-GFAP(n-18) Goat 1:200 Santa Cruz SC-617 
anti-Tuji Mouse IgG2a 1:1000 Covance MMS435P 
anti-Map2 (a+b) Mouse IgGi 1:200 Sigma M1406 
anti-GABA Rabbit 1:800 Sigma A2052 
anti-TH Rabbit 1:200 PeiFreeze P40101-0 
anti-RC2 Mouse 1gM 1:20 DSHB RC2 
anti-Vimentin Mouse 1gM 1:20 DS}IB 40E-C 
anti-nestin Mouse 1gM 1:50 DSHB Rat-401 
anti-caspase-3 Rabbit 1:400 R&D AF-835 
anti-s10013 Mouse IgGi 1:500 Sigma S-2532 
anti-ER Rabbit 1:50 Santa Cruz EC-20 





anti-kaiso clone 6F Goat 1:1000 Upstate 05-659 
anti MBD2 Sheep 
1:200/1:1000 
WB 
(Ng et al., 1999) S923 
anti Kaiso (1303) Goat 1:500 Abeam AB1303 
Anti GFP 
polyclonal Chicken 
1:200 Chemicon AB16901 
anti flag M2 Mouse 1:1000 Sigma F3165 
anti-MBD3 c- i 8 Goat 1:1000 Santa Cruz SC-9402 
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Anti MBD3 (N..20) Goat 1:200 Santa Cruz SC-9400 
anti-atubulin Mouse 1:1000 Santa Cruz SC-5286 
anti-GAD65/67 Rabbit 1:200 Chemicon AB 1511 
Anti-Gata4 Goat 1:200 Santa Cruz SC-1237 
Secondary antibodies: 
All secondary antibodies used in immunocytochemistry were Alexa Fluor, 
Molecular Probes, used 1:1000 dilution. 
Secondary antibodies used in western blot were ECL peroxidase labelled anti-mouse 
and anti-rabbit (Amershan) and anti-goat (Sigma). 
2.2 Molecular biology methods 
2.2.1. Plasmid isolation 
Overnight cultures of single bacterial colonies in LB broth were used to 
isolate plasmid DNA using Quiagen's mini, midi and maxiprep kits for small, 
medium and large scale preparations respectively, according to manufacturers 
instructions. 
2.2.2 Genomic DNA isolation 
ES cells and NS cells: 
Cells were grown in 96 well plate (or 4 well plate (Nunc) to confluence, 
harvested, centrifuged 5 minutes at bOg, washed in PBS, centrifuged again, and 
resuspended in 10-25tl of lysis buffer. This solution was incubated at 55 °C for two 
hours and 94°C for 10 minutes. 2t1 of lysis sample was used as template for 
genomic PCR. 
2.2.3 RNA isolation 
Total RNA was isolated from cells using Tri Reagent TM (Sigma), according 
to the manufacturer instructions. 
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2.2.3 DNA purification 
Same volumes of DNA solution and phenollchlorophorm are mixed and 
centrifuged at 10600g for 3 minutes. The aqueous phase is extracted and mixed with 
same volume of chlorophorm. The solution is centrifuged at 10600g for 3 min and 
the water phase is extracted to precipitate DNA by incubation with 2 volumes of 
100% ethanol and 0.1 volumes of NaOAc at -80 0C for 30 minutes. The solution is 
then centrifuged at 20000g for 30 minutes at 4 0C, washed with 70% ethanol and 
resupended in TE buffer. 
2.2.4 Polymerase chain reaction 
PCR were carried out using Red Hot Taq (Abgene) following manufacturers 
instructions with 7.5pmol4tl of reverse and forward primers, 5-100ng DNA as 
template, Thermocycling incubations were done in DNA engine DYAD. 
2.2.5 RT-PCR 
First strand cDNA was synthesised from 1 tg of total RNA using SuperScript TM II 
reverse transcriptase or M-MLV RT (Invitrogen) according to manufacturers 
instructions. 
2.2.6 qRT-PCR 
Quantitative real time PCR was done using a Roche light cycler. The 
optimised PCR reaction contained: 2t1 of LightCycler Master SYBR Green I mix 
(Tth DNA polymerase, reaction buffer, dNTP mix and SYBR Green I), 2.5t1 of 
dH20, 0.25tl of reverse and forward primers (10pmol/t1). The following reaction 
conditions were used: 
95°C -5 mm 
95°C -14 sec 
X -5 sec 
72°C -14 sec 
Annealing temperatures (X): 
Gapdh, Sox2 and Kaiso: 58°C 
Mbd2, Mbd3a, Mbd3b: 64°C 
MI 
Mbdl: 60°C 
2.2.7 Methylation of DNA fragments 
Methylation reactions using MSssI methyltransferase (NEB) were carried out 
according to manufacturers instructions with the exception that the methylation 
reactions were incubated for 2-3 hours at 37'C, followed by purification with 
Zymoclean Kit (Zymo Research) and re-methylated for another 2-3 hours at 37 °C. 
2.2.8 Radiolabelling 
Probe radiolabelling was done using replacement synthesis method. 
1 OOng of methylated (MeCG 11) and unmethylated (CG 11) DNA probes were 
incubated with T4 DNA polymerase, 100tM dATP, 1X buffer and BSA(100tgIml) 
for 15 min at 12°C to activate the 3'5' exonuclease activity of T4 DNA polymerse, 
eliminating G bases of the 3' end of the MeCG 11 and CG 11. After this time 100mM 
dTTP and dGTP were added as well as P 32 -adCTP (40tCi, -3000 Ci/mmol, 
Amersham) and incubated for 15 min at 12°C. The enzyme was inactivated by 
addtion of 0.5M EDTA. Final radioactivity of the probe was read with a liquid 
scintillation analyzer (Tri-Carb, Packard). 
2.2.9 Nuclei extraction from mouse liver 
25m1 Homogenization buffer was used to homogenise the liver using a tight 
fitting dounce. The solution was centrifuged through a lOml cushion of 
homogenization buffer at 0 °C 24000 rpm in a SW28 rotor for 40-50 minutes. The 
pellet was resuspended in 5 ml of resuspension buffer and stored at -80 °C 
2.2.10 Nuclei extraction from ES and NS cells 
Cells were washed with PBS and harvested with a cell scraper. Suspension 
was centrifuged at 1500g for 3 minutes and the pellet washed in PBS and 
resuspended in 10 volumes of buffer A and incubated on ice for 10 mm. The 
suspension was centrifuged at 1500g for 5 min and the pellet resuspended in 3 
volumes of buffer A. The suspension was homogenized using a tight fitting dounce 
and then diluted 3 fold in 2M sucrose in buffer A. The lysate was centrifuged at 
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1500g for 5 mm, 20% glycerol was added and the sample was stored at -80 °C until 
needed. 
2.2.11 Salt extraction of nuclear protein 
The frozen solution was thawed and resuspended in same volume of buffer C, 
homogenized with a loose fitting dounce, stirred for 1-2 hours on ice and centrifuged 
at 13000 rpm at 4°C for 30 min in a SS-34 rotor. 
2.2.12 Measurement of protein concentration 
Protein concentration was measured using Bradford reagent (Sigma) 
according to manufacturer instructions. The absorbance at 595nm was analysed and 
recorded using a precision microplate reader (Molecular Devices). 
2.2.13 SDS-PAGE 
Gels were prepared as follows: Separating gel (1.5 M Tris pH=8, 20% SDS, 
TEMED, acrylamide and APS concentration depending on percentage of separation 
desired) was casted on an assembly kit (Bio-Rad), and subsequently 5% stacking gel 
was casted on top and assembled in a Bio-Rad mini protean apparatus. Proteins were 
diluted in loading buffer, boiled for 5 min at 100 °C and loaded on the gel. Gels were 
run in tri-glycine electrophoresis buffer at room temperature until the loading dye 
migrated off the bottom of the gel. 
2.2.14 Transfer to nitrocellulose membrane from SDS-PAGE gel 
Gel and nitrocellulose membrane (Protran, Whatman) were assembled in Bio 
Rad mini protean apparatus according to manufacturer instructions and run at 90V 
for 1-2 hours at 4 °C in transfer buffer. 
2.2.15 Western blot 
Membrane was washed in PBST for 10 mm, incubated in blocking solution 
for 30 mm, and incubated with primary antibody in blocking solution overnight. 
Secondary antibody was added after washing with blocking solution for 2x10 mm 
and incubated for 1 hour at room temperature. All washes and incubations were done 
in a shaker. Subsequently the membrane was washed in PBST, air-dried, and 
incubated with freshly mixed ECL reagents (Amershan) for one mm. Membrane was 
wrapped in cling film and exposed to Kodak film. Development of the film was done 
using SRX- 101 A developer. 
2.2.16 Electrophoretic mobility shift assay: 
5 tg of protein, 104cpm methylated (MeCG1 1) or unmethyated (CG 1 1) probe 
(Meehan et al., 1989), and 2tg of E.coli DNA as competitor were incubated on ice 
with binding buffer for 30 mm. The binding reaction was loaded in a 1.5% agarose 
gel in TBE buffer, and run at 4°C for 4-5 hours. Gel was dried on two layers of 
0.2mm Whatman paper in a gel drier (Bio Rad 583) and exposed to a phosphor-
imager screen overnight. Images were developed the next day using phosphoimager 
Fujifilm FLA 3000. 
2.2.17 Cloning and subcloning 
Vector construction involved restriction enzyme digestion, gel purification 
and ligation. Restriction enzyme digestions were performed according to NEB's 
instructions. Digested DNA was isolated by electrophoresis of (TAE) 0.8% -2% 
agarose gel for fragment resolution. DNA was then isolated from desired gel 
fragment using Zymoclean (Zymo Reearch). Vector and insert ligation was done 
using Rapid DNA ligation Kit (Roche) according to manufacturers instructions. 
2.2.18 Transformation of competent cells. 
100tl of competent cells and lO-lOOng of DNA were incubated on ice for 30 
minutes, heat shock treated for 45 seconds at 45 °C and incubated on ice for 3 
minutes. Solution was diluted with 400 .i1 of SOC media (Invitrogen) and incubated 
at 37 °C for 60 minutes. Bacteria were spread evenly over the surface of LB agar with 
antibiotic plates using a sterile bent glass rod. Plates were inverted and incubated 
overnight at 37'C. 
2.2.19 Analysis of transformants 
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Colonies grown in agar plates were screened to isolate the desired vector 
using the following protocol. Single colonies were inoculated in a 5ml LB broth 
containing the appropriate selection and incubated in a shaker at 37 °C overnight. 
3.5m1 of overnight culture was centrifuged for 5 min at 107g. Pellet was 
resuspended in 100tl of Solution 1 and 200tl of Solution 2 (see pg 82), mixed 
gently and added 150tl of 3M NaOAc pH=4.8. The solution was mixed, centrifuged 
at 20000g for 10 mm, and from the supernatant plasmid DNA was purified as 
described before for genomic DNA (2.2.3). 
2.3 Cell culture methods 
Cells were maintained at 7.5% CO2 at 370C in a humidified incubator. All 
solutions were tested for bacteria contamination before use. All tissue culture 
manipulations were undertaken inside a laminar flow sterile hood (Microflow) and 
surfaces and objects were sprayed with 70% industrial methylated spirits (IMS) 
before use. Cell suspension centrifugation was done at 200g for 3.5 min unless 
specified. 
2.3.1 Cell culture media 
ES cell medium: Glasgow modified Eagle's medium (GMEM), 10% fetal bovine 
serum (Gibco), 1mM sodium pyruvate (Gibco), IOOX MEM non-essential amino 
acids, 2mM L-glutamine (Gibco), 0. 1mM 2-mercaptoethanol (BDH). 
N21327 medium: DMEM!F12 and Neurobasal 1:1 mixture (both Gibco), N2 (25 
gIml insulin, 100 [tg/ml apo-transferrin, 6 nglml progesterone, 16 tg!ml putrescine, 
30 nM sodium selenite and 50 pg/ml bovine serum albumin fraction V (Gibco), lOOx 
B27 supplement (Gibco), 1mM L-glutamine and 0.1mM 2-mercaptoethanol. 
NS medium: NS-A (Euroclone), 1mM L-glutamine (Gibco), l0ng!tl bFGF and 
10ngItl EGF (Prepotech). 
Trypsin solution: 0.025% trypsin (Gibco), 1.3mM EDTA, 0.1% chicken serum 
(Flow Labs) in PBS. 
PA-6 co-culture differentiation medium: GMEM, 10% knock-out serum 
replacement (Gibco), 1mM sodium pyruvate, 100X MEM non-essential amino acids, 
2mM L-glutamine and 0. 1mM 2-mercaptoethanol. 
PA-6 co-culture induction medium: N21327 medium supplemented with 200PM 
ascorbic acid, 100X MEM non-essential amino acids, 2mM L-glutamine. 
Neurosphere medium: DMEM/F12 medium supplemented with B27, 25tg4il 
bFGF, lOOx antibiotic-anti-mycotic solution (Invitrogen). 
Neurosphere differentiation medium (NB+): Neurobasal medium supplemented 
with B27, 1mM L-glutamine, 0.1mM 2-mercaptoethanol and lOOx antibiotic-anti-
mycotic solution. 
2.3.2 ES cell routine culture 
ES cells were cultured on 0.1% gelatine-coated tissue culture flasks or plates 
in Glasgow modified Eagle's medium (GMEM) supplemented with 100units/ml 
leukaemia inhibitory factor (LIF). LIF was prepared in house by transfecting COS-7 
cells with a human LIF expression plasmid and harvesting the medium. The 
concentration of LIF was assayed using CPI indicator cells (LIF preparation was 
done by L. Taylor). All media reagents were pre-warmed at 37 °C. 
To passage the cells, media was removed and cells were washed twice with 
PBS. lx (0.025%) trypsin (Invitrogen) was added at the minimum volume required 
to cover the cell monolayer and incubated at 37 °C for 1 mm. Subsequently the cell 
suspension was diluted with GMEM media (4 ml of media per every lml of trypsin). 
The cell suspension was centrifuged and the cell pellet was resuspended in media to 
achieve a cell concentration of 106  cells per 25cm2 culture surface. ES cells were 
passaged every 2-3 days. 
2.3.3 Freezing cells 
Cells were harvested as described above, and the cell pellet was resuspended 
in the required media and 10% dimethylsulphoxide (DMSO, BDH) at concentration 
of 106  cells per cryotube (Nunc) vial. Cryotubes were immediately transferred at - 
80°C overnight and then transferred to a liquid nitrogen cell bank (Series 2300, 
Custom biogenic systems). - 
To freeze cells in 96 or 24 well plates, cells were harvested with trypsin 
solution and cell suspension was diluted with freezing mix (150t1 for 96 well plate 
or 500tI for 24 well plate). Freezing mix for ES cells consisted of ES media, 10% 
DMSO and 20% FCS for ES cells; freezing mix for NS cells consisted of NS-A 
media, 10% DMSO and 3% BSA (Sigma) for NS cells). Plates were placed in a 
polystryrene box and stored at -80 0C. 
2.3.4 Thawing cells 
Frozen cryotubes were thawed at 37 0C for 1-3 min and immediately 
transferred to a universal tube with 9.5ml of required media and centrifuged. Cell 
pellet was then resuspended in lOmi of required media and transferred to a 25cm 2 
flask. An additional media change was done 8-10 hours later to remove dead cells 
and remaining DMSO. 
To thaw cells in 96 or 24 well plates, pre-warmed media was added to cover 
the well, and cell suspension was transferred to a gelatin-coated parallel plate. Media 
was replaced with fresh media after 8-10 hours. 
2.3.5 Monolayer differentiation (ES neuroectoderm differentiation) 
ES cells were passaged the day before the experiment to 90% confluence. 
Next day ES cells were harvested, and resuspended in GMEM media with 10% FCS. 
Cells were centrifuged and the cell pellet resuspended in Neurobasal media and 
centrifuged again. Cell pellet was resuspended in N2B27 and counted using a 
haemocytometer. Culture wells were coated with 0.1% gelatin and incubated for 30 
mm. To aid even cell distribution within the well gelatin was then aspirated and 
N2B27 media was added to the well into half the volume required for the culture. 
Cells suspension was diluted in half the total required volume and plated at a density 
of 106  cells per 10cm2 surface. N2B27 media was replaced with fresh N2B27 media 
every two days to remove dead cells and cell debris. 
2.3.6 Replating monolayer cultures 
Plates (usually 1.88 cm  growth area) were coated with lOOx poly-D-lysine 
(Sigma) in filtered distilled water (MilliQ Biocel, Millipore) and incubated at room 
temperature for at least 30 minutes. Poly-D-lysine (PDL) was removed, wells were 
allowed to dry and washed twice with PBS. Then the wells were coated with 1000x 
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laminin (Sigma) for 3 hours at 37 °C and subsequently removed and washed twice 
with PBS. 
Monolayer differentiation cultures were harvested using pre-warmed PBS, 
incubating for 5 min at 37°C and gently pippetting up and down the cell culture to 
achieve cell suspension. Cell suspension was then diluted with N21327 and 
centrifuged at 200g for 3.5 mm. Cell pellet was resuspended in N21327 media and 
plated in PDL/laminin pre-coated wells as described above at a density of 2-2.5 10 4 
cells/cm2 when replating 7 days old monolayer cultures or 3.5-4 104/cm2 when 
replating 10 day old monolayer cultures. N2B27 media was replaced with fresh 
media every 3-4 days to remove dead cells and cell debris. 
2.3.7 PA-6 co-culture differentiation protocol 
PA-6 feeder cells were routinely cultured in the same conditions as ES cells 
(as described above) in ES media without addition of LIF. PA-6 cells were irradiated 
to arrest proliferation, harvested and plated at a cell density of 8x10 4 cells/cm2 one 
day before the differentiation experiment. ES cells cultured at 90% confluency which 
had been passaged previous day were harvested, centrifuged and resuspended in 
differentiation medium. ES cell suspension was counted and plated on the PA-6 
feeder monolayer at a density of 25-30 cells/cm2. Differentiation media was replaced 
from the wells after 4 days and on the 8th  day replaced with induction media. Media 
was then replaced every 2 days with fresh induction media for 8 days. 
2.3.8 Neurosphere culture 
Embryonic age E14.5 or E16.5 mouse cortices were dissected and dissociated 
by pipetting up and down using a fire polished Pasteur pipette to obtain single cell 
suspension in PBS supplemented with 1 unit (potency contained in 0.60tg of 
Penicillin G master standart) of penicillin, 100 tg streptomycin and 0.0025tg of 
ampothericin B per ml of media (antibiotic-anti-mycotic 100X solution, 
Invitrogen.). Cell suspension was passaged through a 40tm nylon mesh (BD 
Falcon), diluted in DMEMJ'F 12 media and centrifuged. Cell pellet was resuspended 
in neurosphere medium and plated in single cell suspension in 25cm 2 flasks at 
density of 5000 cells/cm 2 for 7 days. After 7 days, primary neurospheres were 
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collected by centrifugation and the cell pellet resuspended in 1-2 ml neurosphere 
media. Suspension was pipetted up and down first with a fired polished Pasteur 
pipette followed by same procedure with a polished Pasteur pipette with narrower 
aperture. The cell suspension was passaged through a 40jtm nylon mesh and diluted 
with neurosphere media. The single cell suspension was centrifuged, resuspended in 
neurosphere media, counted in a haemocytometer and plated at the same density as 
for primary neurospheres. 
2.3.9 Neurosphere differentiation 
Glass coverslips (13mm diameter) were sterilised by ultraviolet exposure for 
30 min and allocated in 24 well plates. Subsequently the coverslips were coated with 
Poly-D-lysine and Laminin as described before. Primary and secondary neurospheres 
grown in 25cm flasks were collected by centrifligation and resuspended in NB+ 
medium. 1:3 of the cell suspension was plated on the coated plates and cultured for 5 
days. 
2.3.10 Routine passage of NS cells 
When they reached 30-60% confluent, NS were harvested and trypsined in 
lOx trypsin solution. Harvested cells were resuspended in NS medium and 
centrifuged at 300g for 4 mm. Cell pellet was resuspended in NS medium to achieve 
a cell density of 8-16x10 4 cells/cm2 . Tissue culture plastic had been incubated with 
0.1% gelatin for at least 30 mm. 
2.3.11 NS cell derivation from embryonic cortex 
Embryonic age E14.5 or E16.5 cortices were dissected and dissociated as 
explained before. The entire cell suspension from each embryonic cortex was plated 
on 25cm2 flasks in NS media. After 1-2 days cells were collected by centrifugation 
and replaced with fresh NS media. Cultures were allowed to form neurospheres for 7 
days. After this time, neurospheres were collected by centrifugation at lOOg for 1 
min and plated on gelatinised 25cm 2 flasks. Flasks had been coated with gelatin at 
37°C for at least 30 mm. From this point cells were maintained in adherent 
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monolayer and passaged when 30-50% confluent aiming for homogeneous cell 
morphology. 
2.3.12 NS cell derivation from ES neuroectoderm monolayer 
10 cm2 dish ES monolayer differentiation cultures were harvested after 7 
days, centrifuged and resuspended in 20ml NS media. The cell suspension was plated 
in 75cm2 flasks for 2-3 days in suspension. After this time, formed neurospheres 
were collected by centrifugation at lOOg for 1 mm, plated in gelatin-coated 75cm 2 
flasks and cultured for 6-8 days. From this point cells were maintained in monolayer 
and passaged when 30-50% confluent as explained before. 
2.4 Transfection of DNA into ES cells by electroporation 
2.4.1 Stable transfection 
200 -300tg of DNA was linearised by appropriate restriction enzyme 
digestion and checked for correct digestion by 1% agarose gel electrophoresis. DNA 
was purified by phenol/clorophorm and ethanol precipitation as described above. 
DNA was resuspended in 80tl of TE buffer inside the laminar flow sterile hood. 90-
100% confluent culture of ES cells in T75cm 2 flask was harvested, centriftigated and 
resuspended in 800tl of PBS. Cell suspension was transferred to a sterile 
electroporation cuvette and mixed with the linearised DNA. Cells were then 
electroporated at 800V and 3tF for 0.1 seconds (BioRad Gene Pulser). Cells were 
left to rest in the cuvette for 10 min and then resuspended in ES media and plated on 
10-15 pre-gelatinised 18cm 2 dishes. After 24 hours, drug selection was added 
(Hygromicin B 100tg!ml, puromycin 1tgIml, Gancyclovir 25mM 0.1N HCL l000x, 
Neomycin 1 66tg/mI) and media was changed every 2-3 days. 6-8 days later medium 
sized ES colonies were selected and transferred into 2-3 96 well plates. When 
colonies formed confluent cultures in 96 well plates, plates were replicated as 
explained above (2.5.6) for freezing stock and for screen the correct targeting by 
genomic PCR. 
2.4.2 Transient transfection 
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5x106 ES cells were electroporated as described above with 50tg of non 
linearised (pCAGCreIP) plasmid to achieve transient Cre recombinase expression. 
After electroporation cells suspension was diluted with ES media and plated in a 
gelatinised 75cm2 flask and cultured for 24-35h. After this time, cells were harvested 
and plated at clonal density in gelatinised dishes. Cells were cultured until colony 
formation and then proceeded as described above for selection of the clones with the 
correct recombination by Cre recombinase. 
2.5 Transfection of DNA into ES cells by lipofection 
Lipofection was done using TransFastTM  tranfection reagent (Promega). DNA 
plasmid was cut and purified as described before and resuspended in TE. 1 ig of 
DNA was incubated with 6tl of TransFast reagent in 250tl pre-warmed media for 
15 min at room temperature. ES cells were harvested, centrifuged and resuspended in 
ES media to a concentration of 2x10 6 cells/ml. Cell suspension is prepared to a 
concentration of 5x10 5 cells/250tl and mixed with DNA-TransFast solution. 
Subsequently the total 500t1 are plated in 24 well plate and incubated for 1 hour. 
After this time, lml of media was added and culture overnight. Next day media was 
replaced with fresh media and 48 h later cells were harvested and plated in 10cm 
diameter dish at clonal density (1000 ES cells). 
2.6 Transfection of DNA into NS cells by eletroporation 
10x106 NS cells were mixed in 100tl PBS solution with 50tg of plasmid 
DNA transferred to a sterile electroporation cuvette and electroporated at 250mV and 
9.6 capacitance. Immediately after cells were resuspended in 10 ml of NS media and 
plated at a density of 106  cellsper 10cm diameter dish. Media was changed every '4 
days until colonies became large enough to be transferred to 96 well plate (about 10-
15 days). 
2.7 Transfection of DNA into NS cells by nucleofection 
Nucleofection was done using Amaxa Biosystems nucleofector and solution 
V cell kit for NS cells. Nucleofector solution was pre-warmed at room temperature 
and NS media with 10% serum was pre-warmed at 37 °C. NS cells were harvested, 
counted and centrifuged at 300g for 4 minutes. Cell pellet was resuspended in 100tl 
of nucleofector solution B to a cell density of 2-5x10 6 cells and 2tg of plasmid DNA 
was mixed to the solution. Subsequently the cell suspension was transferred to a 
nucleofection cuvette and nucleofected using program T-030. Immediately after 
nucleofection, cells were transferred into an eppendorf with lml pre-warmed media 
and left to rest for 5 mm. After this time cells were gently transferred to pre-
gelatinised plates and media was changed to replace any trace of serum in the next 
two hours. 12 hours later drug selection was added to the media. 
2.8 MTT assay 
Cell proliferation quantification was done using the CellTiter' 96 AQueous  one 
solution cell proliferation assay (Promega) according to manufacturer's instructions 
with the following modifications: lOx10 4cells were plated in 150tl of media and 
30p1 of CellTiter reagent was added to the culture. The absorbance was read after 4 
hours using a precision microplate reader (Molecular devices) at 490nm wavelength. 
2.9 Cell sorting 
Cells were harvested and resuspended in 1 ml of FACS sorting solution (10% 
FCS and 100 U/ml penicillin andlOO [tg/ml streptomycin in PBS for ES cells and or 
3% BSA, penicillin/streptomycin in PBS for NS cells and monolayer differentiation 
cultures). Cells were sorted by J. Vrana using Cytomation MoFlo flow cytometer 
into tubes containing N21327 medium. Immediately after cells were plated on pre-
gelatinised plates at desired cell density with appropriate media or lysed for RNA 
extraction as described above. 
2.10 Flow cytometry analysis. 
Sox]-GFP knock-in ES (46C) cultured in 6 well plates in N2B27 serum-free 
monolayer system were harvested at days 3-8, centrifuged and resuspended in lml of 
FACS solution. Analysis was done using FACScalibur flow cytometer (Becton 
Dickinson) using CellQuest software. 10,000 events were scanned. Electronic gates 
were set by forward scatter (size) and side scatter (cell complexity) criteria to 
eliminate cell debris from the analysis. ES with no GFP knock-in after monolayer 
differentiation were used as a control to eliminate autofluorescence events. 
2.11 Immunocytochemistry 
Cells cultured in tissue culture plates were fixed with 4% PFA (pre-warmed 
at 37°C) for 30 mm, and washed three times in PBS. Cells were blocked in a 3% 
serum (goat or donkey if using goat or donkey host respectively as a secondary 
antibody) and 0.1% Triton-X for 60 min. Primary antibodies were diluted in 3% 
serum PBS solution and incubated overnight at 4°C. Cells were washed three times 
in PBS and incubated in secondary antibody solution (3% serum in PBS) for 1 hour 
at room temperature. After this incubation time, secondary antibody solution was 
removed and cells were washed three times in PBS. 4'-6-Diamidino-2-phenylindole 
(DAPI) solution of 1:5000 in PBS was incubated for 10 min and washed with PBS. 
Immunocytochemistry experiments were visualised using Olympus (WO) 
microscope and images were captured with Olympus DP50 camera. 
2.12 Quantification of immunolabelled cells 
Velocity software was used for cell number (DAPI positive nuclei) and 
neuronal number (TuJ1 positive) quantification. 
2.13 Statistical analysis 
Data statistical analysis. was performed using ANOVA test and Bonferroni 
method with XLSTAT software. 
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CHAPTER 3 
INVESTIGATING THE ROLE OF KAISO IN NEURAL STEM CELL 
FUNCTION AND DIFFERENTIATION 
3.1 Introduction 
DNA methylation is a major epigenetic modification in mammalian genomes 
affecting gene expression. DNA methylation mediates transcriptional silencing, 
mainly functioning in tumour suppressor gene inactivation (Herman and Baylin, 
2000), imprinting genes (Reik and Walter, 2001) and X chromosome inactivation 
(Robertson, 2005) by methylation of CpG islands, and to suppress repetitive DNA 
elements during murine embryogenesis. DNA methylation is also implicated in the 
regulation of cell- and tissue-specific gene expression (Bird and Woiffe, 1999; 
Jackson-Grusby et al., 2001). 
Transduction of the DNA methylation signal is primarily induced by the methyl-
CpG binding proteins (MeCP5) that selectively bind methylated CpG dinucleotides. 
The MeCPs can exert transcriptional repression to the methylated locus (even at long 
distances (Kass et al., 1993; Nan et al., 1997)) by recruiting chromatin remodelling 
corepressor complexes to the methylated site and changing the functional gene status 
(Jones et al., 1998; Nan et al., 1998; Ng et al., 1999; Sarraf and Stancheva, 2004; 
Wade et al., 1999; Yoon et al., 2003b). 
MeCPs are ubiquitously expressed in somatic cells while are expressed at very 
low levels in ES cells, giving evidence to support a critical role in regulating tissue-
specific gene expression. MeCP2, Mbd2 and Mbd 1 are members of the MBD family 
of proteins, that share the methyl-CpG binding domain that has the ability to bind to 
methylated CpG dinucleotides (Nan et al., 1993). In contrast, Kaiso belongs to the 
zinc finger family of transcriptional repressors. Kaiso is the only MeCP that binds 
specifically to two to three consecutive methylated CpG dinucleotides by zinc 
fingers with the highest reported affinity of any protein of methylated DNA 
(Prokhortchouk et al., 2001). Two target genes have been found to be bound (Aranyi 
et al., 2005) and repressed (Yoon et al., 2003b) by Kaiso through recognition of its 
specific binding site, human tyrosine hydroxylase TH and MTA2. In addition, Kaiso 
can bind through its zinc fingers unmethylated sequences that contain the consensus 
Kaiso binding site. xKaiso has been shown to repress transcription of the genes 
MATRYSILIN(Spring et al., 2005) and Wnt-11, Siamois and Xnr3 (Kim et al., 2004; 
Park et al., 2005) in Xenopus, which are target genes of the canonical Writ signalling 
pathway. Thus, xKaiso cooperates with TCF/LEF to repress transcription of 
canonical Writ pathway target genes. The canonical writ pathway is very important in 
cell fate specification and development. In the central nervous system, this signalling 
pathway is crucial in the decision of precursors to proliferate or differentiate during 
mammalian neural development (Hirabayashi et al., 2004) (Chenn and Walsh, 2002; 
Otero et al., 2004; Zechner et al., 2003). 
Kaiso mediates transcriptional repression by association with the corepressor 
complex N-CoR in HeLa cells (Yoon et al., 2003b) and in Xenopus (Kim et al., 
2004). The N-CoR complex is formed by more than ten proteins, containing histone 
binding proteins and histone deactylases. N-CoR associates with the RestlNrsf 
transcriptional repressor bringing histone deacetylase activity to the promoter of 
neuronal genes to drive their repression in noñ-neuronal cells (Jepsen et al., 2000). 
N-CoR plays a crucial role in the regulation of early fate specification in neural 
stem cells (Jepsen et al., 2000). N-CoR deficient mice show during brain 
development early neuronal Map2 positive and astrocytic Gfap positive populations 
while their neural precursor population is decreased, indicating aberrant fate 
specification. Concordantly, N-CoR deficient neural stem cells undergo spontaneous 
astrocytic differentiation bypassing the bFGF-induced self-renewal signal. Moreover, 
N-CoR overexpression inhibits astrocytic differentiation (Hermanson et al., 2002). 
Hence, these detailed in vitro studies revealed that N-CoR regulates nestin positive 
bFGF dependent neural stem cell fate specification. 
Since Kaiso is a key component of N-CoR repressor complex, I decided to study 
its function in vitro in neural stem cells. The hypothesis to be tested in this study is 
that Kaiso will play an important role in neural stem cell function via its role in the 
N-CoR complex. 
3.2 Generation of Kaiso null ES cells expressing Soxl-GFP 
Neural differentiation in vitro from ES cells has been demonstrated to 
correlate in time with neurogenesis in vivo (Qian et al., 2000; Shimozaki et al., 
2003). Soxi is a specific transcription factor of the earliest stages of neural 
development and it is present in the first neuroectoderm cells commited to the neural 
lineage (Pevny et al., 1998). Soxi is largely coexpressed with Nestin in 
neuroectodermal cells and it can be used as a marker for neural progenitors. 
To study the capacity of ES cells to differentiate into neural stem cells, 
previously generated Sox]-Gfp knock-in ES cells (46C) (Ying et al., 2003b), were 
chosen to be targeted with a Kaiso conditional deletion construct (a gift from Dr. E. 
Prokhortchouk) (figure 3.1 .A). This construct consists of two fragments of mouse 
genomic DNA from the Kaiso locus (left arm and right arm) of 1925bp and 1282 bp 
respectively, and a neo/tk selectable marker cassette cloned into pBluescript II SK-
(pBS KS- in Fig. 3.1.A) (Prokhortchouk et al., 2006). The Kaiso fragments right arm 
and left arm confer the homology necessary for homologous recombination to occur 
(Thomas and Capecchi, 1987). The neo/tk cassette contains the neomycin-resistance-
encoding gene which confers neomycin resistance for positive selection and the 
herpes simplex virus type-i thymidine kinase (Tk) gene, which confers ganciclovir 
- sensitivity for negative selection (Hone et al., 1995). The Kaiso cDNA of the 
construct is tagged with C-terminal Flag, although this tag has not been used in this 
thesis. After Flag, the Kaiso cDNA is ended with a stop codon and 3' untranslated 
region (UTR) Kaiso sequence. 
In the first targeting step, G418 resistant clones that had correctly replaced 
Kaiso with the Kaiso foxed construct were selected by genomic PCR (figure 3.1 .A). 
Kaiso is a X-linked gene, allowing me to use PCR genotyping in our XY ES cells. 
One selected clone (46CT) was transfected with a Cre expression construct (PE-
CRE) which expresses under a weak promoter (PE), the Cre recombinase protein that 
efficiently causes recombination between two loxP sites (Muller, 1999). Thus two 
different set of clones were selected: null clones with the selection cassette and Kaiso 
cassette deleted (figure 3.113 I), and foxed clones that have the selection cassette 
deletion only (figure 3.1 .B II) . The PE-CRE plasmid was chosen because of the low 
activity of its promoter in order to obtain both foxed and null lines. 
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Figure 3.1 A) 46C Sox-GFP ES cells were targeted with the Kaiso deleting construct 
(Prokhortchouk et al., 2006). Correctly targeted cells (46CT) were identified by genomic 
PCR. B) Transient transfected with Cre expression vector results in three different 
recombinations I: clones with completed recombination giving a null allele, II: clones with 
Kaiso foxed allele and III: clones with Neo/TK cassette allele. After TK negative 
selection, 46C foxed (II) and 46C Kaiso 1 (I) ES cell clones were identified by genomic 
PCR. C) PCR with genomic DNA from parental line (46C), Targeted clone (46CT), 2 
clones carrying floxed allele (FlO. ElO), 2 Kaiso' 1 clones (C3, E4) and Kaiso deleting 
plasmid as control (pBS KS(-). indicates LoxP site, li , 0 : indicates primer 
positions for PCR results shown in C) 
3.3 Quantification of neural precursors in the absence of Kaiso 
ES cells require LIF and Bmp4 signalling to maintain an undifferentiated state 
(Ying et al., 2003a), and in the absence of both factors ES cells in monolayer cultures 
undergo differentiation into predominantly (70%) neuronal cells in about 7 days, 
with the first Soxi positive neural precursors appearing at around 4 days in culture 
(Ying et al., 2003b). This well established system was chosen as a tool to study the 
neuroectoderm formation capacity of Kaiso ES cells. 
Two Kaiso ES cell clones, E4 and C3, were challenged to differentiate using 
the monolayer differentiation protocol and Soxl-GFP expression was monitored 
from days 3 to 8 by flow-cytometry of GFP in comparison with the parental ES cell 
line, 46C. During this process of differentiation, GFP-positive 46C cells appear 
around D3, peak at day 6, and start to decrease after day 7. Days 3 to 8 were chosen 
to screen both possibilities of early or delayed differentiation compared with the 
control line. The results of this experiment demonstrate that there is no defect in 
differentiation of ES cells lacking Kaiso protein into Sox 1-positive neural precursor 
cells (figure 3.2). 
3.4 Study of differentiation potential of ES-cell derivated neuroectoderm 
Monolayer differentiation cultures of the null cell lines were studied by 
immunocytochemistry to investigate the expression of markers of terminally 
differentiated cells such as astrocytes and neurons. The markers TuJ1 for post mitotic 
neurons and Gfap for astrocytes were assayed at different time points of 
differentiation to cover both possibilities of delay or early differentiation 
abnormalities, as described above. These experiments demonstrate that Kaiso is not 
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Figure 3.2 Kaiso is not required for neural precursor differentiation from 
ES cells. A) RT - PCR from two independent Kaiso •' clones and wild type 
FACS-sorted Sox]-GFP cells. B) Quantification of Soxl-GFP positive 
neural progenitors generated from day 3 to day 8 during monolayer 
differentiation from two independent Kaiso' clones and its parental one 
wild type 46C cell line. Error bars indicate SETv1 of three independent 
experiments. Test Anova: p=0.980. hence samples are not significantly 
different. C) FACS analysis of typical neuroectoderm differentiation at D4. 
In the top left corner histogram of percentage of GFP populations for 
control cell line with non-modified cells (no Sox]-GFP knock-in), wild 
type cells (46C) and two independent null cell lines (A and B). Left below 
dot plots of cell granularity on the x-axis versus cell size. The gate 
represent all viable cells. On the right panel are histogram that represent 
fluorescence on the x-axis versus the number of cells on the y-axis. Ml is 
set to exclude 99% of control cells (non-modified) and M2 represent SoxI-









































100 	t 1 	...•'•  163- 	10 
FL 1-H : GF P 









M l 0 • A. 








CD . i[L. 	 ••.... ........ 
Ii 	 I•) 	 - 




WT 46C 	. 









.. ,'•'. 	 • ... 
• 	.. t-.g... _1CS • : 




Figure 3.3 Kaiso is dispensable for neuron and astrocyte formation in 
the monolayer differentiation system. Left panels: wild type 46C cells, 
right panes: two independent Kaiso differentiation cultures. Left 
panels: TuJ I; right panels: Gfap in red and Dapi in blue. 
3.5 Study of neural stem cell function, self-renewal and differentiation. 
Recently an in vitro system has been discovered to cultivate and maintain in 
monolayer culture a pure population of neural stem cells that undergo indefinite 
symmetric self-renewal divisions in the presence of the EGF and bFGF growth 
factors (Conti et al., 2005). This is an extraordinary useful tool to dissect neural stem 
cell function in the dish since analysis of pure clonigenic stem cells can be done. 
This is in remarkable contrast with neurosphere assays where cells undergo various 
differentiation stages within the neurosphere, or neuroepithelial primary cultures, 
where reproducibility is undermined by differences in dissection, various cell 
differentiation phases, and the inability to mantain long term cultures. 
Since ES cell derived neuroectoderm differentiation is not affected by the lack of 
Kaiso, I decided to generate pure population of Kaiso (-/ -v) NS cells to specifically 
study the function of Kaiso from a cell status independent of ES cell differentiation. 
The previously studied Kaiso C3 and E4 ES clones were chosen to derive NS cell 
lines. The derivation of such cell lines appeared normal compared with the control, 
as was their proliferation and self renewal. Imrnunostaining for key neural stem cell 
markers Rc2, Nestin and Vimentin revealed uniform Kaiso NS cultures, where all 
the cells were positive for the three markers, and were indistinguishable from the 
46C wild type NS line (figure 3.4). 
Subsequently, Kaiso 	NS cells were assayed for their differentiation potential 
into neurons and astrocytes. For differentiation into neurons, NS cells are plated on 
Poly-D-Lysine and Laminin coated wells for one week in media with N2 and bFGF 
only, and a second week with B27 only. After 15 days of differentiation, cells are 
fixed and immunostained for markers of neurons and astrocytes. The data processed 









Figure 3.4 Kaiso) NS cells are indistinguishable from wild type 46C 
NS cells and do express neural stem cell markers Rc2 (top panels, 
green), Nestin (middle panels, red) and Vimentin (bottom panels, 
green). All cells are counterstained for Dapi (blue). 
Figure 3.5 Kaiso ' NS cells have normal differentiation potential. A 
and C wild type 46C, B and D Kaiso) NS cells. A and B TuJI in 
green. Dapi in blue. C and D Gfap in green, Dapi in blue. 
3.6 Summary and discussion 
Kaiso-null ES and NS cells were used to study the role of Kaiso in the 
proliferation, differentiation and self-renewal capacity of neural stem cells. In vitro 
neuroectoderm formation from Kaiso was indistinguishable from wild type 
cultures and the frequency of neuronal and astrocytic differentiation was normal. 
Moreover, the capacity to form neural precursors, which was quantified by a clear-
cut method, was remarkably identical between Kaiso and wild type 46C parental 
lines. From these experiments I can conclude that Kaiso is not required for neural 
stem cell function. Depletion of xKaiso in Xenopus embryos causes an overall 
developmental arrest and cellular apoptosis (Ruzov et al., 2004). In contrast, my 
results presented here and parallel studies demonstrate that Kaiso is dispensable in 
mice (Prokhortchouk et al., 2006). This surprising dissimilarity between Xenopus 
and mice adds more evidence to a wide divergence between mice and Xenopus in 
DNA methylation-dependent function. This could be explained by species-specific 
developmental differences; in Xen opus zygotic transcription occurs later than 
mammalian embryos and the later may not be affected by the earlier transcriptional 
activation in the absence of Kaiso (Prokhortchouk et al., 2006). 
In a recent study, Kaiso labelling by in situ hybridisation has been described 
to be uniform through the whole mouse brain, with a neuronal expression rather than 
glia (Della Ragione et al., 2006). Interestingly, my experiments with quantitative real 
time RT-PCR show astrocytes as the cell type with highest expression of Kaiso (see 
figure 4.1). 
The localisation of Kaiso within the cell is still unknown, and the multiple 
Kaiso studies remain inconsistent whether localisation of Kaiso is predominantly 
nuclear or cytoplasmic. It will be interesting to study the Kaiso localisation further at 
the cell level, since it can bring insight into the function of this protein. I have tested 
several published Kaiso antibodies and none showed a Kaiso-specific band in 
western blot that was not present in null samples. Therefore, these antibodies 
probably also recognises Kaiso-like proteins. 
It is rather surprising that ES and NS cells lacking a component of the N-CoR 
corepressor complex, which has been shown to be essential in neural stem cell 
function, are indistinguishable from wild type cells in all the experiments described 
above. Kaiso is one of the four characterised methyl-CpG binding proteins. There is 
previous evidence of key genes involved in neurogenesis that can function 
redundantly such as the SoxBl family (Wegner, 1999). Their overlapping roles have 
previously precluded the elucidation of the function of the individual proteins with 
the study of individual mice knock out models (Nishiguchi et al., 1998). It is 
plausible that functional redundancy occurs among this family of proteins and even 
in the absence of Kaiso, neural stem cells can function normally. 
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CHAPTER 4 
INVESTIGATING THE ROLE OF THE METHYL-CPG BINDING 
PROTEINS IN NEURAL STEM CELLS. 
4.1 Introduction 
DNA methylation is essential for embryonic development since mice lacking the 
enzymes that establish and maintain methylated DNA cannot survive after day 9.5 
dpc (Li et al., 1992; Okano et al., 1999). The cause of lethality is most likely due to 
an aberrant gene expression that causes disruption of developmental programs, while 
ES cells lacking methyltransferases remain immune to this disruption and can grow 
aphenotypically lacking normal DNA methylation levels (Li et al., 1992; Okano et 
al., 1998b). The maintenance methyltransferase Dnmtl and de novo 
methyltransferases Dnmt3a and Dnmt3b are dynamically expressed in neurons 
throughout development and appear necessary for their function (Feng et al., 2005; 
Goto et al., 1994; Okano et al., 1999). Transgenic mice that specifically lack Dnmtl 
in neural precursor cells from E9-E10 embryonic age have impaired neuronal 
function and die postnatally (Fan et al., 2001). 
Mutations in the MeCP2 gene cause the neurological disorder Rett syndrome in 
girls (Amir et al., 1999) and cause Rett-like phenotype in mice (Chen et al., 2001; 
Guy et al., 2001). Mice lacking Mbd2 are viable and fertile, but show gene 
missexpression in T cells (Hutchins et al., 2002) and mutant mothers show abnormal 
maternal behaviour with nurturing impairment that affect their pups development 
(Hendrich et al., 2001). Mice lacking Mbdl are also viable and fertile, and no 
obvious abnormalities have been found in their brain structures. However, Mbd1 
adult neural stem cells have a defect in neuronal differentiation which encompasses a 
defect in learning ability of the dentate gyms region of the hippocampus (Zhao et al., 
2003). This impairment was discovered with functional analysis in vitro of adult 
neural stem cells. 
Therefore, disruption in the transduction of the methylation signal seems to 
trigger neural malfunction. While methyltransferase disruption has lethal 
consequences, the absence of methyl-CpG proteins leads to relatively mild 
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phenotypes with the exception of Rett-like phenotype in MeCP2 mice or no 
phenotype in the case of Kaiso (previous chapter and Prokhourtchouk et al., 
2006). 
This leads to two interelated questions: why has evolution come up with four 
independent MeCPs in mammals to regulate transcription in methylated sites, and 
what are their functions? It is possible that methylated-dependent transcriptional 
repression occurs simultaneuously through multiple overlapping MeCPs to ensure 
gene silencing. Or it could be that their only function is fine silencing tuning and the 
only consequences of their disruption are visualised in complex neuronal function 
that we are barely beginning to understand. 
In favour of the first possibility multiple methyl-CpG binding proteins have been 
shown to be associated with methylated genes in vivo (Fournier et al., 2002; 
(Ballestar et al., 2003; Fraga et al., 2003; Koizume et al., 2002), raising the 
possibility that these proteins may provide independent, but normally redundant, 
silencing activities at methylated genes. In favour of the second possibility is the 
slow but steady unveiling of specific and unique targets for the most extensively 
studied MeCP, MeCP2, involved in neuronal circuitry (Chen et al., 2003; 
Martinowich et al., 2003; Horike et al., 2005). 
Hence, the question to be addressed in this chapter is: Do MeCPs display 
functional redundancy such that the absence of one has no overt consequence 
because there are still another three known proteins to apply methylated-dependent 
silencing, or is their function specialised in precise but distinct cell functions and 
therefore their absence has no major consequences? 
To address this question, Mbd2MeCP2Kaiso triple null mice (3KO) were 
engineered in our lab. 3K0 mice are viable and fertile but develop same Rett-like 
phenotypes indistinguishable from those displayed by MeCP2" mice although they 
die earlier than do MeCP2 mice (Caballero et al., in preparation). This is evidence 
that the simultaneous lack of three MeCPs is more severe than MeCP2-deficiency, 
consistent with the hypothesis that the MeCPs are redundant. Therefore mice lacking 
three MeCPs have a stronger phenotype than single knock out. 
Given this evidence and since mild phenotypes occurring in the absence of single 
MeCPs were only visualised through ex vivo analysis (Hutchins et al., 2002; Zhao et 
111 
al., 2003), I decided to investigate the function of MeCP2, Mbd2 and Kaiso 
simultaneously with the well characterised neural stem cell in vitro system. 
4.2 Investigation of MeCP expression levels 
Both Dnmtl and MeCP2 are highly expressed in postmitotic neurons (Fan et 
al., 2001; Shahbazian et al., 2002b). This could be due to a DNA methylation 
independent role of these proteins, or as a strategy of the cell to ensure the necessary 
Dnmtl and MeCP2 protein levels through life. The investigation of the gene 
expression levels on study is crucial to begin the understanding of their function. 
This was achieved with real time PCR on the cell types and tissues I have used 
through my experiments. A particularly important advantage in this experiment is the 
uniformity/purity that most of the cell types used in the extraction of RNA have. 
The cell types chosen were: 
ES cells, 
Soxi positive facs-sorted cells, 
Astrocytes: NS cells after 4 days of differentiation in the presence of 1-3% 
serum. In these conditions, 100% of the cells express the astrocytes marker Gfap. 
Neurons: 15 days NS differentiation cultures, where is believed that only 2 cell 
types are in majority: astrocytes and neurons, with a small population of 
undifferentiated Rc2 positive NS cells. 
Adult brain. 
For the studyof Mbdl expression, triple null adult brain was also analyzed, 
in search of a possible upregulation of Mbdl in the absence of other 3 Mbds, 
following the hypothesis of redundancy. I found an upregulation of Mbdl of about 3 
fold in the triple null brain sample, thus the upregulation of Mbdl in the absence of 
MeCP2, Kaiso and Mbd2 could be caused by a compensation effect (figure 4.1). 
The expression of Mbdl, Mbd2, Mbd3a and Mbd3b, Kaiso and MeCP2 
mRNA was analysed. Additionally, I included Sox2 as a reference gene for which 
expression levels are known. Sox2 is expressed in ES cells (Yuan et al., 1995); after 
neural induction, Sox2 is expressed in proliferating neural precursors along the entire 
antero-posterior axis of the developing embryo and is detected in neurogenic regions 
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in the postnatal and adult CNS (Ferri et al., 2004; Tanaka et al., 2004). Therefore, it 
is expressed in all the cell types chosen in the experiment. 
As predicted, all the cell types express the four MeCPs studied throughout 
this thesis, plus Mbdl, and Sox2. The highest expression of MeCP2 is in neurons, 
being the highest expression among all the Mbds. This finding correlates with 
previous studies (Shahbazian et al., 2002) (figure 4.1). 
To investigate whether MeCPs are expressed in NS cells, which have been 
used as a tool fQr this thesis, western blot and immunocytochemistry were performed 
for MeCP2 and western blot for Mbd2. From these experiments I can confirm the 
expression of both proteins in NS cells (figure 4.2). 
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Figure 4.1.Real time RT-PCR expression with the cell types of study. Upper 
panel normalised against ES cell (46C ES cells) expression levels. Lower 
panel normalised against adult brain expression. All expression levels were 
measured in triplicate. Error bars indicate SEM. 
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Figure 4.2. A) Western blot for Mbd2 in ES, wild type NS and Kaiso/Mhd2 null 
NS cells, (/)xKy.  nuclear protein (from left to right). B) Western blot of MeCP2 
with NS nuclear protein: upper, anti-MeCP2 (from Upstate); lower anti-MECP2 
674 (Nan et al.. 1998). C) lmmunofluorescence for anti-MeCP2 in wild type NS 
cells. NIeCP2 in red. Rc2 in green, Dapi in blue. Scale bars represent 20tm 
4.3 Electrophoretic mobility assays 
The defining characteristic of the MeCPs is their ability to bind methylated 
DNA; to a single mCpG dinucleotide in the case of MeCP2 and Mbd2 and to a 
double or triple mCpG dinucleotide in the case of Kaiso. Therefore, it is necessary to 
determine whether these proteins do bind to methylated DNA within NS cells and to 
determine whether the triple null NS cells contain the known MeCP activity encoded 
by Mbd2 and Kaiso (Prokhourtchouk et al., 2001; Hendrich et al., 2001). 
The electrophoretic mobility shift assay (EMSA) is based on the observation 
that protein-DNA complexes migrate more slowly than free DNA molecules when 
subjected to non-denaturing polyacrylamide or agarose gel electrophoresis (Revzin, 
1989). EMSA has been the key assay to investigate the properties of the family of 
methyl-CpG binding proteins, and its binding pattern is well characterised (Cross et 
al., 1997; Hendrich and Bird, 1998; Hendrich et al., 2001; Meehan et al., 1992). A 
methylated or unmethylated probe (CG 11) containing four HhaI sites (GCGC) and 
two HpaII sites (CCGG) (Meehan et al., 1989) was incubated with NS cell nuclear 
extract in the presence of competing bacterial DNA. The mix was loaded on 1.5% 
agarose gel to resolve protein-DNA complexes from free DNA and subsequently an 
autoradiography revealed the complexes formed. 
As expected, nuclear extract from wild type NS cells bound the methylated 
probe MeCG1 1 forming a shift band of similar size to the well-characterised doublet 
band in liver nuclear extract (Meehan et al., 1989). This doublet band is formed by 
two complexes, a slow migrating complex (complex I), and a faster migrating 
complex (complex II) which is not dependent upon Mbd2 for its formation (Hendrich 
et al., 2001) . On the other hand, both Mbd2 MeCP2Kaiso' NS extract and 
Mbd2Kaiso NS cell nuclear extract produced very weak binding. From these 
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Figure 4.3. EN'ISA with methylated probe MeCG 11 (left) in comparison 
with unmethylated probe CG II (right). In the MeCG 11 experiment, a 
doublet (indicated by two arrows (complex I and II)) is shifted in wild 
type NS cell nuclear extract as well as wild type liver, meanwhile triple 
MeCP2/Mbd2/Kaiso NS cell nuclear extract (NS 3K0) and double null 
Mbd2/Kaiso NS cell nuclear extract (NS 2K0) does not. Mbd2 null NS 
(Mbd2KO) shift a faint (complex 11) that is not present in the 
unmethylated panel. 
4.4 Neurosphere assays from embryonic cortex 
Embryonic age E14.5 is the peak of neurogenesis in mice, and E16 is the 
starting point of astrocytogenesis (Ghosh et al., 1995). Both stages were chosen to 
study neurosphere formation from mouse embryonic forebrain. 
The neurosphere assay is a well-established method that has been extensively 
used in the field to study neural stem cell function. Hence, I used the neurosphere 
assay as a tool to investigate whether MeCP2, Kaiso and Mbd2 play redundant role 
in neural stem cells. First, I studied the proliferation capacity of single, double and 
triple null neurospheres (see table 4.1) by analysing the frequency that neurospheres 
were formed from single cells. Neurospheres were measured after a week of culture 
in size and number. 
Single null Mbd2 MeCP2 Kaiso 
Double null Mbd2MeCP2 MeCP2'Kaiso Mbd2Kaiso 
Triple null Mbd2MeCP2Kaiso 
Table 4.1 Mouse genotypes analysed by neurosphere assay. 
Secondly, to study the stem cell self-renewal ability in the absence of MeCPs, 
neurospheres that had been cultured for one week were dissociated to single cells in 
cloning conditions to study the ability of each single cell to form a new neurosphere. 
Again the frequency of neurosphere formation and the size were measured. 
The data obtained from these assays was highly variable within the different 
clones obtained from different embryos, regardless their genotype. Therefore, no 
conclusions could be obtained and the data has been disregarded. This observation 
will be discussed at the end of the chapter. 
Finally, to study the potential of neurospheres to differentiate into two 
different post-mitotic cell types, neurons and glia, neurospheres were cultivated for 
one week, plated on PDL/Laminin without growth factors and maintained in 
differentiation medium for 5 days. After this time, cells were immunostained to 
analyze the number of multipotent neurospheres giving rise to both neuronal and 
astrocytic cell types, or neurospheres with only astrocytes or only neurons. 
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Additionally, the same differentiation assay was performed from the second 
neurosphere generation obtained. 
This assay proved to be the only informative neurosphere assay, and I could 
conclude that all the neurosphere populations derived from single, double and triple 
mutant and wild type brains had normal differentiation potential, being multipotent 
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Figure 4.4 Neurosphere assay. 1. Neurosphere ICC after 5days in differentiation 
conditions. A: Wt, B: Mbd2 null, C: Kaiso null, D Kaiso/Mbd2/MeCP2 null. 
TuJI in red, GFAP in blue 2. Multipotency 1st and 2nd Neurospheres, % 
colonies Gfap positive!TuJ 1 positive or only Gfap positive. 
4.4 Derivation of neural stem cell lines from embryonic cortex. 
As described before, a neural stem cell must be able to proliferate 
indefinitely, have unlimited self-renewal capacity and be clonogenic. Additionally, 
neural stem cells must be multipotent, giving rise to differentiated cell types by 
asymmetric division (Reynolds and Weiss, 1996). Since the neurosphere assay was 
not able to address the question of self-renewal and proliferation, I took the 
advantage of the recent discovery of NS cells, that as I described previously, are a 
pure population of neural stem cell that can be maintained in monolayer conditions 
(Conti et al., 2005), and are a very useful tool to address the questions I needed to 
study. 
As in the neurosphere assays, embryonic stages E14.5 and E16.5, which are 
the beginning of neurogenesis and astrocytogenesis respectively, were chosen. 
Embryonic forebrain was extracted out from the embryonic brain, and the cortex 
was dissected. The tissue was dissociated and single cells were plated regardless of 
cell density in the presence of EGF and bFGF. After two or three days cells were 
forming neurospheres and these were collected and plated on gelatin. After several 
days, characteristic cells attached to the flask were dispersing out of the neurosphere. 
These are the derived NS cells that, after several passages, will form a pure 
population of neural stem cells. The cell lines that were derived are described in table 
4.2. 
Embryonic age E14.5 E16.5 E14.5 E16.5 E14.5 E16.5 
Wild type V V 








Triple null Mbd2 	Me CP2' Kaiso V 
Table 4.2 Genotypes of NS cell lines derived from embryonic cortex. 
However, because previous experiments with neurospheres showed a 
tendency for overlapping characteristics regardless of the genotype, I decided to 
concentrate on the investigation of triple null versus wild type genotypes. 
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4.5 Characterisation of NS lines 
Three independent E14.5 triple null NS cell lines were selected to 
characterise their neural stem cell function. 
4.5.1. Neural stem cell marker expression: 
Cell lines were screened for the proper expression of neural stem cell markers 
Rc2, Nestin and Vimentin, and the absence of differentiated cell markers TuJ1 and 
Gfap. This was done at several points during more than 20 passages within these cell 
lines that have been studied (figure 4.5). 
One working hypothesis was the possibility of spontaneous astrocytic 
differentiation during the culture of NS cells or, the possibility of early astrocytic 
differentiation. This hypothesis was driven by the observation that global 
hypomethylation, caused by deletion of Dnmtl in mice, causes precocious 
astrocytogenesis in the developing central nervous system, due to demethylation of a 
Stat binding element within the Gfap promoter (Takizawa et al., 2001) and the 
overall elevation in Jak-Stat signalling activity (Fan et al., 2005). s10013, GFAP and 
Stat promoters display highly methylated CpGs in neuroepithelial cells at early 
stages of development, and lose their methylation at later stages, in parallel with the 
onset of neurogenesis in the developmental brain. These three promoters are 
associated with MeCP2 during the highly methylated neurogenic stages of the 
neuroepithelial cells (Fan et al., 2005). As explained before, the absence of three 
methyl-CpG binding proteins could result in removal of compensation activities and 
result in a phentoype that resembled the Dnmtl knock out phenotype. However, I 
found no precocious or spontaneous astrocytic differentiation in the triple null NS 
cell cultures. Therfore, I can conclude that the absence of Kaiso, MeCP2 and Mbd2 




RC2 	 Nestin 	 Vim 
Figure 4.5. Characterisation of triple NS cell lines. tmmunocytochemistry 
of neural stem cell markers Rc2, Nestin and Vimentin in red, Dapi in 
blue. A Wild type NS clone 4 B. C and D: 3 independent MeCP2/ 
Kaiso/N4bd2 triple null NS clones. 
4.5.2 Proliferation 
The MTT assay measures the bioreduction of the tetrazolium 
compound MTT to a coloured formazan product by the mitochondria of 
living cells, and therefore colorimetric analysis provides an accurate 
quantification of cell proliferation . To study the proliferation rate of the 
triple null NS cell lines, MTT assays were performed in 5 independent 
experiments for 2 different cell lines of each genotype, and 3 
independent experiments for an extra cell line of each genotype. The 
conclusion of these experiments is that proliferation of NS cells is not 
affected by the simultaneous absence of MeCP2, Mbd2 and Kaiso as 
measured by the mitochondria respiration compared with wild type NS 
cells (figure 4.6). 
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Figure 4.6 Triple null NS cells proliferate at a normal rate. NS cell 
proliferation rates were compared by MTT assay. Data for three independent 
MeCP2/Kaiso/Mbd2 triple null NS cell lines and two independent wild type 
NS cell lines are shown. 
4.5.3 Self-renewal 
Triple null NS cells were maintained for between 20 and 60 passages without 
displaying differences in growth rate, maintaining the expression of neural stem cell 
markers and retaining the ability to give rise to neurons and astrocytes when plated 
on differentiation conditions. Triple null NS cells were able to form colonies from 
single cells at a normal rate compared with wild type. 
4.6 Astrocytic differentiation potential 
NS cells are able to differentiate to Gfap expressing astrocytes in less than 48 
hours in the presence of serum or Bmp4 and in the absence of growth factors (Conti 
et al., 2005). Lif and Bmp signalling share gp130 as a signal transducing receptor 
component in the activation of the JaklStat pathway (Fan et al., 2005; Nakashima et 
al., 1999b). As mentioned above, one working hypothesis was the possibility of early 
astrocytic differentiation in 3K0 NS cells. However monitoring of differentiation at 
8h, 12h, 20h, 24h time points I did not observe any difference in astrocytic 
differentiation between triple null and wild type NS cells. Both wild type and triple 
null lines were able to differentiate to astrocytes normally in more than 5 
independent experiments where cell density, serum concentration and 
presence/absence of LIF were tested along the 40 passages of three independent 
3K0 NS cell lines. 
Reverse transcription analysis revealed that both wild type and 3K0 
astrocytes express the expected genes of astrocytes: Gfap and sl00I3 as well as Blbp 
(Feng et al., 1994) (figure 4.7.13). Interestingly, neural stem cell markers such as 
Nestin and Pax6 were also expressed in some cell lines regardless of genotype. These 
results could suggest that not all the cells are fully differentiated into astrocytes 
Figure 4.7 Triple null astrocytes are indistinguishable from WT. Immunostaining 
after 4 days of NS cell culture in presence of serum and removal of growth factors. Left 
panels: bright field. Right panels: GFAP in green, Dapi in blue. A WT NS cells derived 
astrocytes. B and C two independent 3K0 NS-derived astrocytes. D RT-PCR of astrocyte 
and NS cell markers. Cell types from left to right: 2 wild type NS-derived astrocytes (4 and 
Con) two triple null NS-derived astrocytes, one wild type NS cell line, one 3K0 NS cell 
line, Adult brain and ES cells. 
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Figure 4.8 Astrocytes differentiated from E14-derived NS cells have 
different morphology than E16-derived NS cells. A and B: two 
independent E16.5 derived NS cell lines. C and D: two independent E14.5 
derived NS cell lines. E: Astrocytes differentiated from ES-derived NS 
cells. Left panels: bright field Right panels: Gfap in green, Dapi in blue. 
However, during the process of characterization, I have observed a morphological 
divergence that make astrocytes differentiated from E14.5-derived NS cells (E14A) 
distinguishable from astrocytes differentiated from E16.5-derived NS cells (E16A) 
independently of their genotype. E16A were spiky, with long processes and 
connections to neighbour cells while E14A were short processed and fibrous with 
more cytoplasmic surface (figure 4.8). This different morphology could be a cell 
density effect, given that in a less dense environment cell-cell contact could be 
affected. I investigated further the morphology that E14.5 and E16.5 NS derived 
astrocytes were having at different densities. Wild type E14.5 derived NS cells were 
plated for astrocytic differentiation at densities of X, 2X, X/2, and 1 2.5X. In these 
experiments I observed no morphological difference between different densities and 
no similar morphology to E16.5 in the more dense cultures. Therefore I conclude that 
the morphological difference is independent of cell density at the time of 
differentiation (figure 4.9). 
Figure 4.9 Astrocyte morphology is independent of cell density during 
differentiation from NS cells. E14.5 embryonic age wild type NS derived cells were plated 
at densities of lO, 8x104 4x104 and 2xlO4cells/well and cultured in astrocytic conditions 
without observing morphological differences. Left panel bright field. Right panel: Gfap in 
green, Rc2 in red and Dapi in blue. 
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The cause of a cell morphology difference is difficult to dissect; 
immunostaining markers were similar in both cases, with all cells being Gfap 
positive. Additionally, in both groups there was always present a small population of 
Rc2 positive cells that were simultaneously Gfap positive. 
Radial glia and subventricular zone neural stem cells differentiate into 
primarily protoplasmic astrocytes. NS cells are believed to have characteristics of 
radial glia, and are indeed derived from cells residing where radial glia are located, 
lining the subvcntricular zone. However, protoplasmic astrocytes hardly express 
Gfap while NS derived astrocytes do express Gfap. Therefore, the astrocytie 
morphology expected to be predominant from NS cell differentiation would be closer 
to E 14 morphology than EI6A morphology. 
Pure NS cell cultures are most likely to be independent of the embryonic age 
from which they were derived. This independency can be due to two explanations: 
first, neural stern cells in vivo at those stages are immersed in a different 
concentration of growth factors and other signalling molecules, while in vitro are 
exposed to the exactly same conditions and concentration of growth factors. 
Secondly, the effect of cultivating and passaging the cells is likely to unify the age-
derived possible differences. However, morphology is indeed different in two E16.5 
NS derived astrocyte cultures compared with two wild type E14.5 NS derived 
astrocyte cultures, and it is independent of the cell density. Furthermore, ES-derived 
NS cells differentiate into astrocytes resembling the type from E14.5 NS cell-
derived. This difference is in relation with the findings that cultured radial cells 
produce different progeny depending on the age where they were isolated, being 
primarily neuronal colonies with few glial or mixed colonies when isolated from 
E14-E16 embryos and mostly glial colonies with few neuronal colonies when 
isolated from E18 (Qian et al., 2000; Takizawa et al., 2001; Malatesta et al., 2000). 
In conclusion, the different morphology of the astrocytes differentiated from E14.5-
derived NS cells and E16.5-derived NS cells could be due to an epigenetic readiness 
after E 16 to differentiate into astrocytes. 
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4.6 Neuronal Differentiation potential 
To investigate the role of the simultaneous action of MeCP2, Mbd2 and 
Kaiso in neuronal differentiation, I next studied the capacity of 3K0 NS cells to form 
post-mitotic neurons with wild type parallel experiments as comparison. NS cells 
were plated on PDL/Laminin for a period of 7 days in the presence of bFGF and 
further 7 days without growth factors in the presence of B27 for nutrition of the 
neurons. This protocol yields the highest NS neuronal differentiation (Conti et al., 
2005). After 15 days in differentiated conditions three populations of cells could be 
identified: post-mitotic neurons, astrocytes and Rc2 positive NS cells. In these 
conditions, post-mitotic neurons marked by TuJ1 were in the 3K0 NS cell cultures at 
the same frequency as wild type (figure 4.10). Hence, 3K0 NS display normal span 
neuronal differentiation. 
However, neuronal differentiation frequency achieved after only 7 days, 
where bFGF was still present, was remarkably lower than in wild type NS cells. 
Three NS lines derived from three independent E14.5 triple null embryos were 
investigated in comparison with four independent wild type cell lines, which one was 
derived from E16.5 wild type embryo and three from three independent E14.5 wild 
type embryos. The rate of Tuj I positive neurons was dramatically reduced in the 
triple null cultures with statistical significance (p<0.0024) according to the 
Bonferroni method (Gordi and Kkiamis, 2004). In summary, while a normal 
differentiation span leads to indistinguishable neuronal differentiation capacity 
between wild type and triple null NS cells, 3K0 NS cells show an initial delay in 
neurogenesis as compared to wild type NS cells (figure 4.11). 
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Figure 4.10 Neural differentiation of triple null NS cells is not impaired. NS cells 
are cultured for 15 days in neuronal differentiation conditions and subsequently 
immunostained. A and B, cultures derived from wild type NS cell clones: A wild 
type NS clone derived from embryonic age Eló.5. B wild type clone derived from 
embryonic age E14.5. C and D cultures derived from two independent triple null NS 
cell clones TuJI in green. Gfap in red, Dapi in blue. E and F,MAP2 as a marker for 
mature neurons. G and I-I Gad67, GABAergic marker. E and G wild type. F and H 
triple null. Scale bars represent 5lAm  in A-D. and 31.lm  in E-H 
% TuJi +ve D7 differentiation 
Figure 4.11 A) Triple null NSs have fewer differentiated TuJI positive neurons after 7 days 
of differentiation. A, Wild type E14.5 derived NS. B triple null E14.5 derived NS. TuJ1 in 
green, Dapi in blue.C. Wild type El 6.5 derived NS. D, Wild type E14.5 derived NS. E and 
F, triple null E14.5 derived NS. TuJ 1 in green, RC2 in red. Dapi in blue. A and B scale bars 
represent 1Otm.C,D,E,F scale bars represent Slim. B) Quantification of NS-derived TuJI 
positive neurons after 7 days of differentiation. On the left wild type NS cells form 2.5 fold 
more neurons than triple null NS cells on average. This phenotype is independent of 
embryonic age. All NS cell lines are E14.5 embryonic age-derived, with the exception of 
first left wild type NS cell line, which is E16.5 embryonic age-derived. 
4.7 Summary and Discussion 
4.7.1 MeCP2, Kaiso and Mbd2 are dispensable for neural stem cell 
function 
Following the postulated hypothesis of functional redundancy among the 
methyl-CpG binding proteins, triple null neural stem cell lines were analysed in 
order to study their function. 1 can conclude that the triple null neural stem cell lines 
have no abnormal capability compared with the wild type, as both wild type and null 
NS cells showed comparable proliferation, self-renewal and differentiation 
capacities. Hence, my results do not support any role for MeCP2, Kaiso and Mbd2 in 
neural stem cell function. 
4.7.2 Methyl-CpG binding protein and functional redundancy 
This surprising finding raises the question of why there is no abnormal neural 
stem cell function in the absence of three out of four methyl-CpG binding proteins? 
One possible explanation for these results is that there are more methyl-CpG 
binding proteins currently uncharacterised, and therefore the absence of three 
proteins is not sufficient to disrupt neural stem cell function. Indeed, two additional 
methyl-CpG binding proteins have been discovered. These proteins, called ZBT134 
and ZBT1338, are closely related to KAISO in that they can bind sequences 
containing a single methylated CpG and can function as methyl-dependent 
transcriptional repressors (Filion et al., 2006). Given their expression pattern and 
homology it is very plausible that they share functional redundancy with the first 
BTB/POZ methyl-CpG binding protein discovered. Hence, the lack of phenotype 
observed in my studies could be attributed to functional redundancy with other 
methyl-CpG binding proteins. 
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Another explanation could be that although all the evidence indicates a role 
of the methyl-CpG binding proteins in neural stem cell function, it could be that only 
Mbdl is involved in the mechanisms of differentiation of neural precursors. In 
concordance with this possibility, a role for MeCP2 in neural stem cell function has 
been recently ruled out, being in contrast confirmed a neuronal role for this protein 
(Kishi et al., 2004). 
4.7.3 A role for methyl-CpG binding proteins in neuronal function 
My experiments demonstrate that despite the dispensability of Kaiso, 
MeCP2, and Mbd2 for neural stem cells, the number of TuJ 1 positive neurons after 
seven days of differentiation in vitro is dramatically reduced in triple null cultures, 
while after a complete period of differentiation of 15 days there is no observable 
difference. 
These results could be the consequence of a delay in neuronal maturation in 
3K0 lines, and therefore after an extended neuronal differentiation period would be 
indistinguishable from wild type. On the other hand, as only the expression of the 
postmitotic neuronal protein f3 tubulin III has been quantified, it is plausible that 
only the expression of this particular marker is delayed in 3K0 lines. Therefore, it 
would be interesting to investigate the expression of additional neuronal genes that 
mark different neuronal differentiation stages, such as early maturation events (NeuN 
and Map2) and more advanced stages of differentiation (Neurofilament triplet 
proteins NF-L, NF-H, NF-M and synaptophysin) (Izant and McIntosh, 1980; Matus, 
1990; Mullen et al., 1992; Przyborski and Cambray-Deakin. 1995; Steinschneider et 
al., 1996) 
Consistenly with a delay in neuronal maturation phenotype in 3KO lines, 
several groups have suggested a role for MeCP2 in neuronal maturation (Shahbazian 
et al., 2002; Kishi et al., 2004; Matarazzo, 2004). Matarazzo et al, studying olfactory 
receptor neurons identified a delay in terminal differentiation of olfactory neurons 
that also leads to axonal disruption. On the other hand, Young and colleagues 
(Young et al., 2004) described a possible role of MeCP2 in neuronal survival, when 
plating 1:1 wild type and null neurons observed that after 7 days the majority of the 
cells were wild type, suggesting that the MeCP2 null neurons would die during 
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culture. If this were the case, neuronal survival should be affected both at day 7 and 
day 15, but I only see an observable difference after the first week of differentiation. 
Additionally, Kishi et al described a reduced size and arborisation of MeCP2-
null neurons in the neocortex that is linked to a defect in late stage post migratory 
maturation of the neurons. Moreover, MeCP2 is also believed to have a role in the 
establishment and maintenance of synapses (Johnston et al., 2001; Kaufmann et al., 
2005; Moretti et al., 2006) (Fukuda et al., 2005). Therefore, MeCP2 is essential for 
proper regulation of neuronal gene expression that is fundamental in the complex 
balance of transcriptional factors involved in neuronal function (Chen et al., 2003; 
Horike et al., 2005; Martinowich et al., 2003; Nuber et al., 2005; Samaco et al., 
2004). 
Given this evidence it is not surprising to find delayed neuronal 
differentiation in my in vitro system. However, an additional role for Mbd2 or the 
combination of MeCP2, Kaiso and Mbd2 in controlling the specific transition 
between neural stem cells and neurons cannot be ruled out. 
4.7.5 Astrocyte morphology 
During my NS differentiation studies I observed an unequivocal 
morphological difference in astrocytes that was embryonic age-related instead of 
genotype dependent. I concluded that E14.5 embryo-derived NS cells differentiate 
into more flat and less spiked astrocytes with fewer connections than do E16.5 
embryo-derived NS cells. As explained before, this is a surprising effect given that 
these cell lines are thought to be very homogenous since there are a pure population 
of cells that undergo continuous asymmetric divisions and are maintained in the 
same constant balance of growth factors. 
This morphological difference is not observed in other differentiation assays 
when astrocytes are not induced by BMP4 present in the serum but other factors are 
involved in the process (PDL/Laminin, bFGF and b27)(figure 4.10). It would be very 
interesting to study what is the cause of the morphological difference. Which are the 
signals and factors that determine one shape or the other? Does different astrocytical 
morphologies correlates with different functions? 
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4.7.6 Heterogeneity of neurosphere assay 
The neurosphere assay, although extensively used, has the drawback of 
heterogeneity. In the neurosphere, apart from the neural stem cell population that 
maintains the neurosphere status, there are other cells at various differentiation 
stages. Therefore, there are different cell growth rates and self-renewal capabilities 
within the same neurosphere. Hence, unless a study would involve a very dramatic 
phenotype it is very possible to dismiss it through this system, or alternatively, obtain 
results that are not easily reproduced in independent experiments involving different 
embryos. 
The variability I found in the results of proliferation and self-renewal could 
be due to the combination of no differential phenotype and heterogeneity of 
neurospheres formed from individual embryos regardless their genotype. 
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CHAPTER 5 
INVESTIGATION OF THE ROLE OF MBD3 IN NEURAL STEM CELLS 
5. 1 Introduction 
Mbd3 forms part of the NuRD complex and may function as a scaffold 
protein, since in the absence of Mbd3 the complex is not correctly formed. This is 
shown by the failure of components of the complex to coimmunoprecipitate in the 
absence of Mbd3 (Kaji et al., 2006). Mbd3 is required for the transition of 
pluripotent cells of the blastocyst to mature into epiblast upon implantation, resulting 
in early post implantation lethality. Accordingly, Mbd3 ex vivo inner cell mass 
culture fail to differentiate into epiblast (Kaji et al., 2006). 
Mbd3 was also fished out in an mRNA substractive cDNA hippocampal 
library as a gene that was being expressed higher in the embryonic brain than in the 
adult brain (Jung et al., 2003). The consequent immunohistochemical and in situ 
analysis of Mbd3 in mouse and rat brain delineated an early Mbd3 expression in 
embryonic cortex and hippocampus around the onset of neurogenesis that decrease 
toward adulthood. In contrast, striatum, olfactory bulb and cerebellum had a later 
expression during embryonic development that continued into adulthood. This 
differential expression parallels the presence of progenitor neural cells in these 
structures, and it could correlate with a role for Mbd3 in neural stem cell function. 
5.1.1 Generation of Mbd3 ES cells 
Although Mbd3 	blastocysts fail to proliferate in culture making the 
derivation of Mbd3' ES cells from blastocysts impossible, Mbd3 ES cells have 
been made by selecting for loss of the wild type allele and duplication of the mutant 
allele by homologous recombination (Fix2 and Sp12 ES cell lines)(Kaji et al., 
2006)(figure 5.1 .A). A second null line was generated through the targeting of loxP 
sites flanking the entire Mbd3 gene (31'lox ES cell line) and consequent 
recombination of loxP sites by transient expression of Cre recombinase (3K0 cell 
line)(Kaji et al., 2006). 
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There are three Mbd3 isoforms, Mbd3a, Mbd3b and Mbd3c (figure 5.1.B). 
Cre recombination of loxP sites in the 21ox ES cell line resulted in Mbd3c-expressing 
ES cell line (A7), as explained in figures 5.1 .A and 5.1 I.C. To ensure that the defects 
explained below are a consequence of the absence of Mbd3 in the cells, rescued cell 
lines were generated by stable transfection of Mbd3a or Mbd3b isoforms in Mbd3 
ES cells (Kaji et al., 2006). 
Previous experiments have shown decreased proliferation of Mbd3 	ES 
cells compared with wild type (Kaji et al., 2006). Mbd3 ES cells can grow at 
clonal density in the absence of LIF. Furthermore Mbd3 ES cells expressing 
Puromycin and GFP under the Oct4 promoter (Oct4-GFP-ires-pac (Ying et al., 
2002)) could be cultured and passaged under puromycin selection and the absence of 
LIF for more than 2 weeks, with the aberrant expression of Fgf5, which is reversed 
after addition of LIF to the culture (Kaji et al., 2006). These experiments demonstrate 
that Mbd3 ES remain pluripotent (Oct4 positive) independently of LIF signalling. 
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Figure 5.1 A) Schematic representation of the generation of Mbd3"21°, Mbd3 
and Mbd3 (1,)  cell lines. !4bd32 1 ES cell line which have exon I foxed 
between two loxP sites was generated from ES cells which have 
Hygromycin/Thymidine Kinase cassete upstream of Exon I (HyTk/-). Mbd3 (h/) 
ES cell line (A7) with Exoni deletion in one allele was generated from I4bd3 21"' 
ES cell line by Cre recombination. A4bd3 ES cell lines (clones Sp12 and Fix2) 
were obtained by loss of the wild type allele and duplication of the mutant allele 
from HygTk/- cells by gancyclovir selection. Exons are indicated as boxes and 
non-coding sequences as unfilled boxes. Exon I contain both coding and non-
coding sequences. Black triangles represent loxP sites. ES cell line names are 
indicated in red. These cell lines were generated by Dr. Hendrich and R. Macleod. 
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Figure 5.1 B) Schematic representation of the generation of Mbd3(30)  and 
Mbd3 clone named 3K0. A cell line (I lox) was generated from foxed ES 
cell lTlyTkI- by Cre recombination, then subsequently targeted with a construct 
designed to leave the entire Mbd3 gene flanked by two loxP sites (Mbd3 31 "). 
After Cre recombination of Mbd3(51.t.)  cell line, Mbd3 	3K0 is generated. C) 
Schematic representation of Mbd3 isoforms: Mbd3b is a splice isoform, which 
lacks half of methyl CpG binding domain. Mbd3c might be translated from 
I methionine in exon 2 as the transcripts are detectable in AT SDsplice donor. 
SA=splice acceptor D) Western blot using Mbd3" . l-lyTK)/-, Mbd3 
(A7), and Mbd3 	cell lines cell lines from left to right (Kaji et al., 2006). 
5.1.2 Studies of differentiation capacity in Mbd3&'  ES cells 
In the analysis of differentiation capacity, there were previously performed 
embryoid body (EB) differentiation experiments in the absence of LIF and gene 
expression analysis by RT-PCR at key time points of differentiation (Kaji et al., 
2006). In embryoid bodies, the external endoderm signals, which correlates with the 
primitive endoderm in the embryo, differentiation and endoderm specific gene 
expression are necessary to form the columnar ectoderm layer (Li et al., 2004). 
The results from these experiments (Kaji et al., 2006) revealed an 
unequivocal defect in differentiation of Mbd3 ES cells, denoted by two reasons. 
Firstly, Mbd3 embryoid bodies expressed pluripotent markers Oct4, Nanog and 
Rexi after 10 days of differentiation, and secondly, Mbd3 EBs could be 
dissociated and cultured as ES cells, being positive for alkaline phosphatase. While 
Mbd3 ES cells seem to maintain undifferentiated conditions in absence of LIF, 
they do have activation of trophectoderm markers Tbpa, and Pi-1 after 10 days, 
informing of an aberrant gene expression (Kaji et al., 2006). 
Interestingly, Fgf5, which is normally activated in EBs after 3 days was also 
activated in Mbd3 EBs but failed to downregulate its expression after more than 
10 days in culture. Mbd3 ES cells differentiate efficiently and lose Oct4 
expression in presence of retinoic acid, giving evidence that differentiation is not 
fully blocked and Mbd3 is not required for survival of differentiated cells (Kaji et al., 
2006). 
Chimera analysis shows that Mbd3 ES cells can undergo some level of 
differentiation into primitive ectoderm and early mesoderm when placed in the 
appropriate signalling context. This differentiation is abnormal, and impedes the 
normal embryonic development of the host blastocyst, in a degree directly dependent 
on the level of Mbd3 contribution. Chimera analysis with Oct4-GFP labelled 
Mbd3(./): FI) ES cells shows continuous expression of Oct4 at 8.5 dpc, long after 
Oct4 should be switched off, reflecting that this defect is cell autonomous. These 
deficiencies could be restored upon addition of Mbd3b or partially restored upon 
addition of Mbd3a (Kaji et al., 2006). 
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These studies lead to an interesting question: What is the role of Mbd3 in 
neuroectoderm differentiation from ES cells? In contrast with embroid bodies, in the 
serum-free monolayer differentiation system the primitive endoderm and endoderm 
gene expression are absent, and therefore it makes an ideal system to investigate 
Mbd3 ES differentiation capacity in the absence of endodermal and mesodermal 
signalling. Additionally, I became interested to study the function of Mbd3 in cells 
independent of Oct4 signalling, and given the previous reports of a possible Mbd3 
function in the developing nervous system (Jung et al., 2003), I aimed to isolate 
Mbd3 neural stem cells to study their function. 
5.2 Neuroectodermal differentiation of Mbd3 null ES cells 
The parental cell lines 3171ox (Mbd3(3F10)  and 2Lox (Mbd3(210 ); the 3K0, 
Sp12 and Fix2 (Mbd3') ES cell lines and the A7 (Mbd3 X1)  (figure 5.1 .A)ES 
cell line (Mbd3c expressing ES cell line) were challenged to differentiate in 
monolayer cultures in serum-free medium. These cultures were fixed and 
immunostained at different time points for the plunpotency marker Oct4, neural stem 
cell marker Nestin, the postmitotic neuron marker TuJ 1, and the astrocytic marker 
Gfap. 
5.2.1 Neural and neuronal differentiation 
Very consistently during the 5 independent experiments performed, all three 
Mbd3 ES cell lines used presented a deficiency both in differentiation and in 
proliferation compared with wild type. These cells showed deficient differentiation 
into not only neurons but also Nestin positive neural stem cells. Both cell types were 
identified very rarely in the cultures after 10 days of differentiation in 12 well plates 
(figure 5.3). A7 cell line (Mbd3 displayed different behaviour, since there was 
no observable proliferation defect, but the cells showed a differentiation defect. The 
cultures have few colonies positive for neural precursor and neuron markers although 
more than in null cell lines. In general, A7 cultures present a high number of cells 
with a characteristic flat, geometrically shape and an apparent normal proliferation. 
This is consistent with previous studies in the lab, were there was no proliferation 
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Figure. 5.2 Serum-free monolayer differentiation time course from day 2 to day 8. 
Mbd3' cultures remain as tight round ES colonies during the 8 days, and the 
proliferation is reduced; Mbd3 (AF""') do not display a proliferation defect but do display 
a differentiation defect with characteristic flat geometrically shaped cells in the cultures. 
A) Cell lines: Mbd3j'°' Mbd3 and Mbd3 "'E"" B) Cell lines Mbd3'21°"' Mbd3 
Mbd3a Ibd3dI3b . 
To demonstrate that the above phenotype is caused by the lack of Mbd3, 
parallel experiments were performed with the two rescued cell lines previously 
described (5.1.1). Both rescued cell lines showed normal differentiation 
undistinguishable from wild type cultures (figure 5.3.B). The Mbd33a  cell line 
showed an overall better degree of differentiation (even more than wild type) (figure 
5.3.E, F). Although this observation can be merely due to intrinsic cell line 
differences, it could be also due to the presence of the Mbd3a isoform and absence of 
Mbd3b and Mbd3c isoforms. As mentioned before, in ES cells the more abundant 
Mbd3 isoform is Mbd3b, although Mbd3a and c can also be detected (Kaji et al., 
2006). Mbd3b is also reported to be more prevalent in the embryonic brain, although 
Mbd3a increases its expression during differentiation (Jung et al., 2003). 
Additionally, the Mbd3b-rescued lines express near normal levels of Mbd3b, while 
Mbd3a lines express approximately two-fold higher levels of rescuing protein. 
Taking all together, the higher degree of differentiation observed in the Mbd3a-
rescued cell line in monolayer differentiation conditions could be explained by 2 
independent possibilities. First, Mbd3a could be involved in maintenance and/or 
differentiation of neural precursors into post-mitotic neural cells in a higher level 
than Mbd3b. This possibility would be backed by the increased presence of Mbd3a 
in the mature brain. Secondly, the increased levels of Mbd3 in the Mbd3 a-rescued 
cell line could be responsible to push ES cell differentiation into neuroectoderm 
lineages to a higher degree than in wild type ES cells. This possibility will be 





5.4.2 Oct4 positive cells 
Mbd3 	ES cell lines differentiated for 10 days had a majority of Oct4 
expressing cells in the culture. (figure 5.4 and figure 5.5). Although Oct4 positive 
cells can be observed in wild type cell lines after ten days of differentiation, there are 
very few compared with the null cell lines, as it is shown in figure 5.5. Further, 
colonies entirely positive for Oct4 are often observed in Mbd3 null cell lines. This is 
also the case for the Mbd3 cell line, although still the phenotype is less severe 
than in the null cell lines. In general, Mbd3 null cells appear during the entire 
differentiation protocol as ES cell-like compact rounded colonies and they fail both 
to proliferate and to differentiate (figures 5.2.A, 5.3.C-D and 5.4). 
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Figure 5.4 A4bd3 	cells remain Oct4 positive after 10 days of 
differentiation conditions. lmmunocytochemistry on monolayer culture 
system after 10 days of differentiation conditions. Oct4 red, TuJ I green in 
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Figure 5.5 Mbd3 	and Mbd3 A1M3h rescued cell lines do 
differentiate in the same degree as foxed cell lines 3flox and 21-ox. Left 
panels: TuJI in green and Oct4 in red. Right panels: Dapi in blue. 
5.4.3 Astrocyte differentiation 
In order to obtain Gfap positive cells in the monolayer cultures, I replated 
seven day old monolayer cultures in Poly-D-Lysine and Laminin-coated 12 well 
plates. In general, with the serum-free monolayer system I have observed that the 
presence of Gfap positive cells is dependent upon time of differentiation requiring at 
least 15 days in culture. I have also observed that replating the cultures increases the 
proportion of Gfap positive cells. This is consistent with previous findings describing 
that in vitro cultures tend to mirror what happens in vivo in terms of timing in the 
appearance of neurons versus astrocytes differentiation (Fan et al., 2005; Qian et al., 
2000; Takizawa et al., 2001). Replating may benefit from the elimination of both non 
neuroectodermal differentiated and dead cells three dimensionally clustered in the 
monolayer; but most importantly from the enrichment of neural precursors that 
adhere in PDL coated surfaces (figure 5.6). 
Fetal calf serum contains Bmp4, which is a potent astrocytic induction signal 
(Gomes et al., 2003; Gross et al., 1996), therefore I studied whether addition of 
serum after the first days of neural induction in serum-free monolayer system would 
have an effect in astrocytic differentiation. I have found that addition of 10% serum 
in N21372 culture media after 6-7 days does not improve astrocytic differentiation 
nor neuronal differentiation in this culture system. On the other hand, I have detected 
that addition of serum improves cell survival (figure 5.8), which is a positive factor 
given the long term culture necessary to obtain astrocytes in this system. 
Neither Mbd3' ES cells, from two independent cell lines or Mbd3 ES 
cells differentiated into astrocytes in any of the conditions described above (figures 
5.6 and 5.7). These results suggest that Mbd3 is necessary for astrocytic 
differentiation, since no Mbd3' astrocytes can be generated from Mbd3"' ES cells. 
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Legend: GEAP is in green. NJ  
in red and DAPI in blue. 
Figure 5.6 Mbd3 	can not 
differentiate into astrocytes in 
N21327 differentiation 
conditions. Monolayer cultures 
replated after 7 days and 
cultured for additional 4 or 6 
days. A, B wild type cell lines 
1bd3(2t 	C, D 
.%ibd3 	cell lines. E, F Rescued 
cell lines, isoform Mbd3b (E). 
isoform Mbd3a (F). G, Mbd3 
Figure 5.7 Immunocytochemistry 
for Gfap (green), TuJI (red) and 
DAPI (blue) in replated 
monolayer cultures 6 days old in 
addition of serum. 
5.4.4 Long term cultures and apoptosis 
Although my experiments this far show that Mbd3 is important for 
neuroectoderm differentiation after 10 days, it remain possible that this effect is due 
to a delay in differentiation more than a block in dfferentiation. To address the 
question of whether Mbd3 cells show a delay in differentiation defect instead of a 
lack of differentiation, non replated long term cultures of 17 days were stained for 
TuJ1, Gfap and activated Caspase-3 which is a marker of apoptosis. Cleavaged or 
activated Caspase-3 belongs to the protease subfamily of caspases that execute the 
apoptotic response during programmed cell death (Boatright and Salvesen, 2003). 
The 11 components of this subfamily are present in neural precurors, neurons and 
glia, since apoptosis plays an important role in brain development. Activated 
Caspase-3 filters the pro-apoptotic signals from both the mitochondria (intrinsic 
pathway) and the membrane (extrinsic pathway) to catalyse the specific cleavage of 
key cellular proteins (Troy and Salvesen, 2002). 
My conclusion from these experiments is that Mbd3 	cells do not present a 
delay in differentiation because there was no improvement in the phenotype in longer 
cultures (figure 5.9). in general, long term cultures show better survival in addition 
of serum, but the differentiation capacity is compromised (figure 5.8). Hence, these 
experiments demonstrate that the absence of Mbd3 prevents ES cells from 
undergoing neuroectoderm differentiation regardless the time in culture. 
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Figure 5.8. lmmunocytochemistry for Caspase-3 (green), TuJI (red) and 
DAPI (blue) after monolayer differentiation for 17 days with two independent 
WT ES cell lines. Addition of serum improved cell viability but interferes 














Figure. 5.9 Mhd3 	cells do not shov delayed neural differentiation. 
Immunocytochemistry on monolayer cultures after 17 days of differentiation 
conditions. TuJI red, Gfap green and DAPI blue. This assay confirms that 
addition of serum does not improve astrocytic differentiation but rather 
decrease differentiation capability. 
5.4.5 Time points monolayer differentiation RT-PCR 
To investigate the expression of genes known to be important in neural stem 
cell fate decisions, RNA was extracted from five time points of monolayer 
differentiation from day 0 to day 12 from the seven different cell lines, and 
subsequently RT-PCR was performed for the stem cell markers Sat], Sox2, Sox3, 
Pax6 and Blbp. In parallel, the expression of Oct4, TuJJ and Gfap was assayed. As 
can be observed in figure 5. 10, AIbd3 cell lines show a complete lack of detectable 
expression for neural stem cell markers from day 2 to day 8. On the other hand, the 
exon one deleted cell line does express the studied neural stem cell markers although 
not as high as the wild type cultures. In contrast, the Mbd3Mb(!31  rescued cell line 
has recovered the expression of the studied genes in a parallel pattern to the wild 
type cell line. These experiments suggest that Mbd3 is involved in the differentiation 
from ES cells into neuroectoderm lineages, such that Mbd3 cells fail to express 
genes that are key of neural stem cell differentiation, at least at detectable levels by 
RT-PCR (figure 5.10). 
In summary, although there are usually differences among the cell lines in 
terms of degree of differentiation capacity, there is always consistency among the 
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Figure 5.10 Mb13' -) cells do not express NSC markers in differentiation conditions. Ri'-PCR panel with neural stem 
adult brain markers gene expression from ES cells to D12 of monolayer differentiation NS= NS cells. Br  
5.5 PA-6 co-culture differentiation system. 
My previous studies demonstrated that Mbd3 is necessary for the transition 
from UclA-positive ES cells to differentiated neuroectoderm. Very few Nestin 
positive neural precursor cells and neurons and no astrocytes can be observed when 
Mbd3 ES are challenged to differentiate in vitro. These results generate a 
subsequent question: Can Mbd3 differentiated cells survive, or do Mbd3 ES 
cells fail to transit to a differentiated cell fate? 
To address this question, the PA-6 co-culture differentiation system was used 
(Kawasaki et al., 2000). In this system, differentiation of ES cells proceeds in 
adherent co-cultures of ES cells with PA-6 stromal cells in serum free media. The 
main difference of this system is the decreased cell death compared with the 
monolayer differentiation system. Therefore, I could investigate whether Mbd3 
cells die during the differentiation process by studying the apoptotic behaviour of 
Mbd3 cells in comparison with wild type ES cells. This protocol consists of 
plating a low number of ES cells in a layer of PA-6 cells in serum-free media 
containing knock out serum replacement KSR, known as 'differentiation medium' 
for a period of 7 days, followed by another 7 days in N2B27 medium containing 
ascorbic acid described as 'induction medium'. 
PA-6 cells are derived from skull bone marrow and produce an inducing 
signal called stromal cell-derived inducing activity or SDIA (Kawasaki et al., 2000). 
Although other stromal cells promote neural differentiation when used as feeders, 
PA-6 cells have been found to produce higher induction. The SDIA effect remains 
through a filter (though results in weaker induction), does not condition the media 
and is not destroyed by fixation of stromal cells (Kawasaki et al., 2000). Therefore 
SDIA could be mediated by secreted factors that would anchor to the cell surface. 
The experiment was designed to screen the presence of apoptosis at 
correlated time points during the process of PA-6 co-culture differentiation by 
immunocytochemistry for activated caspase-3. The time points selected were day 0, 
day 4, day 8, day 12 and day 16. It was observed in these experiments that cells 
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Figure 5.11 Mbd3do not die by apoptosis upon differentiation conditions. 
Immunocytochemistry analysis after 4 time points in PA-6 co-culture 
differentiation system. Caspase-3 green, TuJ I red. DAPI blue. 
In summary, the previous experiments demonstrate that Mbd3 ES cells 
induced to undergo neural induction neither show a delay in differentiation nor die 
during the process. Rather, Mbd3 ES cells maintain their undifferentiated Oct4 
positive state without expression of neural genes throughout the time in culture. In 
conclusion, these data suggest that Mbd3 is necessary to switch off pluripotency 
markers to transit ES cell to differentiated cell state. 
5.6 Study of Soxi overexpression in Mbd3 overexpressing cell lines 
I have previously demonstrated that the lack of Mbd3 impairs ES cells to 
differentiate into neuronal lineages. A following question is whether overexpression 
of Mbd3 would lead to the opposite effect increasing the degree of differentiation in 
ES cells. During neuroectoderm differentiation experiments from ES cells I observed 
that the 	 rescued cell line achieved a higher degree of neuronal 
differentiation than wild type or Mbd3Mh7(i3I  rescued cell lines. Mbd3 	'id3ci ES 
cells overexpress Mbd3 approximately two-fold (K.Kaji personal communication). 
Further, I also observed that Mbd31,13a  ES were marked by Soxi expression by 
RT-PCR (figure 5.10). Sox! is a marker of neural precursors and is not observable in 
ES cells by RT-PCR in normal conditions. Soxl overexpression has been shown to 
direct neuroectodermal differentiation in ES cells (Zhao et al., 2004). Given these 
previous observations, I decided to investigate whether an overexpression of Mbd3, 
which presumably leads to Soxi overexpression, could cause an increased and/or 
premature neural differentiation. 
-  
Overexpressing ES cell lines 46C Mbd3a  and 46C 	-Mbdih  were created by inserting 
Mbd3a and Mbd3b expression construct respectively into Sox]-GFP knock-in ES 
cells (46C). Additionally, a mock construct with only puromycin selection was 
inserted in 46C ES cells as a control (46C' °"). Colonies from these transfections 
were obtained at normal rates and the clones selected had no obvious abnormalities. 
However, RT-PCR experiments revealed no overexpression of Sox  (figure 5.12). 
To study whether Mbd3 overexpression could lead to premature and/or increased 
neuronal differentiation, two Mbd3a and two mock transfected 46C ES clones were 
selected to undergo neuroectoderm differentiation by serum-free monolayer system. 
The degree of differentiation was monitored from day 0 to day 10, and no obvious 
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neuronal differentiation was found in 46CMM31  ES cell lines compared witth wild 
type (figure 5.12). To study a possible premature neural differentiation, 3 day and 4 
day cultures were immunostained to check the expression of Nestin to quantify 
neural precursor differentiation. I observed same degree of Nestin positive staining 
in ,mock and wild type cultures (figure 5.13). 
From these experiments I can conclude that the overexpression of Mbd3 in ES 
cells does not lead to precocious or increased neural differentiation. 
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Figure 5.12 A) Mbd3 overexpressing ES cells were differentiated and immunostained for 
Nestin at day 3 and 4 of monolayer differentiation. B) RT-PCR reveal no overexpression of 
Soxi in 46C ES cell lines overexpressing Mbd3a or Mbd3b compared with mock 46C 
lines. The highest Sox I expression corresponds to Mhd3 	ES cells after 8 days in 
serum-free monolayer differentiation conditions. From left to right: Mhd3(3 /'b0 	ES cells, 
Mbd3- -tlhd3a  Mbd3a overexpressing ES cells, 46C ES cells, 46C Mbd3a overexpressing 
ES cells, 46C Mbd3b overexpressing ES cells, 46C Mock ES cells, D8 monolayer 
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Figure 5.13 Monolayer differentiation at D8 and D 1 live cultures shows 
no precocious or increased neuronal differentiation in overexpressing 
46CM 3 a cell line, in comparison with both its parental line 46C and Mock 
cell line. 
5.7 Study of neural stem cells lacking Mbd3 
5.7.1 Mbd3 NS from Mbd3 -'I-1 ES 
I observed a differentiation defect of Mbd3 ES cells into neural precursors and 
terminally differentiated neural cells. These observations raise the question of 
whether this deficiency is due to a defect in ES-specific signalling pathways, or 
whether Mbd3 is involved in other stages of differentiation. To answer that question, 
I aimed to obtain a pure population of Mbd3' neural stem cell lines (NS cells). 
A first attempt to derive Mbd3 NS cells from Mbd3 ES cells was 
unsuccessful. This result was expected since the number of neural progenitors in the 
first step of neuroectoderm differentiation in monolayer is dramatically reduced in 
Mbd3 cultures. This was the case both for Mbd3' and Mbd3' ES cells, 
although the later formed neurosphere-like colonies that failed to produce NS cells. 
These experiments may indicate that Mbd3 is necessary for the ES-NS cell 
transition. 
5.7.2 Mbd3° iiI ) NS Crc-deletion 
Subsequently, a variety of strategies were tested to obtain Mbd3 NS cell lines. 
In first place, Mbd3 foxed NS cells (Mbd3 (3FIox/-))  which have two loxP sites 
flanking the entire Mbd3 gene, were electroporated with CAG-CRE-IP. This 
construct contains a CAG promoter that drives the expression of the Cre 
reco,nbinase and puromycin-N-acetyltrans[erase (pac) genes simultaneously due to 
the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) 
(Mountford et al., 1994). The CAG promoter, which includes chicken 3-actin 
promoter and a CMV immediate-early enhancer element (Niwa et al., 1991), drives 
robust transgene expression in ES cells (Niwa et al., 2000; Chambers et al., 2003). 
Additionally, the plasmid CAG-IP was electroporated in a control set of cells 
(mock experiment). I also co-transfected 1/10 amount of a CAG-GFP-IP construct, 
as an early marker for transfected cells. With this strategy, GFP positive NS cells 
were sorted out and replated at clonal density. However, no NS colonies could be 
obtained by this strategy in comparison with the mock transfected group where 
colonies were recovered at expected frequencies. 
IM 
These results could be due to three reasons; first, Mbd3 NS cells may not be 
viable, and as soon as Mbd3 is not present in the cell, NS cells die. Second, Mbd3 
NS cells may survive but can not proliferate and divide symmetrically in NS 
daughter cells to give rise a colony. Third, Mbd3 NS may be viable and can 
proliferate but the efficiency of Cre transfection is so low that colonies cannot be 
detected. 
5.73 Mbd3 NS from 1Ibd3 °' Cre-ER T2 ES 
To determine whether Mbd3 	NS cells are viable, a second strategy was 
designed to obtain Mbd30  NS cells where Mbd3 could be deleted at a determined 
time point. This strategy consisted in making conditional knock out Mbd3 ES cells 
using the tamoxifen inducible form of the Cre recombinase, Cre-ER T2, where the Cre 
recombinase is fused with the ligand binding domain of the estrogen receptor (ER) 
(Metzger et al., 1995). A mutation in the binding site of the receptor prevents the 
binding of cell endogenous estradiol, and is only activated by synthetic ligand 4-
h1droxytarnoxifen (OHT or tamoxifen) (Fell et al., 1996; Fell et al., 1997). This 
strategy would allow discerning in which different steps from ES cell to 
differentiated cell Mbd3 is necessary. 
Mbd301 ES were stably transfected with the vector CAG-Cre-ER T2-IP and 
CREERT2 -ES clones were selected based on a correct response to tamoxifen. This 
selection screened those clones where Mbd3 was not detected by genotyping PCR in 
addition of tamoxifen. However, PCR experiments denoted that some clones already 
contained cells where Mbd3 had been deleted in absence of tamoxifen. This effect 
may be caused by the strong CAG promoter of the construct that would start the 
synthesis of Cre in the absence of tamoxifen. Nevertheless, I decided that it would be 
worth while to continue with the derivation of the NS cell lines (from the clones with 
less "leaking"), since my previous data showed that Mbd3 ES cells are unable to 
differentiate into NS cells and so, those undifferentiated cells would be eliminated by 
the differentiation conditions. 
Subsequently, four different clones of Mbd3'° CRE-ERT2 ES cells were 
chosen to derive NS cell lines (A8, C4, Fl and F4), and once obtained, Mbd30 
CRE-ERT2 NS cells were further characterised. To ensure that the tamoxifen 
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concentration necessary for the experiment is not toxic for the NS cells, I tritated the 
tamoxifen concentration that NS cells can tolerate and found that wild type cells can 
be maintained in double the working tamoxifen concentration without any 
observable effect. During derivation of NS cell lines, the cultures consist of a mixed 
population of cells, yet they become progressively more homogenous with the 
passages in the presence of EGF, bFGF and NS-A media. Hence, although, 
Mbd30 CRE-ER ' 2 NS cultures were expressing neural stem cell markers (Rc2, 
Nestin and Vimentin) (figure 5.14.2A-2E) in this non-pure first step, they had 
different morphology than Mbd3 NS cultures (figure 5.14. 1A-1E), and other 
non NS cell types were found in the cultures. Mbd3 deletion on addition of 
tamoxifen was confirmed by PCR genotyping. However, as in the case of the ES 
cells, a percentage of NS cells were already Mbd3 null even without addition of 
tamoxifen (figure 5.14.3). 
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Figure 5.14. 1&2.Both Mbd3 3"° and Mbd3'3flbCREERT 2  cell lines express 
neural stem cell markers after 3 passages from ES derivation. Panel I. 
A1bd3 11'. Panel 2. Mbd3(tb0CREERT 2 . A,Vimentin. B, RC2 and C, Nestin. 
D. E. F. bright field. Panel 3. Genotyping PCR, from left to right wild type NS 
cells. !vfbd3 3 t1 foxed clones A8, C4, Fl and F4, Cre plasmid, Mbd3 ES 
cells and negative control (water sample) with and without tamoxifen. From up 
to down, set of primers to amplify Cre, foxed allele (Flox) and null allele. 
Mbd31can be detected in absence of tamoxifen. 
Mbd3 311° CREERT2 clone A8 
Mbd3(3fb0x1') A8 
in iv-. 	- 
-I'. 
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Figure 5.15 Mbd3 311 ' CRE-ERT2 stop proliferation and loses neural 
stem cell marker expression after 8 passages. Panel 1. Mbd3(1lt  - Panel 2. 
Mbd3 311" CREERT2 clone A8. A: Vimentin, B: Rc2 and C: Nestin. D, E 
F, bright field. 
During subsequent passages the control wild type NS cell line was forming a 
uniform looking culture, consisting of a pure population of NS cells. In contrast the 
four CRE-ERT2 NS lines were losing their ability to proliferate and self renew until it 
was not possible to maintain the lines. Concordantly, these lines stopped expressing 
neural stem cell markers. This effect was observable both in the presence or absence 
of tamoxifen, although those not treated with tamoxifen showed a slightly higher 
proliferation rate (figure 5.15). 
To study the effect of lack of Mbd3 in differentiated cells, Mbd3 lHoO  Cre-
ERT2 NS lines were differentiated into astrocytes in the presence of serum and 
absence of growth factors. In these experiments 1 could observe that, although there 
were some Gfap positive astrocytes in the cultures (figure 5.17), they were dying by 
apoptosis within 6 days, in contrast with control experiments with Mbd3'°' Mock 
NS lines (figure 5.16). This effect was observable both in the presence and absence 
of tamoxifen, and it cannot be definitely concluded that Mbd3 is necessary for the 
maintenance of healthy astrocytes, because without tamoxifen, not all of the 


















Figure 5.16 Upper panel. Day] upon astrocytic differentiation conditions. 
Serum and growth factors withdrawal. Lower panel, Day6 upon astrocytic 
differentiation conditions. In contrast with Mbd3'flx -. Mbd3l10 'C RE-
ERT2 undergoes apoptosis after 5 days. 
Mbd3 3 ° 
Mbd3(3fb )CRE..ERT2 
cloneA8 
Mbd3(3r10x/- )C REERT2 
clorteC4 
Figure 5.17 lmmunocytochemistry of differentiated astrocytes from 
Mbd3" CRE-ER12  cell lines in comparison with wild type. The frequency 
of astrocyte differentiation is dramatically lower, which correlates with a 
slower proliferation, loss of neural stem cell markers, and apoptotic process as 
seen in fig 5.17. Upper panel, immunostained for Gfap in green and Rc2 in 
red. Lower panel stained for Vimentin. The results are independent of 
tamoxifen addition. First and third row, Tamoxifen added. Second and fourth 
row, no tamoxifen added. 
Given that the CreERT2  system could not give a conclusive answer to 
whether Mbd3 is necessary for NS cell formation, a third strategy was designed. The 
drawback of transfection by electroporation in NS cells is the low cell viability after 
electroporation, thus I felt necessary to test whether the absence of Mbd3 NS 
colonies after transfection was due to the inability for NS cells to survive in the 
absence of Mbd3 or to the combination of very low transfection efficiency and very 
low cell survival after electroporation. To test this hypothesis the nucleofection 
system was used instead. This system allows much higher cell viability after 
transfection and happens very rapidly because it delivers the DNA directly into the 
nucleus. The biggest benefit is, however the higher efficiency of transfection of 70% 
compared with 20% by electroporation. 
Mbd3° NS cells were nucleofected with the CAG-Cre-IP and CAG-IP( 
as control) constructs. The transfected cells were separated in two groups, one was 
cultured in the presence of puromycin, and in another group Gfp positive cells were 
FACS sorted. These experiments were done in duplicate. In the first experiment drug 
selection was maintained for 5 days and in the second experiment drug selection was 
maintained for 3 days. Surprisingly, colonies were recovered in both groups, 
although in a much lower frequency than same cells electroporated with a Mock 
plasmid GFP-IP (table 5.1) 
CAG-CRE-IP 
PURO FACS sorted 
Expi CRE 5.6% 22.29% 
Exp2 CRE 17.53% 17.32% 
Table 5.1 Percentage of recovered colonies after deletion of Mbd3 by Cre 
recombination of Mbd30 NS cells in two independent experiments. In 
experiment 1 puromycin selection was maintained for 5 days, while in experiment 2 
puromycin selection was maintained for 3 days. 
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All the surviving colonies were picked, expanded and genotyped. The 
approximate frequency of Mbd3 colonies by genotyping PCR was 23%, and from 
them 5 were expanded and stocked (figure 5.18.A). Thus, Mbd3 is not required for 
NS cell viability. 
5.7.4 Mbd3 NS astrocytic differentiation 
Two Mbd3" NS cell lines were selected for astrocytic differentiation. Mbd3 
NS cells, in the presence of serum and absence of EUF and bFGF, did differentiate 
into morphologically normal astrocytes. Immunocytochemistry confirmed that 100% 
of the cells were Gfap positive. Hence, astrocytes can be maintained in the absence 
of Mbd3 (figure 5.18.13) 
In addition, I wanted to study whether deletion of Mbd3 would affect astrocytic 
viability. To determine this, Mbd3"° were plated in astrocyte differentiation 
conditions for 7-10 days, and subsequently were harvested and co-transfected by 
nucleofection with Cre expression and Gfp constructs previously described. The 
survival after replating of differentiated astrocytes was proven to be very low 
independently of transfection, since non-transfected replated astrocytic cultures show 
similar recovery to transfected cultures. The efficiency of transfection, estimated by 
the number of Gfp positive cells, was as well very low, and there was no evidence 
for proliferation. Genotyping PCR showed no Mbd3' in the cultures. It is possible 
that in order the gene to be deleted in the nucleus the cell need to be in a proliferative 
state (figure 5.19.A). 
In a independent experiment, Mbd3'°" NS were transfected with Cre 
expression construct and consequently exposed to serum to promote astrocytic 
differentiation at different time points. In addition, a set of clones were cultured with 
puromycin selection and other set without purornycin selection. Subsequently, these 
clones were genotyped by PCR. From these experiments I can conclude that Mbd3 
Gfap positive astrocytes can be maintained in vitro (figure 5.19.13). 
In summary my experiments demonstrate by two independent strategies that 








Figure 5.18. Mbd3 -) colonies can be expanded, and Mbd3 and 
undergo astrocytic differentiation, A) bright field Wild type versus 
MbdY -) colony. B) NS-derived astrocytes immunocytochemistry, 
Wild type astrocytes in top left, MbdY -) astrocytes derived from 
Mbd3 NS clone creplB2 in top right and clone crepiCi in the 
bottom. GFAP in green, Rc2 in red, Dapi in blue. 
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Figure 5.19 
Mbd30 -) NS-derived astrocytes 10 days old are transfected with Cre or 
Mock plasmid. The efficiency of transfection is low. Below, genotyping PCR 
to amplify wild type allele (WT) and null allele (Null) for 40 cycles reveals 
no deletion of Mbd3. Samples from left to right: Mbd3 1" NS-derived 
astrocytes transfected with Cre plasmid (Cre), with Mock plasmid (Mock), 
Mbd3( - -, ES as positive control, and negative control (-ye). 
NS cells were transfected and subsequently serum was added after 24 
hours. Immunoctychemistry reveals Gfap/Gfp coexpression (Gfap is in red 
and Gfp in green). Below, genotyping PCR reveals Cre deletion of Mbd3 in 
NS derived astrocytes. From left to right NS-derived astrocytes in the 
following conditions: Crc transfected (Cre), Cre transfected with puromycin 
selection (Cre Puro), Mock transfected (Mock), Mock transfected with 
puromycin selection (Mock Puro), Cre transfected (Cre), Mock transfected 
(Mock), wild type, Mbd3 -) ES as negative control (Null), and water sample 
as negative control (-ye). 
5.8 Summary 
Mbd3 ES cells show neuroectodermal differentiation impairment. Mbd3 
ES cell neuronal differentiation efficiency is extremely low and they cannot 
differentiate into astrocytes in two different systems tested: serum free monolayer 
differentiation and PA-6 co-culture. Mbd3 cells do not die during differentiation 
since the number of caspase-3 positive cells is not higher, rather is lower, than wild 
type cells. Mbd3 cells can remain as undifferentiated ES cells positive for Oct-4 
in the absence of LIF and serum for minimum of two weeks, and neural stem cell 
markers cannot be detected by RT-PCR. Overall, these experiments demonstrate that 
Mbd3 is necessary for ES cells to transit from Oct4 positive pluripotent cell to neural 
cell. 
The efficiency of colony formation in conditionally deleted Mbd3 NS cells 
is much lower than the control. However, Mbd3 NS cells can be obtained, and can 
differentiate into Gfap positive astrocytes. Hence, Mbd3 is not essential for NS cell 
and astrocyte survival. 
5.9 Discussion 
5.9.1 Why only neurons? 
Why are Mbd3 ES cells able to differentiate into post-mitotic neurons and 
not other cell types that could be marked by Gata4 or Gfap in the monolayer 
differentiation system? Is it because cells have an intrinsic neuronal differentiation 
default mechanism (Tropepe et al., 1999) and therefore, even in impaired 
differentiation conditions such as the lack of Mbd3 is still possible for the cell to 
become a neuron? Although Nestin is a marker for all neural precursors and there are 
TuJ1 positive cells, there is a negligible proportion of Nestin positive cells in the 
cultures. Is this transition specifically faster in the absence of Mbd3 so that Nestin 
positive cells are rarely detected? 
5.8.2 Terminally differentiated astrocytes? 
Interestingly, although Mbd3 ES cells did not differentiate into astrocytes, 
Mbd3" NS cells could, apparently healthily and efficiently. Is this because once the 
178 
null NS cell is developmentally beyond the Mbd3-dependent signal that prevents 
differentiation and maintains its pluripotency can function normally? This is unlikely 
to be the case given the extreme difficulties and low efficiency of Mbd3 NS cell 
derivation. On the other hand NS cells can differentiate into Gfap positive cells in 
less than 8 hours in the presence of Bmp4, and surprisingly, they can regain neural 
stem cell characteristics with Bmp4 withdrawal and bFGF/EGF signalling (S. 
Pollard, personal communication). Hence, it is possible that Gfap positive NS 
derived cells are quiescent progenitor cells and not fully differentiated post-mitotic 
astrocytes. Although Gfap is the key astrocytic marker in the field, it is increasingly 
clear that Gfap "positiveness" is not synonymous with terminal differentiated post-
mitotic cell. Mouse post natal and adult radial glia, and human and primate radial 
glia are GFAP positive regardless of neurogenic capability (Choi and Lapham, 1978; 
Levitt and Rakic, 1980) (Malatesta et al., 2000). There are as well several reports 
where astrocytes have neurogenic potential (Casper and McCarthy, 2006; Garcia et 
al., 2004; Sanai et al., 2004). Therefore, I suggest that Gfap should be considered 
more as stem cell marker than as post-mitotic fully differentiated marker. 
In conclusion, it may be possible that Gfap positive Mbd3 cells obtained 
after growth factor withdrawal and addition of serum are quiescent progenitor cells 
and not terminally differentiated Mbd3 astrocytes. If this would be the case, the 
question of whether astrocytes can survive without Mbd3 would remain to be 
answered. 
5.8.3 Aberrant TuJ1 expression 
In Mbd3 monolayer cultures, there are cells stained with the antibody TuJ1, 
and though the signal is not high, it is above the background. TuJl is a monoclonal 
antibody that reacts with c-terminal class III f3 tubulin, which is the earlier marker of 
neuronal differentiation after or during cell division (Lee et al., 1990b). There is 
evidence of TuJ 1 positive cells in sertoli cells of the testis (Lewis and Cowan, 1988), 
transiently in non neuronal embryonic tissues (Lee et al., 1990a) and in some types 
of tumorigenic cells (squamous cell carcinomas, lymphomas and melanomas) (Scott 
et al., 1990). Perhaps, the immunoreactivity of Mbd3 ES cells to TuJ1 in 
differentiation conditions could be associated with its differentiation into another 
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type of embryonic tissue or its differentiation deficiency, which could lead to 
aberrant cell types TuJ1 positive. 
5.8.4 Further directions 
A key cell model to understand the function of Mbd3 in a non pluripotent cell 
is the use of NS cell technology. As explained in this chapter, to obtain Mbd3 NS 
cells is extremely difficult. However, I have demonstrated that Mbd3 NS cells can 
survive and can undergo apparent astrocytic differentiation. It will be very interesting 
to characterise these cells further and analyse their proliferation, self-renewal and 
differentiation into neuronal lineages. 
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CHAPTER 6 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
6.1 DNA methylation, MeCPs and history 
Great discoveries in the field of DNA methylation have been achieved during 
the last few years. These frantic advances have lead to an evolution in the 
comprehension of the function of the methyl-CpG binding proteins. Biochemical 
analysis demonstrated the existence of four methyl-CpG binding proteins to 
interprete the DNA methylation signal (Cross et al., 1997; Hendrich et al., 1998). 
The MeCPs can induce transcriptional repression by the recruitment of chromatin 
remodelling complexes to the methylated DNA. The repression machinery partners 
for each MeCP have already been revealed (Jones et al., 1998; Nan et al., 1998; Ng 
et al., 1999; Sarraf and Stancheva, 2004; Wade et al., 1999; Yoon et al., 2003b). 
Several years ago, researchers in the field were expecting global gene 
expression changes in the MeCP2 null animal models (Nan et al., 1997;(Willard and 
Hendrich, 1999). Given that MeCP2 was shown to require only a single methylated 
CpG base pair to bind, it was predicted that this protein would act as a global 
transcriptional repressor, and its absence would cause transcriptional noise (Nan et 
al., 1997). This binding capability is also shared by Mbdl and Mbd2 (Cross et al., 
1997, Hendrich et al., 1998). Later, and progressively, it was understood how 
MeCP2 was most likely involved in silencing of individual targets- (Chen et al., 2003; 
Martinowich et al., 2003). Recently, K!ose and colleages discovered that MECP2 
needs an AlT run in its binding site. This finding opens a new view for MeCP2 and 
its relation with the rest of the MeCPs. In the first place this specificity will allow to 
quickly find new targets for MeCP2, which before was believed to only need a single 
methylated mCpG (Kiose et a! 2006). Although MeCP2 can not occupy Mbd2 
binding sites, Mbd2 can bind MeCP2 binding sites, thus Mbd2 could fit in the role of 
global transcriptional repressor. However, Mbd2 null mice have proven this not to be 
the case (Hendrich et al, 2001). In contrast, specific target genes have been revealed 
to be regulated by Mbd2 (Hutchins et al., 2002; (Auriol et al., 2005). Mbdl can bind 
specifically with its zinc finger domain to unmethylated CpGs as well as mCpGs 
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with its MBD (Jorgensen et al., 2001). Mbdl was found to bind the human FGF2 
CpG island promoter via its CxxC zinc finger domain (Ueba et al., 1999), although 
further studies have ruled out FGF2 as a target gene of Mbdl (Jorgensen et al., 
2001). The Kaiso binding site has two consecutive mCpG pairs and consequently, 
several candidate target genes have been proposed . However, Kaiso null mice have 
recently been shown to have no misregulation of these candidate genes 
(Prokhortchouk et al., 2006). 
6.2 MeCP- redundancy or tailor-made MeCPs? 
It has been widely hypothesised a possible functional redundancy between 
the MeCPs, as a clever mechanism to ensure silencing of methylated genes. The 
hypothesis was driven to answer two obvious questions: why does the vertebrate 
genome encode four methyl-CpG binding proteins, and why does the disruption of 
Mbdl, Mbd2 or Kaiso cause mild phenotypes in mouse models (Zhao et al, 2003; 
Hendrich et al., 2001; Prokhortchouk et al., 2006)? In concordance with this 
hypothesis, studies carried out in our lab demonstrated how the mice survival to the 
RTT-like disease was directly regulated with the number of MeCPs that they still had 
left. 
In disagreement with this hypothesis, and as discussed above, Mecp2 can not 
bind Mbd2 sites, and the knock down of Mbd2 does not cause binding to Mbd2 sites 
by MeCP2 or Mbdl (Ariol et al., 2005). It is possible that each MeCP targets 
repression to currently unkown individual target genes but as part of several other 
layers of transcriptional repression machinery to ensure correct silencing. 
Surprisingly, this year was demonstrated the existence of another two methyl-
CpG binding proteins, closely related with Kaiso and enlarging the family (Filion et 
al., 2006). What is more, this study opens the door to the possibility of many other 
unknown methyl-CpG binding proteins! 
6.3 MeCPs and the central nervous system 
Irrespective of whether there is functional redundancy between the 6 MeCPs 
or they play very specific silencing roles, what is still clear is that MeCPs have an 
important role in the central nervous system. This is where they are primarly 
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expressed, and the absence of MeCP2, Mbdl or Mbd2 causes cognition-related 
dysfunctions. In addition to Rett Syndrome, there is a number of other neurological 
diseases caused by epigenetic dysfunction in which defects in synaptic circuits and 
neuronal maturation are involved (Zoghbi et al., 2003; Martin and Sun, 2004) . This 
demonstrates the consequences of the aberrant activation or silencing of 
epigenetically regulated genes that are crucial for neuronal function. 
In this thesis I have investigated the hypothesis of whether MeCPs Mbd2, 
MeCP2 and Kaiso control neural stem cell decisions and whether this process occurs 
in a functionally redundant manner. This hypothesis was driven by the observations 
that MeCP2 control neural stem cell neurogenesis in Xenopus laevis (Stancheva et 
al., 2003), that Mbdl is involved adult neural stem cell neurogenesis (Zhao et al., 
2003) and that the Kaiso-containing NCoR complex is necessary to maintain 
undifferentiated neural stem cells (Jepsen et al., 2000, Hermanson et al., 2003). 
My studies reveal that MeCPs are not necessary for neural stem cell function. 
This conclusion is driven by studies both from individual MeCPs as well as a triple 
knock out of the MeCP2, Mbd2 and Kaiso genes. This conclusion agrees with 
parallel findings in the study of MeCP2 function in neurospheres where MeCP2 is 
found innocent of 'neural stem cell-ness matters' in mouse (Kishi and Macklis, 
2004). In concordance with the lack of a role for Kaiso in neural stem cells, Kaiso 
has not been found to be a component of NCoR in mouse cells (Prokhortchouk, 
personal communication). 
On the other hand, I found that MeCPs may be important in neuronal 
differentiation and maturation, following the train of recent discoveries in the field 
that appoint the most extensively studied MeCP, MeCP2 as an important player in 
neuronal maturation. Hence, although there may not be functional redundancy 
because the proteins have specific targets, it is possible that the maturation reflects 
several deficits accumulated within the cell to differentiate into neuronal fate. It will 
be very interesting to discern this question by studying the neuronal differentiation in 
MeCP2 and Mbd2 single null NS lines. 
Once determined in vitro which protein or proteins are involved in neuronal 
maturation, it would be worth while to undertake detailed in vivo behavioural tests 
and learning and memory assays in mice to study whether the absence of MeCPs do 
183 
cause disruption of the complex neurocircuitry of the brain, in addition to what is 
already known for MeCP2-null mice. 
6.4 Mbd3 rules pluripotency. What about multipotency? 
In contrast with these findings, the only MBD protein that does not bind 
methylated DNA has been revealed in this study and in combination with the work 
of Dr. Hendrich and Dr. Kaji in the lab, indispensable for cell fate determination in 
embryonic stem cells. Mbd3 is the scaffold protein that brings together the NuRD 
corepressor complex. Although Mbd3-deficient ES cells present a severe defect in 
the differentiation into post-mitotic neurons, this differentiation pathway is not 
completely blocked and may correspond with a derepression of genes involved in 
this pathway by NuRD complex. Hence, the isolation of neural stem cell state in the 
absence of Mbd3 was proven to be possible, although inefficient. Since Mbd3 
NS cells have been generated, it would be very interesting to use them as a base for 
microarray experiments comparing wild type and null NS cells to search for possible 
gene upregulations in Mbd3 NS cells that could aid the finding of candidate genes 
involved in neural stem cell function. 
The next question to ask is whether Mbd3/NuRD regulates gene 
signalling involved in neural specification and/or neural self-renewal. Is Mbd3 only 
involved in early cell fate decisions so that the consequences are driven into blocking 
all types of tissue specification or is Mbd3 involved in most cell fate decisions? In 
agreement with this last hypothesis, Mbd3 is ubiquitously expressed throught the 
organism and MTA-3, a cell-specific subunit of NuRD is involved in B cell fate 
determination (Fujita et al., 2005). It would be very interesting to compare these 
results with the microarray studies performed previously in the lab between wild type 
and null ES cells and study whether there would be many or few overlapping 
upregulated candidate genes (figure 6.1) 
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Figure 6.1 Diagram of hypothetical NuRD target genes. Mbd3-containing 
NuRD corepressor complex has been shown to be necessary for ES cell 
differentiation (Kaji et al., 2006). The next question to be resolved is whether 
NuRD plays a role in multipotency decisions. In the neural stem cell system, 
NuRD may mediate transcriptional silencing of genes involved in neural stem 
cell fate decisions. A and B represent hypothetical NuRD target genes and C 
represent a target gene of B gene. 
6.5 Mbd3 and the central nervous system 
Evidence accumulated over the past three years suggests a specific role for 
Mbd3 in neurogenesis ((Fan and Hutnick, 2005; Jung et al., 2003) and this thesis). 
Since the absence of Mbd3 results in such dramatic consequences from very early 
development, it it has not been possible to study the role of Mbd3 in the brain. It is 
demanding to develop conditional Mbd3 animal models to allow the study of the 
role of Mbd3 in vivo at different times of brain development and adult brain. It will 
be very interesting to study Nestin-Cre/Mbd3'° animal models where Mbd3 will 
be deleted by Cre recombination once neural precursors start to be formed in the 
developing brain (E9-E10 dpc) (Bates et al., 1999; Trumpp et al., 1999), as well as 
aCamKII-CreIMbd3'31°  mouse models where the deletion of Mbd3 occurs only in 
cells expressing aCamKII, which is a postmitotic specific kinase (Tsien et al., 1996). 
These animal models are in preparation in the lab. Further information would be 
retrieved by the generation of Cre-ER T2/Mbd3 3° mice, to study selectively at a 
variety of time points through the development the consequences of Mbd3 deletion 
in the central nervous system. 
Through the neuroectoderm differentiation model system used in my studies I 
found that in parallel with the Mbd3 ES differentiation deficiency, ES cells 
expressing Mbd3c isoform, Mbd3' had impaired differentiation although less 
severe. Therefore, it would be very interesting to study the consequences of the 
exclusive presence of Mbd3c in mice, to determine the extent to which it can rescue 
the Mbd3-null phenotype. 
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